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I’m grateful to the members of the jury who have taken the time to evaluate 
this manuscript. Prof. P. Joris, Prof. A. Snik, Prof. P. Van de Heyning and Prof. A. 
van Wieringen. Two more jury members have played a crucial role in my 
surgical training, being very important for the preparation of this PhD project: 
Prof. T. Lenarz and Prof. E. Truy, thank you both for your devoted teaching and 
for sharing your wisdom when I was at your institutions. I thank all jury 
members for their valuable comments and for the ongoing professional 
collaboration. Your presence in Leuven today is greatly appreciated.  
Prof. Mark Jorissen, als diensthoofd en collega, wil ik u bedanken voor de 
continue ondersteuning. U gaf me carte blanche voor dit project. Uw woorden 
bij aanvang “het zal veel weekend-werk worden” waren inderdaad niet gelogen. 
Uw belangrijke steun bij het begin van mijn carrière waardeer ik ten zeerste. 
Prof. Frans Debruyne, het is me een eer om in uw voetsporen te mogen treden. 
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Ik zal trachten dit met respect en succes te doen. Dank voor uw intelligente en 
professionele raad. Ook de oprechte steun van overige stafleden, Prof. Pierre 
Delaere, Prof. Peter Hellings, Prof. Greet Hens, Prof. Ann Goeleven en Prof. 
Vincent Vander Poorten apprecieer ik enorm. Verder wil ik ook Prof. Torfs en 
Prof. Robberecht, rector en vicerector van de KU Leuven en Prof. Goffin, decaan 
aan de faculteit geneeskunde, bedanken om mij de kans te geven een 
doctoraatsthesis aan deze universiteit te realiseren.  
Dit project was niet mogelijk geweest zonder de financiële ondersteuning van 
het Fonds voor Wetenschappelijk onderzoek Vlaanderen en het Klinisch 
Onderzoeksfonds van UZ Leuven, waarvoor mijn respectvolle dank. 
Michael, zoals aangetoond met gedeelde auteurschap in één paper, wil ik je 
bedanken voor je intellectuele en technische hulp. Je hebt me veel 
wetenschappelijk inzicht bijgebracht en was bij momenten quasi mijn tweede 
co-promotor. Mijn bureaugenootjes, Heleen, Astrid, Sofie en later Raphael. Van 
bij het begin van mijn PhD kon ik op jullie rekenen als luisterend oor. Ik was 
steeds opgetogen om even in onze navorsende wereld onder te dompelen 
tussen al het hectische UZ werk door. Jullie waren vaak bereid om me te helpen 
met statistiek, om onderzoeksvragen te bespreken of gewoon ontspannend te 
lachen. Andere ExpORL en LAW leden (Tom, Frieda, Tinne, Anneke, Jaime, Tine, 
Sophie, Rob, Maaike, Charlotte, Lore, Marjolein, Hanne P, Robin, Hanne, Kelly, 
Hanneke, Nathalie, Dimitar, enz.) bedank ik van harte voor de leuke tijd samen. 
Ik besef maar al te goed dat het dagelijkse klinische werk tijdens mijn onderzoek 
in het lab verdergezet werd door de NKO assistenten en daarvoor ben ik hen 
stuk voor stuk dankbaar. Onze dienst is werkelijk gezegend met jullie als 
enthousiaste en betrouwbare medewerkers. Dit geldt ook voor het hele 
audiologische en MUCLA team van het UZ (Ermelinde, Katleen, Ann, Ellen, 
Charlotte, Eveline, Lies, Gerda, Yasmine, Liesbeth, Annelies en Chelsea), voor 
Prof. R. Hermans van dienst radiologie, voor Wilfried en voor ons uitermate 
professioneel secretariaat olv Lea. Katleen wil ik in het bijzonder bedanken voor 
haar voortreffelijke bijdrage bij de klinische implementatie van dit project. Het 
is werkelijk aangenaam en uitdagend samenwerken en onze patiënten 
waarderen dit eveneens. Ook apprecieer ik de belangrijke inzet van onze 
verpleging zowel op de raadpleging, in het OK als op de verpleegafdeling, 
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Abstract 
Hearing problems have been associated with poor quality of life, cognitive 
decline and a source of frustration. Over the past years, an essential progress 
has been made in hearing aids improving the wearing comfort, speech 
processing in noise and wireless connectivity. In a subgroup of patients with a 
combination of an important sensorineural hearing loss and a conductive 
component, defined as severe to profound mixed hearing loss, hearing 
rehabilitation was lagging behind. Conventional middle ear surgery and/or 
hearing aids would not suffice to overcome the degree of hearing loss and often 
local anatomical issues were complicating the hearing aid use. This subgroup is 
growing in number because of an increased awareness for hearing with two 
ears and for communicating. Also because of an aging population, the 
sensorineural hearing loss component is becoming increasingly important.  
With the recent development of a new hearing system, a direct acoustic 
cochlear implant (DACI), the inner ear can be stimulated acoustically at the oval 
window. In this way, the amplified signal is provided directly to the cochlea and 
pathological external and middle ear structures are bypassed. This dissertation 
explores, for the first time, the functioning of direct acoustic cochlear 
stimulation in several domains. First, as guidance for evidence-based research, a 
systematic review of the literature on the hearing rehabilitation of mixed 
hearing loss was carried out. Next, the clinical application and thorough 
evaluation of DACI compared to the best current alternative are described. 
Finally, objective electrophysiological measures and new coupling strategies for 
DACI are developed.  
In the first study, the clinical outcome and safety of a whole range of acoustic 
hearing implants in adults with mixed hearing loss was assessed through a 
systematic review of the literature. It was concluded that acoustic hearing 
implants and the respective various coupling strategies were beneficial in terms 
of speech perception in quiet, patient-reported outcome measures and safety 
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regarding residual hearing. Overall, the level of evidence and the quality of the 
included studies was judged to be moderate to low.  
The second study consisted of a prospective, multicenter evaluation of nineteen 
subjects with severe to profound mixed hearing loss due to several etiologies. 
The DACI treatment was compared to the best-aided preoperative treatment. 
The mean speech reception threshold (SRT), a measure for speech in noise 
understanding and representative for real-life communication, improved with 
7.9 dB compared to the preoperative aided condition for the study cohort. A 
mean postoperative aided SRT of 2.6 dB SNR was noted. Patient-reported 
questionnaires indicated a significant global benefit in hearing ability and in 
quality of life. The DACI surgery was regarded as a safe and efficient treatment.  
In the third study, we focused on the development of an objective 
electrophysiological assessment of the device’s coupling and stimulation of the 
entire auditory pathway. By investigating the feasibility of evoked auditory 
transient (ABR) and steady-state responses (ASSR), we opened the path for 
future intra-operative applications. Responses were recorded to click trains in 
the 40 Hz and 90 Hz range in three DACI subjects. A direct stimulation setup for 
reliable auditory response recording was developed in a first set of 
experiments. Next, by comparing amplitude growth function and phase delay in 
the same stimulus range, validity of the recorded responses was confirmed in 
DACI subjects. Electrophysiological stimulation thresholds could objectively be 
determined from the ABRs and ASSRs in all subjects and the relation with 
behavioral thresholds was made. Estimated latencies were in agreement with 
electrophysiological auditory pathway studies, with apparent latencies of about 
40 and 25 ms for 40 and 90 Hz, respectively. For the first time, auditory evoked 
potentials could reliably be recorded and analyzed in patients with a digital 
speech processing DACI. 
The fourth study aimed to explore the coupling of a DACI transducer to an 
anatomically easy accessible inner ear site, being the lateral semicircular canal 
(LC). This could simplify and shorten the surgical procedure. Fresh-frozen 
human cadaver heads were implanted with the DACI device stimulating the LC 
in different coupling situations. The LC was kept intact, blue-lined (i.e. thinning 
but keeping the last shell of bone closed) or opened, respectively, and each 
condition was compared with standard oval window coupling. As a measure of 
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the performance of the device and its coupling efficiency, the round window 
velocity was determined using a laser Doppler vibrometry setup. Pairwise 
comparisons in three frequency ranges showed that round window velocity was 
significantly lower in case of intact LC stimulation than in the standard oval 
window coupling condition, confirming the added value of direct inner ear 
stimulation. Equivalent output calculations showed a modest but significant 
added value of blue-lining over the intact condition. Opening the canal resulted 
in a significantly higher round window velocity than in the intact or blue-lined 
conditions for all frequency ranges, similar to the oval window coupling. 
Experimentally induced stapes footplate fixation did not impede the DACI 
performance when stimulating the opened LC.  
In the different studies in this project important steps have been made towards 
reliable hearing rehabilitation, even in difficult listening situations, objective 
electrophysiological measures and easier surgery in the challenging treatment 
of severe to profound mixed hearing loss.  
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Korte Inhoud  
Gemengd gehoorverlies ontstaat door de combinatie van geleidingsverlies, 
zoals bij buiten- en/of middenoorproblemen, met een 
binnenoorslechthorendheid. In de (zeer) ernstige vorm, kunnen hoortoestellen 
of middenoorchirurgie vaak onvoldoende versterking aanbieden. In de 
afgelopen decades werden verschillende akoestische hoorimplantaten 
ontwikkeld met gunstige functionele resultaten voor louter conductief of 
beperkt gemengd gehoorverlies. Helaas kon de groep van patiënten met (zeer) 
ernstig gemengd gehoorverlies niet of onvoldoende geholpen worden. Zeker 
niet in moeilijke luistersituaties, zoals in het dagelijkse leven vaak voorkomt. 
Hierdoor onstaan toenemende communicatie-problemen, sociale isolatie en 
soms zelfs cognitief verval. Daarenboven neemt dit patiëntenaandeel toe, mede 
door toenemende veroudering van de wereldpopulatie en het belang van horen 
met twee oren.  
Recentelijk werd een nieuwe vorm van akoestische hoorimplantatie ontwikkeld. 
Via een prothese doorheen de stijgbeugelvoetplaat, ter hoogte van het ovale 
venster, wordt het binnenoor of cochlea direct aangedreven door een nieuw 
elektromagnetisch hoorimplantaat. Preliminaire studies met dit krachtig direct 
akoestisch cochleair implantaat (DACI) toonden een veelbelovende verbetering 
van het hoorvermogen aan in een selecte groep van patiënten. Een verdere 
implementatie in de kliniek werd echter nog niet uitgevoerd gezien 
vergelijkende klinische en experimentele studies, die het effect van deze 
stimulatie-vorm onderzochten, vooralsnog ontbraken. Dit doctoraatsonderzoek 
onderzocht, als eerste, verschillende aspecten van direct akoestisch cochleaire 
stimulatie zowel op het klinische vlak als op het electrofysiologisch en 
anatomisch experimenteel vlak. 
Vanuit een “evidence-based” oogpunt werkend, werd als eerste doel van dit 
doctoraatsonderzoek de literatuur retrospectief en systematisch nagekeken om 
de huidige behandeling van puur gemengd gehoorverlies in kaart te brengen. 
Een bijzondere focus lag op veiligheid met betrekking tot het restgehoor, 
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spraakverstaan en subjectieve tevredenheid van de patiënt zelf. Hieruit bleek 
dat de meeste akoestische hoorimplantaten efficiënt zijn voor spraakverstaan in 
stilte, veilig zijn en dat de patiënt tevreden is. Kwaliteitsvolle vergelijkende 
studies rond spraakverstaan in achtergrondruis ontbraken echter, zeker voor de 
(zeer) ernstige vorm van gemengde slechthorendheid. 
Vervolgens werd een prospectieve, multicentrische klinische studie uitgevoerd. 
De behandeling van direct akoestische cochleaire stimulatie werd onderzocht in 
vergelijking met het best mogelijke alternatief, zijnde een hoortoestel of een 
beengeleidingstoestel. De resultaten gaven een duidelijke verbetering in 
spraakverstaan met DACI aan, zowel in stilte als in ruis, met een gemiddelde 
verbetering van 7.9 dB ten opzichte van de preoperatieve 
spraakverstaanbaarheidsdrempel mét hoor- of beengeleidingstoestel. 
Vragenlijsten toonden een duidelijke verbetering in het hoorvermogen en de 
levenskwaliteit aan. De chirurgie werd veilig en efficiënt geacht.  
De derde doelstelling in dit doctoraatsonderzoek was het ontwikkelen van 
elektrofysiologische methoden om via objectieve gehoormetingen de efficiëntie 
van direct akoestische cochleaire stimulatie na te gaan. In een eerste reeks van 
experimenten werden technische aspecten rond de codering van de DACI-
spraakprocessor ontrafeld en een directe stimulatie-methode ontwikkeld voor 
het opmeten van auditief geëvokeerde potentialen, di een vorm van auditieve 
elektro-encefalogram opmeting. Vervolgens werd in dit onderzoek aangetoond, 
in DACI-dragers, dat zowel auditory brainstem responses (ABR) als auditory 
steady-state responses (ASSR) betrouwbaar opgemeten konden worden met 
deze stimulatie-methode op een niet-invasieve manier. Door het vergelijken 
van de groei in amplitude en fase van de antwoorden op verschillende klik-
frequenties, konden de antwoorden gevalideerd worden. De opgemeten 
latentietijden kwam overeen met in de literatuur gerapporteerde latentietijden 
voor akoestische stimuli. 
Als vierde doelstelling in dit doctoraatsproject werd ingezoomd op ontwikkelen 
van een eenvoudige koppelingsmethode voor DACI stimulatie van het 
binnenoor. Door het toestel rechtstreeks te koppelen op het lateraal 
semicirculair kanaal van het evenwichtsorgaan, kan men het openen van de 
faciale recessus vermijden. Zo worden risico’s op facialisparese, net zoals bij 
cochleaire implantatie, vermeden. Vers diepgevroren, menselijke 
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kadaverhoofden werden geïmplanteerd waarbij de koppelingsmethode 
onderzocht werd ten opzichte van de standaard, ovale vensterkoppeling. Dit 
werd uitgevoerd door het opmeten van de trillingsnelheid van het ronde 
venster membraan met een laser Doppler vibrometer. Statistisch gepaarde 
vergelijkingen toonden aan dat met het openen van het lateraal kanaal een 
vergelijkbare versterking bekomen werd als met de standaard, ovale venster 
koppeling. Het lateraal kanaal intact laten of enkel uitdunnen, het zogenaamd 
‘blue-linen’, gaf onvoldoende versterking. De koppeling aan het geopend 
lateraal kanaal, gaf voldoende breedspectrum versterking, zelfs in geval van een 
experimentele fixatie van de stijgbeugelvoetplaat, zoals bij otosclerose wordt 
gezien. 
Samenvattend toonde dit doctoraatsonderzoek aan dat direct akoestische 
cochleaire stimulatie een veilige en efficiënte therapie is voor (zeer) ernstige 
gemengde slechthorendheid, zelfs in moeilijke luistersituaties. Er werd, voor de 
eerste maal, onthuld dat objectieve, electrofysiologische metingen uitvoerbaar 
zijn met dit digitaal akoestisch hoorimplantaat. Bovendien werd experimenteel 
aangetoond dat het binnenoor voldoende direct gestimuleerd kan worden via 
het geopend lateraal semicirculair kanaal. Deze resultaten kunnen tot een 
herziening van de huidige therapie van (zeer) ernstig gemengde 
slechthorendheid leiden. 
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  Chapter 1
General introduction 
1.1 Motivation for the present research  
In humans, problems with hearing and communication are regarded as highly 
frustrating and associated with a poor quality of life, certainly among older 
people (Chia et al, 2007). Sustained hearing loss can result in a decrease of 
general health and mood disorders, such as depression (Gopinath et al, 2009). 
Prospective studies have shown that hearing loss is independently associated 
with the all-cause dementia (Lin et al, 2011a). In addition to middle ear surgery, 
hearing aids (HAs) are the primary treatment option in the management of 
hearing rehabilitation but reports state that up to 24% of the HA owners never 
wear them (Hartley et al, 2010). The main reasons for non-use were identified 
as an insufficient benefit provided by the HA and the comfort related to 
wearing the HA (McCormack & Fortnum, 2013). The first issue is more 
frequently encountered in case of a substantial degree of hearing loss, the 
latter in case of anatomical problems related to external or middle ear 
problems. 
In addition to acquired middle ear pathologies, many patients are presenting a 
sensorineural hearing loss demanding adequate amplification. The number of 
patients keeps growing because of an aging population. Furthermore, a slowly 
raising awareness for hearing handicap as well as the progress in technology 
has driven more individuals to seek help. New implantable hearing systems 
have been developed in the past decades. Cochlear implants (CIs) have proven 
themselves very effective for severe to profound sensorineural hearing loss, 
even when associated with chronic otitis media (Leung & Briggs, 2007) or far 
advanced otosclerosis (Merkus et al, 2011). They provide electrical cochlear 
stimulation and are regarded as a well-established therapy. CI treatment, 
however, is associated with mostly an important rehabilitation period. Present-
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day technology does not adequately code speech’s fine structure and shows 
limited F0 information transmission (Toung et al, 2004; Zeng et al, 2008; 
Milczynski et al, 2009; Blamey et al, 2013). Consequently, many experts 
advocate that when some cochlear remaining function exists, it should be 
exploited with a reliable alternative treatment, embedded in a powerful 
acoustic hearing implant (AHI) coupled directly to the inner ear. The clinical 
implementation of this acoustical stimulation and its potential benefits needs to 
be investigated prospectively. 
The attachment of such an AHI to the middle or inner ear structures is defined 
as the ‘coupling’. Currently, as so often in middle ear surgery, this coupling 
mainly relies on the skills, experience and visual inspection of the surgeon 
during surgery. Hearing results can only be appreciated after a period of 
postoperative healing. Although tools have been developed to provide surgical 
feedback on the coupling (Jenkins et al, 2007; Karkas et al, 2012), the underlying 
aided auditory pathway has not been evaluated. Just as cochlear implantation is 
partially relying on intra-operative auditory nerve feedback; 
electrophysiological methods need to be developed for the objective evaluation 
of the coupling of AHIs to the inner ear. So far, absolute electrophysiological 
thresholds have not been determined with AHIs. Accordingly, with the 
perspective of an increasing patient population with severe to profound mixed 
hearing loss (MHL), due to aging, and new evolutions in electro-acoustic hearing 
systems, objective electro-physiological measures for a recently introduced 
hearing implant, a direct acoustic cochlear implant (DACI), are developed and 
analyzed in this PhD project. Furthermore, a new surgical technique for DACI 
coupling to the inner ear is evaluated, potentially broadening its indication 
range and simplifying the surgical implantation. 
In this chapter, a general introduction on hearing loss (1.2) and its treatment 
with acoustic hearing implants (1.3) are given. Moreover, methods for the 
objective evaluation of a hearing implant’s functioning (1.4) and the patient’s 
audiological and self-reported evaluation (1.5) are provided. The introduction is 
followed by the objective and an outline of the PhD project. 
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1.2 Hearing loss  
Hearing loss is a highly prevalent impairment amongst society, with an 
enormous impact on a person’s quality of life. In 2012, the World Health 
Organization released new estimates on the magnitude of disabling hearing 
loss, defined as a hearing loss greater than 40 dB HL in the better hearing ear in 
adults and a hearing loss greater than 30 dB HL in the better hearing ear in 
children. Over 5% of the world’s population – 360 million people – has disabling 
hearing loss (328 million adults and 32 million children). The prevalence 
increases with age, and more than one third of people older than 65 years have 
clinically significant hearing loss. The prevalence in this age group is the greatest 
in Asia Pacific, South Asia and sub-Saharan Africa. It is expected to be between 
18 ‐ 50% from 2010 ‐ 2020 in all regions. 
Different degrees of hearing loss are described using pure-tone thresholds at 
0.5, 1, 2 and 3 or 4 kHz of audiograms. The following categories are 
distinguished: mild HL (25 – 40 dB HL), moderate (40 – 55 dB HL), moderate-
severe (55 – 70 dB HL), severe (70 – 90 dB HL) and profound (> 90 dB HL). In this 
project we will mainly deal with subjects with severe to profound hearing loss. 
For clinical and audiological diagnosis and therapy it is important to associate 
the hearing problem with its origin. Principally, three kinds of peripheral 
hearing disorders are differentiated, i.e. conductive, or sensorineural or their 
combination named mixed hearing loss. In the next sections, first the hearing 
loss and the etiology will be discussed, next the possible therapy will be 
elaborated. Accordingly, recent insights in the pathophysiology of hearing loss, 
relevant for this project, based on up-to-date reviews about cochlear physiology 
and neurobiology (Guinan et al, 2012; Knipper et al, 2013), are discussed briefly 
throughout the following sections.  
1.2.1 Conductive hearing loss 
Conductive hearing loss occurs due to a conflict with the mechanical reception 
or amplification of sound to the cochlea. The interference is in the external or 
middle ear involving the ear canal, tympanic membrane or middle ear ossicles. 
In humans, an ossicular chain spans the middle ear cavity linking the tympanic 
membrane to the inner ear. An important etiology of persistent conductive 
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hearing loss is otosclerosis, a condition characterized by lesions in the 
endochondral bone of the otic capsule, causing progressive fixation of the 
stapes footplate in the oval niche of the cochlea (Chole & McKenna, 2001). In its 
active phase, known as otospongiosis, highly vascular lesions resorb bone 
surrounding the inner ear. The active lesions mature into calcified otosclerotic 
plaques that are responsible for stapes fixation. Other causes of conductive 
hearing loss can be enumerated: tympanic membrane perforation; chronic 
otitis media with cholesteatoma and/or retraction pockets compromising the 
ossicular chain’s integrity; tympanosclerosis, explained as a scarring process in 
the middle ear; congenital or acquired malformation of the external and/or 
middle ear; temporal bone fracture. 
1.2.2 Sensorineural hearing loss 
Sensorineural hearing loss, the most common type of hearing loss among 
adults, results from damage to or malformation of the cochlea and the 
sensorineural elements that lie internally beyond the oval and round windows. 
These elements include the auditory nerve and its connections in the 
brainstem. The most common cause of sensorineural hearing loss is age-related 
hearing loss or presbyacusis. This gradual bilateral hearing loss, associated with 
aging, is due to a progressive degeneration of cochlear structures, auditory 
nerve and more central auditory pathways. The functional integrity of three 
major components of the cochlea, organ of Corti, stria vascularis / spiral 
ligament, and spiral ganglion neurons are compromised (Kim et al, 2014). 
Recently, cellular oxidative stress and inflammatory responses have been 
reported to facilitate morphological and ultrastructural degeneration (Massudi 
et al, 2012). The hearing loss usually begins with the high frequencies then 
progresses to sounds of middle and low frequencies. If mainly outer hair cells 
are affected, supra-threshold stimuli will still evoke synchronized neural 
potentials in the auditory nerve and brainstem pathways. Therefore, affected 
subjects typically benefit from hearing aids or acoustic hearing implants. In case 
of inner hair cell synapse or auditory nerve defects, as in auditory neuropathy, 
even with audibility being normal or restored, speech comprehension is 
impaired and often not improved with hearing aids (Moser et al, 2013). 
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Another frequent cause is sound induced hearing loss. This is generally 
associated with a reduction in cochlear sensitivity due to outer and inner hair 
cell loss (Liberman & Dodds, 1984). Recent animal investigations, likely to apply 
for humans as well, show that excitotoxic effects of noise at afferent synapses, 
causing a loss of afferent fibers, are also to be taken into account (Lin et al, 
2011b). Secondary to a degeneration of the afferent dendrites of auditory 
fibers, a neurodegeneration at the level of the spiral ganglion neurons can occur 
(Knipper et al, 2013). Experiments on noise-induced hearing loss in chinchillas 
(Henry & Heinz, 2012) showed that neural coding of signals is less resilient to 
background noise than normal. This confirms the need for new technologies to 
improve the signal-to-noise ratios for subjects with sensorineural hearing loss. 
Other causes of sensorineural hearing loss are known as ototoxic hearing loss; 
Morbus Menière; congenital causes, such as a connexine 26 mutation, or 
perinatal causes, such as rubella infection. A ‘cochlear’ otosclerosis is associated 
with sensorineural hearing loss. It has been estimated that 1.6% of patients 
with otosclerosis will eventually develop profound hearing loss (Shea et al, 
1999). 
1.2.3 Mixed hearing loss 
Mixed hearing loss is defined as a combination of sensorineural hearing loss, 
due to (peri-)cochlear dysfunction, superimposed with a conductive 
component, caused by middle ear pathology. As mentioned above, certainly the 
advanced form of otosclerosis is frequently associated with MHL. Also 
labyrinthine complications of previous stapes surgery can be associated with 
severe to profound MHL. A second pathology possibly resulting in MHL is 
chronic otitis media. Due to inflammation associated with for instance tympanic 
membrane retraction, cholesteatoma or previous surgery, both conductive as 
sensorineural hearing loss can occur (Chapter 2). Poor hearing outcome, even 
after proper placement of a total or partial ossicular replacement prostheses 
(TORP or PORP) (Linder et al, 2009), has been explained by diminished or absent 
ventilation of the middle ear space, prosthesis extrusion, tympanosclerosis, scar 
tissue, tympanic membrane lateralization and eroded ossicles. Morphological 
abnormalities like congenital malformations could present themselves with 
MHL, although isolated conductive hearing loss is more frequently associated. 
Congenital aural atresia consists of a dysplastic or absent external ear and a 
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varying degree of middle and inner ear malformations with possible aberrant 
facial nerve anatomy. The incidence of aural atresia is about 1:10.000 births 
(Melnick et al, 1979). Other more seldom causes are associated with trauma: 
labyrinthine contusion or temporal bone fracture with stapes footplate 
fracture. 
Severe to profound MHL remains a challenge for adequate hearing 
rehabilitation. If conventional HAs or middle ear surgery fail, a treatment gap 
exists between two indication ranges: most AHIs (see section 1.3) are used 
effectively in conductive hearing loss or moderate MHL (Luers et al, 2013), CIs 
are reserved for severe to profound sensorineural hearing loss. Recently, a new 
type of hearing system has been developed filling up this gap, a direct acoustic 
cochlear implant (DACI). In profound MHL, combining conductive with 
sensorineural hearing loss, thus also neuronal degeneration of both efferent 
and afferent fibers, DACI technology faces similar challenges as hearing aids.  
1.3 Acoustic hearing implants 
Over the last decades hearing aids could not always overcome certain 
anatomical and audiological challenges, in spite of a constant improvement. 
Examples of anatomical issues are severe chronic otitis externa and congenital 
aural atresia (Verhaert et al, 2011). Also in chronic otitis media with sequelae at 
the tympanic membrane (perforations or tympanosclerosis) or large open 
(radical) cavities, the use of conventional HAs is problematic and unsatisfactory. 
Audiological issues include feedback issues, sound quality or bothersome 
occlusion effect. 
Although initially proposed for sensorineural hearing loss (Truy et al, 2008; 
Verhaegen et al, 2008), most AHIs are currently used for conductive or mixed 
hearing loss. They can be divided in active and passive implants, whether the 
function of the implants depends on external energy or not. Currently, these 
AHIs cover the broad range of a mostly passive bone conduction system, such 
as bone-conduction implants (BCI), to an active middle ear implant (AMEI) and 
DACI. Figure 1.1 provides an overview of different implant types and depicts 
their respective coupling site in the ear. 
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Figure 1.1 Comprehensive overview of hearing implants and their respective coupling 
site (Delaere (2007), illustration adapted for hearing implants overview). 
Different amplification options for MHL were compared in a recent clinical 
study of Zwartenkot et al (2014), determining the maximum output of these 
devices in dB HL. A short description of the most frequently used devices is 
given below, because of its relevance for Chapter 2 and 3. HAs and CIs were not 
described separately, as they are regarded as well-known therapies. In Chapter 
2 a systematic review with clinical outcomes is described more in detail for the 
different systems. 
1.3.1 Active middle ear implant 
Active middle ear implants couple to a middle ear structure. Semi-implantable 
AMEIs consist of an implanted part with a mostly electromagnetic driver and an 
externally worn speech processor, similar to a CI. In 1996 Fisch implanted the 
Symphonix device, later named Vibrant Soundbridge, with its floating mass 
transducer or FMT (MED-EL, Innsbrück, Austria), and coupled it to an intact 
ossicular chain at the level of the long process of the incus (Goode, 1995; Lenarz 
et al, 1998; Fisch et al, 2001) (Figure 1.2). 
Another AMEI is the Otologics device, with its middle ear transducer or MET 
(Otologics & Cochlear™, Boulder, CO, USA), involving the semi-implantable MET® 
system and the fully implantable Carina® system. In the totally implantable 
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system, the microphone and audio-processor package, including its battery, is 
placed under the skin.  
 
 
Figure 1.2 Schematic presentation of a Vibrant Soundbridge, consisting of (1) speech 
processor, (2) implant and (3) FMT coupled here to the incus. (MED-EL) 
Later on, broadening the indication to conductive and mixed hearing loss 
because of ossicular chain’s deformities or absent ossicles, new coupling sites 
were investigated. Colletti et al (2006) were the first to report the round 
window (RW) coupling for Vibrant Soundbridge. Subsequently, many reports on 
different types of couplers (e.g. fascia, cartilage and titanium couplers) at the 
remaining stapes, oval or round window structures followed rapidly, each with 
its own advantages and disadvantages (Baumgartner et al, 2010; Luers et al, 
2013; Schwab et al, 2012; Tringali et al, 2010; Verhaert et al, 2011). With the 
introduction of titanium couplers (Luers et al, 2013), it is expected that 
variability in functional outcome will decrease, but dislocation of a non-fixed 
stimulator (e.g. Vibrant Soundbridge at the round window) with loss of 
amplification remains a possibility (Bernardeschi et al, 2011). In selected cases 
of chronic otitis media with open (radical) cavities, a two-staged intervention 
with first closure of the middle ear cleft, abdominal fat obliteration and six 
months later AMEI implantation is advised (Verhaert et al, 2013b). This helps to 
avoid cholesteatoma recurrence and possible foreign body infection with a risk 
of extrusion. A more detailed overview of AMEIs can be found in Chapter 2 and 
in Tysome et al (2010).  
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1.3.2 Bone conduction implant 
Bone conduction results from two modes of vibration of the human skull: the 
inertial mode, in which the skull vibrates as a unit and the compressional mode, 
in which the skull is divided into a number of compartments (Tonndorf, 1966). 
Acceleration of the temporal bone surrounding the inner ear causes inertial 
displacements of uncompressible cochlear fluids and subsequently vibrations of 
the basilar membrane (Stenfelt & Goode, 2005). Bone conduction implants, per- 
or transcutaneous, osseointegrated or not, mainly couple to the temporal bone 
and use the bone conduction pathway. The most widely-used type, a BAHA 
(Bone-Anchored Hearing Aid), with different processors from Cochlear Ltd. or 
Oticon Medical, can overcome the sensorineural hearing loss component up 45 
to 50 dB HL, as shown with the body-worn Baha Cordelle (Zwartenkot et al, 
2014). Nevertheless, the life-long daily care and the risk of skin infection with 
the skin-penetrating abutment have driven the development of transcutaneous 
devices (Snik et al, 2005). Considerably less powerful, transcutaneous BCI 
preserve the skin’s integrity. Commercially available transcutaneous 
applications are the recent BAHA Attract system from Cochlear, the Otomag 
Alpha 1 device (Sophono, Boulder, CO, USA) and the active BCI from MED-EL, 
named Bonebridge. Probably in the near future, more active BCI systems will 
become available. Extensive research work on BCIs has been done before and 
lies beyond the scope of this thesis. 
For severe to profound MHL, only powerful implants can produce sufficient 
output to stimulate the remaining cochlear reserve, indicating the need for 
direct acoustic cochlear stimulation, as shown in Figure 1.3 (Zwartenkot et al, 
2014). 
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Figure 1.3 Maximum output of various hearing devices in relation to the sensorineural 
hearing loss component. For BCIs the maximum output is presented as horizontal lines. 
For the Vibrant Soundbridge (VSB) and DACI (Codacs) devices the maximum output 
values are presented as individual data points (Zwartenkot et al, 2014). 
 
1.3.3 Direct acoustic cochlear implant 
Direct acoustic cochlear implants drive directly the inner ear’s perilymph with 
acoustical stimulation. Former reports of coupling an AMEI to a fixed stapes or 
to the RW in case of stapes fixation, showed limited benefit (Devèze et al, 2010; 
Verhaert et al, 2011). To this end, in case of severe to profound MHL because of 
stapes footplate fixation, as in advanced otosclerosis, direct acoustic 
stimulation was explored. Häusler et al (2008) described the coupling of a DACI1 
actuator to the cochlea’s vestibule through a stapes prosthesis in 4 patients 
after complete removal of the stapes footplate or stapedectomy. The study 
showed a clear benefit of direct acoustic cochlear stimulation compared to the 
preoperative situation and compared to a stapedectomy combined with a 
conventional hearing aid. This novel acoustic hearing implant was first designed 
and tested under the collaboration of the Ear, Nose & Throat department 
(Inselhospital, Bern), the hearing industry (Phonak AG), the cochlear implant 
industry (Cochlear Ltd) and microtechnology, with Häusler and Stieger being the 
                                                                
1 Initial reports refer to DACI as DACS and both terms are used in the current literature. 
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main protagonists (Bernhard et al, 2006; Häusler et al, 2008). Also described as 
DACI, but less powerful, Schwab et al (2012) proposed the coupling of a Vibrant 
Soundbridge to a titanium prosthesis into the vestibule in three patients.  
The current Codacs DACI system from Cochlear Ltd. (Sydney, Australia) consists 
of an external digital speech processor and an internal implant connected by a 
wireless radio-frequency (RF) transmission link that provides both power and a 
bidirectional communication link (Figure 1.4). 
 
 
Figure 1.4 Codacs DACI system a) overview with speech processor and implant b) 
anatomical position. (Cochlear Ltd.)  
The RF frames are decoded digitally in the implant and used to drive an electro-
magnetic transducer in the middle ear (Bernhard et al, 2011). This transducer is 
fixed in the mastoid cavity with a fixation system, avoiding dislocation. 
Dislocation in case of direct inner stimulation could not only lead to a loss of 
amplification, but in worst case, to additional inner ear damage due to 
protrusion into the inner ear.  
The electrical input signal is converted into a movement of an actuator, i.e. the 
artificial incus, in turn connected to a conventional stapes prosthesis at the level 
of the oval window. Opening the inner ear through a hole in the stapes 
footplate is known as a classic stapedotomy (as shown in Figure 1.5), but 
instead of coupling to the incus, the prosthesis is coupled to an artificial incus. 
a) b) 
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Figure 1.5 Classic stapedotomy with a stapes prosthesis coupled from the incus to the 
cochlea’s vestibule, through a calibrated hole in the stapes footplate, in case of 
otosclerosis. Sagittal view of the oval window niche (Jackler, 2013). 
The frequency response of the actuator was designed to mimic the middle ear 
transfer function (Bernhard et al, 2011). From intra-operative measurements, 
after coupling to the inner ear and healing, a smooth frequency response with 
broad spectrum amplification was noticed. With a frequency range of 100 to 
10000 Hz and an equivalent maximal sound pressure output of over 125 dB SPL 
with a 1 mW power supply, the authors concluded that the device was well 
suited to treat severe to profound MHL (Häusler et al, 2008; Bernhard et al, 
2011). The device has received CE approval for adult use in 2013.  
As described in Chapter 3, the speech processor is usually fitted eight weeks 
postoperatively by the dedicated audiologist. An input transfer function, 
obtained during intra-operative measurements from the actuator with laser 
Doppler vibrometry (see section 1.4.3), is introduced in the user’s fitting map. 
Sixty-three bins are combined into 20 frequency channels. In a stepwise 
manner, the wearer’s threshold and uncomfortable level are measured with the 
implant. Next, prescription rules and procedures known from hearing aid fitting 
are used. These procedures are based on the desired sensation level or the 
most comfortable loudness level and are used to calculate the target 
parameters such as the maximum power output value and the gain. In several 
sessions, the speech processor can be adjusted according to the subjects’ 
hearing loss and comfort. Different to electrical stimulation with CI, 
rehabilitation with acoustical stimulation is expected to be more rapid.  
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1.4 Objective measures for hearing implants 
Evaluation of a hearing implant’s functioning and its adjustment to the needs of 
the individual patient, the fitting, can be performed not only with subjective 
feedback but also, more independently, with objective instruments. Methods 
have been developed overcoming a certain degree of variability related to the 
voluntary and conscious reaction of the tested subject and the testing 
professional. Furthermore, these methods allow standardization of the 
implant’s functional assessment and its concomitant scientific reporting.  
During auditory stimulation, typical changes related to time-locked variations in 
an acoustical stimulus can be seen in an electroencephalogram (EEG). Geisler 
(1960) described averaging procedures to measure responses to clicks from the 
human scalp. These changes in the EEG, often seen as neuronal aggregates, are 
named auditory evoked potentials (AEPs). In response to acoustic stimuli, 
different parts of the auditory pathway are measured objectively and passively, 
this means without requiring response from the subject. Electric stimuli are 
rather used in combination with a CI electrode or for preoperative testing in CI 
candidates (Brown et al, 1990). AEPs may be classified as transient or steady-
state responses to a short or continuous auditory stimulus, respectively. In the 
following section, first a selected overview of AEPs generated by acoustic 
stimuli, relevant for the research conducted during this PhD project, is given. A 
thorough and updated review on AEPs can be found in Picton (2013) and in 
Rance (2008). Next, a tool for objective quantification of hearing implant’s 
performance in humans is described.  
1.4.1 Transient responses  
Generally spoken, transient responses occur with abrupt increases in stimulus’ 
amplitude. Figure 1.6 provides a visual overview of different AEPs, divided 
according to their latency in relation to the stimulus. Electrocochleography 
(ECoG) responses arise directly from the cochlea and the auditory nerve and 
occur within the first 2 to 3 ms after an abrupt stimulus. The response typically 
consists of three components: the cochlear microphonic, the summation 
potential and the compound action potential. The compound action potential 
can also be described as N1. ECoG, most reliably obtained with invasive needle 
recording at the promontory near the round window, is clinically used for 
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hydrops labyrinthi measurements in Morbus Menière and auditory nerve 
monitoring for CI candidates or vestibular schwannoma surgery (Schoonhoven 
et al, 1995). Some authors use ECoG for comparative measurements during 
AMEI coupling at the RW (Colletti et al, 2012). 
Far field recordings of the electrical activity in the auditory pathway up to the 
cortex can be obtained in the EEG measurement. Auditory brainstem responses 
(ABRs) are commonly defined as transient responses to broadband clicks or 
tone bursts and evaluated in the time domain. Together with ECoG, ABRs are 
regarded as short latency AEPs, i.e. before 10 ms after stimulus onset. 
Discovered more than 40 years ago (Jewett & Williston, 1971), the response is 
characterized as a wave labeled with different peaks related to several parts of 
the auditory pathway up to the level of the brainstem (Figure 1.6).  
 
 
Figure 1.6 Auditory evoked potentials (McCormick, 2004). 
Amongst others, Møller et al (1995) have partially identified the neuronal 
generators: peak I and II originate from the auditory nerve, peak III from the 
cochlear nucleus, peak IV from the superior olivary complex and peak V from 
the lateral lemniscus and inferior colliculus. Peak V is regarded as the most 
robust and ABRs are not affected by sleep or most anesthetics. Therefore the 
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click-evoked ABR has enjoyed wide-scale clinical use for auditory threshold 
determination, auditory neuropathy and detecting retrocochlear pathologies 
such as a schwannoma of the vestibular nerve (Debruyne, 1981; Hall, 2006; 
Koors et al, 2013). ABR threshold determination, regarded as the lowest 
stimulus level at which peak V is present, contains some drawbacks. The 
broadband click stimulus excites a large range of the basilar membrane, mainly 
around 1 to 3 kHz, but lacks frequency specificity. Visual inspection of the 
waveforms by the clinician is a more subjective element. Finally, the ABR does 
not contain information about the thalamocortical level of the auditory system. 
The use of tone bursts, chirps and complex stimuli is more and more exploited 
(Stapells & Oates, 1997; Skoe & Kraus, 2010). ABR methods using more narrow-
band stimuli, such as these tone bursts, provide better correlation with 
behavioral hearing thresholds at different frequencies, but are considerably 
more time-consuming, (Gorga et al, 2006). In the past decade, chirp stimuli 
have been optimized to evoke larger response amplitude (Dau et al, 2000), 
compensating for temporal dispersion of the frequency components of a click 
stimuli at the basilar membrane. Recently, chirp stimuli have been created and 
implemented for the clinical recording of ABR showing a shorter detection time 
and a higher signal-to-noise ratio than the click (Elberling et al, 2007).  
Auditory middle-latency responses (AMLRs) are defined as AEP with latencies 
between 12 and 50 ms after stimulus onset, using click or tone burst 
stimulation. AMLRs are recorded for the evaluation of the functional integrity of 
the auditory system beyond the level of the brainstem, for example in case of 
an auditory brainstem implant placement (Hall, 2006). 
Long latency responses, also known as cortical evoked potentials, occur at 
latencies beyond 75 ms after stimulus onset. They are largely derived from the 
cortex. Frequency-specific evoked response thresholds are feasible, but their 
use is mainly limited to awake and cooperative subjects. Long latency responses 
are used to assess the integrity of the cortical auditory system, to diagnose 
auditory processing disorders and to assess speech perception skills (Hall, 
2006).  
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1.4.2 Auditory steady-state responses 
Auditory steady-state responses (ASSRs) are following responses from the brain 
or brainstem evoked by periodic stimuli or stimuli presented at a sufficiently 
high rate to cause an overlapping of the responses to successive stimuli 
(Stapells et al, 1984; Picton, 2013). They are generally assessed in the frequency 
domain and can typically be evoked by a sinusoidal amplitude- or frequency-
modulated tone (Picton et al, 2003) or modulated white noise (Purcell et al, 
2004). They can also be elicited by repeated clicks (Galambos et al, 1981) or 
tone bursts (Stapells et al, 1984). The largest response amplitudes are seen with 
stimuli around 40 Hz, but responses can also be recorded for other modulation 
frequencies, like around 20 and 80 Hz range (Cohen et al, 1991). As described in 
the upcoming section, the frequency specificity of the stimulus characterizes 
the ASSR response, making it advantageous for objective response audiometry. 
The response detection is completely objective as it is based on statistics. ASSRs 
are used for hearing threshold determination in infants (Luts et al, 2006; Alaerts 
et al, 2010) as well as in adults (Luts & Wouters, 2005) or for the monitoring of 
the remaining low-frequency hearing in case of electro-acoustic cochlear 
implantation (Haumann et al, 2012, unpublished data). 
Response detection  
A comprehensive overview on how ASSRs are obtained is shown in Figure 1.7, 
adapted from Rance (2008). In the following paragraph, different aspects of the 
ASSR recording and analysis are explained using the figure. The EEG signal can 
be recorded with surface electrodes as a small voltage signal, often expressed in 
microvolts (μV). Different scalp electrode positions have been suggested, 
although common placements for single channel ASSR recordings (Johnson & 
Brown, 2005) include the vertex (Cz) for the active (positive) electrode, 
ipsilateral mastoid (TP9 or TP10) for the reference (negative) electrode and the 
contralateral mastoid (TP9 or TP10) for the ground electrode, in accordance with 
the international 10-20 system (Malmivuo & Plonsey, 1995) (see Chapter 4 for 
the stimulation and recording paradigm applied in this PhD project). After the 
recorded EEG signal is amplified and filtered, it is divided into epochs with a 
fixed length, containing an integer number of stimuli responses. This allows for 
the representation of the EEG signal in the time domain, as shown in Figure 1.7. 
Epochs with recording artifacts such as muscle movements and skin potentials 
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are rejected to prevent the erroneous detection of neural responses and the 
distortion of response properties. As the recording continues and more epochs 
are collected into the data structure, they can be combined to sweeps (see 
‘Data structure’ in Figure 1.7). The recorded sweeps contain both brain activity 
related to the stimulus, i.e. signal, in this case the ASSR, and activity that is not 
related to the processing of the stimulus, i.e. noise. Ergo, it is important to 
assess the signal-to-noise ratio (SNR) of the ASSR, i.e. the ratio of the signal 
power to the noise power defined in dB. Averaging, performed by adding 
sweeps together during the same ASSR recording to obtain an average sweep, 
results in a reduced spontaneous EEG activity in a recording that is not linked to 
the stimulus. 
Stimulus parameters 
ASSR stimuli are characterized by a carrier signal and a rate (see upper left 
panel in Figure 1.7). In this figure, a multiple-stimulus was used. The main 
advantage of the multiple-stimulus technique is the reduction in measurement 
time (Lins et al, 1996). A carrier signal varies in amplitude or frequency at a 
certain rate. The rate of the stimulus is defined as the stimulus repetition 
frequency in case of click or tone burst stimuli, or the modulation frequency in 
case of modulated stimuli. The rate of the stimulus is a crucial aspect because it 
is the exact frequency at which the response is evaluated in the EEG spectrum. 
Furthermore, the modulation rate determines where in the auditory pathway 
the corresponding ASSR is generated. And so the ASSR, characterized by its 
amplitude and phase, can be derived from the bin corresponding to the 
frequency spectrum of the average epoch. As shown in Figure 1.7 bottom row, 
steady-state responses can be plotted in different ways. Besides the amplitude 
or power spectrum, a polar notation is commonly used. A polar plot represents 
the response as a vector, with the amplitude of the response in the length of 
the line and the phase being the angle measured counter-clockwise from the x-
axis (Picton et al, 2003). 
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Different approaches have been described to assess whether a response is 
significantly different from noise (Picton et al 2003). A commonly used method 
involves an F-test in the time or spectral domain (as shown in the upper panel 
of Figure 1.7), calculating the F ratio of the power of the response in the signal 
frequency bins relative to the mean power of n adjacent frequency bins (Lins et 
al, 1996). In the complex domain, a one-sample Hotelling T2 test can be used to 
compare the average real and imaginary parts, plotted on the x- and y-axis, 
respectively, of the response bin against the variability of the same response 
bin across epochs (Hotelling, 1931; Hofmann & Wouters, 2012). Both methods 
have the same degrees of freedom and power, they can be applied conversely 
(Dobie & Wilson, 1996). Additionally, a two-sample Hotelling T2 test can be used 
to compare the response bins for two measurements using adjacent stimulation 
rate to determine the presence of a neural response (Hofmann & Wouters, 
2012). 
An important notice for clinical ASSR application is the presence of ‘hostile’ 
characteristics inherent to the operating room, such as ambient acoustical noise 
and electrical interference from the necessary equipment. With specific 
precautions, however, these interferences can be diminished, as shown in an 
unpublished study in older infants from the ExpORL research group (Alaerts, 
2009), where only in two out of 27 children ASSRs could not be recorded. 
However, time-consuming methods remain an important criticism of ASSR 
threshold determination in the intra-operative setting. 
Latency estimation 
The estimated latency can be used to determine the delay introduced by the 
auditory system, as this is related to the neural generators of the ASSRs. An 
estimation of latency is provided through the measurement of the phase of the 
response at different stimulus frequencies. The ASSR phase value can be 
converted into phase delay (in degrees), by subtracting it from 360 degrees. The 
conversion from phase delay into latency, however, is less straightforward 
(John & Picton, 2000). First, filtering can affect the measured phase. Second, 
because of the circularity of phase, the steady-state nature of the response 
makes it difficult to determine how many additional full cycles proceeded the 
cycle wherein the phase delay was measured. John & Picton (2000) proposed 
the ‘preceding-cycles’ technique, plotted as the best fit across different 
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stimulation rates: the mean latency (i.e. group delay in other research domains) 
is calculated as the ratio of the differences of phase delay and stimulation rate 
divided by 2π for corresponding measurements with different stimulation rates. 
For apparent latency to be meaningful the slope of this best fit must be linear 
and the measurement dominated by a single neural generator within the 
frequency range of interest. In literature, some controversy exists regarding 
latency calculations because of some assumptions that are made, e.g. related to 
multiple generators, therefore estimates should be always interpreted with 
caution (Picton et al, 2003). 
Neural generators 
The determination of neural generators plays an important role for neuro-
imaging studies, as it defines the main anatomic correlate on the auditory 
pathway. As described in Picton et al (2003), an amplitude modulated signal 
activates the basilar membrane in a region specific to the carrier frequency. 
Inner ear cells, subject to the rhythm of the modulation, will stimulate the spiral 
ganglion neurons through the mechanism of a neurotransmitter release. The 
firing of the neurons is subject to a half-wave rectification as action potentials 
are only transmitted after depolarization. This results in a recorded auditory 
nerve activity at the modulation rate.  
Many data are available and it is generally accepted that a stimulation rate in 
the 40 Hz frequency range generates cortical responses, and rates around 80 Hz 
frequency range, generate subcortical responses including the brainstem 
(Picton, 2011). Hence, ASSRs have gained wide acceptance for auditory 
temporal processing deficits in different pathologies, such as dyslexia (Poelmans 
et al, 2012) but also for sound localization research (for a review, see Picton, 
2013). In the field of hearing implants, electrically evoked responses have been 
described in CI patients (Ménard et al, 2004) and introduced for the fitting of CI 
(Hofmann & Wouters, 2012). Although 80 Hz responses are less influenced by 
sleep or anesthesia (Cohen et al, 1991) and therefore potentially useful for 
intra-operative monitoring in case of AHI implantation, literature is currently 
lacking. One explanation might be that new experimental methodologies for 
the measurement of AEPs need to be developed first. So far, only one study has 
investigated the use of ASSR, as a relative measurement for the placement of 
an AMEI at the level of the RW (Verhaegen et al, 2010). 
1.4 Objective measures for hearing implants 49 
1.4.3 Laser Doppler vibrometry 
AMEIs and DACI are designed to reproduce the deficient or absent middle ear 
function. Traditionally the acoustic transformer system of the middle ear is 
regarded as a combination of three systems overcoming the impedance 
mismatch between air in the external ear canal and fluid in the cochlea. The 
first system is the catenary lever, because of the tympanic membrane where 
the sound energy is directed away from the edges toward the center of the 
drum. Secondly, the ossicular lever is created by the joint action of the middle 
ear ossicles. Thirdly, the hydraulic lever is formed by the difference in area 
between the tympanic membrane and stapes footplate. Recent investigations 
have added insights regarding the ossicular coupling (referring to the 
frequency-dependent middle ear transfer function), the acoustic coupling 
(difference in sound pressures acting directly on the oval and round windows) 
and the stapes-cochlear input impedance (determined by the impedance of the 
annular ligament, the cochlear fluids, cochlear partition and the RW membrane) 
(Merchant et al, 1997). Many of these insights were gained through 
investigations on human cadaveric temporal bones, using laser Doppler 
vibrometry (LDV) (Voss et al, 1996) or intracochlear sound pressure 
measurements (Nakajima et al, 2009). With these objective tools the middle ear 
transfer function and cochlear mechanics can be investigated in a preclinical 
setting, assessing different pathologies, such as induced stapes footplate 
fixation (Nakajima et al, 2005). But also the performance of different implants in 
the middle ear can be analyzed (Rosowski et al, 2007). The principle of LDV is 
explained below. Anecdotally, it should be noted that other techniques, such as 
finite element modeling of the middle ear, are equally important for the 
examination of the vibro-acoustic characteristics of middle ear implants (Kelly 
et al, 2003). 
LDV allows non-contact optical measurements of the surface of vibrating 
objects (Huber et al, 2001). For acoustic research, mainly single point lasers are 
used, directing the laser beam at the vibrating structure. With high accuracy (< 
1 x 10-4 µm), the vibration amplitude and frequency are extracted from the 
Doppler shift of the reflected laser beam frequency. 
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Figure 1.8 Basic components of laser Doppler vibrometry (Bogue 2010).  
 
Generally the obtained output is a continuous analog voltage that is directly 
proportional to the velocity of the vibrating target along the direction of the 
laser beam (Goode et al, 1996). Figure 1.8 depicts the basic components of an 
LDV, showing the beamsplitter and photodetector, in addition to the laser, as 
the main components. When the laser beam hits the target, some portion of 
the reflected light is captured by the LDV, reflected by the beamsplitter to the 
photodetector. The output of this photodetector is a frequency-modulated 
signal. The resulting signal can be demodulated to derive the velocity vs. time of 
the vibrating target. In general, a multisine tone is used for stimulation (Huber 
et al, 2001) containing multiple frequencies between 100 Hz and 8000 to 10000 
Hz, produced by a signal generator. From the measured velocity, the 
displacement amplitude of the vibrating structure, such as the stapes head or 
round window membrane, can be calculated.  
For the purpose of standardization, a manual for describing the system output 
of AMEIs ex vivo has been published (ASTM, 2005). This ‘standard practice’ 
allows for the determination of the sound-induced stapes velocity, unaided and 
aided with an AMEI. It is built upon the middle ear transfer function and the 
linearity of the hearing system drivers, where a transfer function is the 
frequency-dependent ratio of the output of a device normalized by its input, as 
described by Rosowski et al (2007). The procedure should be regarded as an 
estimation of the sound pressure level based on transfer function information, 
as defined by ANSI 3.7 (ASTM, 2005). This transfer function is related to the real 
ear to coupler difference used to predict the real sound pressure level that is 
delivered by a transducer (i.e. hearing aid) to a subject (Dillon, 2012). The ASTM 
practice advises to use temporal bones of sufficient quality based on 
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acceptance criteria. The criterion range was deduced from a database of 13 
studies by different laboratories involved in human temporal bone research 
(Rosowski et al, 2007). 
With reflective targets on different middle ear structures, LDV allows for 
different velocity measurements, as shown in Figure 1.9. The ASTM method 
predicts the expected equivalent sound pressure level if an electrically driven 
system is attached to the middle ear ossicles. Comparing the sound-induced 
stapes velocity, HTV, to the AMEI-aided stapes velocity, HEV, then allows for the 
computation of the equivalent ear canal sound pressure transfer function, HET: 
 HET = HEV / HTV 
HET is used together with the maximal electrical signal deliverable to the hearing 
system’s transducer, Emax, to compute the maximum equivalent sound pressure 
level, LE,max with units of dB SPL, as in the following equation: 
 LE,max = 20 log10 (HET Emax /2 x 10
-5 Pa) 
Rosowski et al (2007) already stated before that the LE,max estimation assumes 
that HET is linear over the input range under the maximal electrical signal (Emax). 
All of the above calculations can also be applied to a DACI device. However, two 
important remarks related to the current PhD project should be taken into 
consideration. First, both the ASTM practice as well as Rosowski’s work usually 
applies to AMEI, measured at the stapes footplate. The Codacs DACI 
implantation, however, removes the stapes superstructure and couples directly 
to the inner ear. Accordingly the system’s output can only be recorded at the 
RW, probably resulting in a certain underestimation of the implant’s 
performance, as noted also by Maier et al (2013). Second, so far, no standard 
practice for entire cadaver heads investigations has been published. In Chapter 
5, entire heads were used, as they are more representative for real-life DACI 
implantation. Importantly, it should be remarked that LDV can only be 
performed intra-operatively whereas AEPS measures can be recorded both 
intra- (i.e. during surgery) and postoperatively. 
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Figure 1.9 Schematic setup in cadaver head with LDV beam on targets at stapes and at 
RW membrane. 
 
1.5 Behavioral and self-reported evaluation 
In addition to objective measures, the outcome of a hearing rehabilitation 
strategy can be evaluated with clinical audiometry measuring behavioral 
thresholds and with a focus on the patient’s self-reported appreciation. A short 
overview, relevant for this PhD project, of the audiological testing and patient-
reported outcome measures (PROM) is provided. 
Pure-tone audiometry, where the hearing threshold is determined at several 
frequencies important for the listener’s hearing, forms the basic clinical hearing 
assessment. The unaided pure tone average (PTA) can be measured both for 
the air conduction (AC) as for the bone conduction (BC) pre- and 
postoperatively at several intervals. This allows determining the degree and 
type of hearing loss and often, taking into account the medical history and 
examination, its underlying cause. Both for HAs as for AHIs, aided PTA can be 
determined in a sound field measurement. These measurements are often 
performed with warble tones with the speaker positioned at 0° azimuth in 
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unaided and aided conditions. It is important that the contralateral ear should 
be adequately covered or plugged and masked. In case of severe to profound 
MHL of both ears, a masking dilemma can occur (Figure 1.10). Because of an 
important degree of inner ear hearing loss, the Weber tuning fork test is not 
practicable anymore. Therefore, insert phones improving the interaural 
attenuation can be used (Munro, 1999). Also other tests such as the 
Sensorineural Acuity Level test (SAL) or bone conduction ABR are worthwhile 
(Webb & Greenberg, 2000). 
 
 
Figure 1.10 Pure tone audiometry obtained with insert phones, of a subject with masking 
dilemma. 
Speech reception tests, analyzing the ability to perceive and recognize complex 
speech sounds, are more pertinent to the hearing in the daily communicative 
environment. Certainly important is the testing in quiet, such as the 
standardized monosyllabic testing, for example the NVA monosyllables in Dutch 
or Freiburger monosyllables in German. Word recognition scores are tested at 
different intensities, often at 50, 65 and 80 dB SPL. More meaningful to the 
real-life situation is the assessment of the communication in difficult listening 
condition such as background noise (Woods et al, 2010). For this purpose, the 
estimation of the speech reception threshold (SRT) for supra-threshold speech 
stimuli presented in noise is highly valuable. If listeners with an important 
sensorineural hearing loss would be fitted with an HA or AHI according to the 
pure tone thresholds alone, a more affected supra-threshold SRT in noise can 
be overlooked, possibly leading to the general complaint: “I can hear what 
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people say, but I can’t understand them” (Plomp, 1978). For hearing impaired 
subjects, adaptive sentence tests for the assessment of speech understanding in 
noise are often used, with a noise level fixed at 65 dB SPL (van Wieringen & 
Wouters, 2008). As shown in Figure 1.11, the SRT is defined as the SNR, at 
which 50% of the words in a sentence are correctly repeated, most commonly 
done as a simple 1-up 1-down adaptive procedure, with a step size of 2 dB 
(Plomp & Mimpen, 1979). 
 
 
Figure 1.11 Graph represents a speech in noise testing; red line indicates the SRT. 
Self-reported measures, such as the subjective assessment of a hearing system 
reported by its wearer, representing the disability of life, are becoming 
increasingly important. Notwithstanding that most patients are biased because 
they cannot wear HAs for several reasons, establishing functional benefits in a 
veritable world environment through validated standardized questionnaires is 
mandatory. Rapidly, with raising global pressure on healthcare budgets, these 
instruments measured prior to and after the implantation, are gaining 
importance. Many questionnaires are being used; a selection is mentioned 
here. 
The Abbreviated Profile of Hearing Aid Benefit (APHAB) is a 24-item self-
assessment inventory in which the subject reports the amount of trouble 
she/he is having with communication or noises in various everyday situations 
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(Cox & Alexander, 1995). Benefit is calculated by comparing the wearer’s 
reported difficulty in the preoperative unaided condition to their amount of 
difficulty when using amplification. The APHAB produces scores of four 
subscales: ease of communication, reverberation, background noise and 
aversiveness. Higher scores reflect more communication problems. 
The Health Utilities Index (HUI®) is a generic, preference-scored, comprehensive 
system for measuring the health status and the health related quality of life and 
for producing utility scores. The HUI used in 0 is a 15-item self-administered 
questionnaire that has been designed to ask the minimum number of questions 
required to classify a subject’s health status.  
Additionally, evaluating sound localization and spatial aspects in subjects with 
unilateral or bilateral hearing loss with HAs and AHIs can be performed with the 
questionnaire derived from the 50-item Speech, Spatial and Qualities of Hearing 
Scale (Gatehouse & Noble, 2004). For all these questionnaires, validated Dutch 
translations are available. The SSQ was translated to Dutch by members of 
ExpORL-KU Leuven and has been used for the evaluation of the functional 
benefit in percutaneous BCIs (van Wieringen et al, 2011). 
 
1.6 Research objectives 
Direct acoustic cochlear stimulation has recently been proposed as a possible 
treatment of MHL that may resolve power constraints of other AHIs or hearing 
aids. The general aims of this PhD project were 1) the audiological evaluation of 
the clinical application of DACI2 in a limited number of subjects with severe to 
profound MHL, 2) the investigation and development of objective measures to 
quantify the functionality of DACI and 3) the study of optimal coupling 
strategies to the inner ear. These objectives are related to the more specific 
research questions. 
The general research questions were: 
1. What is, in literature, currently regarded as the evidence-based 
treatment of MHL? 
                                                                
2 Unless otherwise specified, the DACI used and referred to in this work is the Codacs 
system (Cochlear Ltd). 
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2. What is the efficacy of a DACI in audiological terms? 
3. Is it possible to develop objective measures for direct acoustic cochlear 
stimulation and can we reliably obtain electrophysiological thresholds 
in subjects implanted with a DACI? 
4. Is it possible to couple the DACI at an easy accessible inner ear site and 
does it provide sufficient gain? 
The first main objective comprised a complete clinical evaluation of the DACI 
device in subjects with severe to profound MHL. Previous studies showed 
beneficial speech understanding in quiet due to its powerful amplification 
mainly investigated in comparison to the unaided situation in a selected group 
of subjects with otosclerosis (Lenarz et al, 2013). Also in DACS-PI (Phonak 
Acoustic Implants SA, Switzerland), the first clinical results on speech 
understanding compared to HAs have recently been reported (Busch et al, 
2013). Together with the surgical aspects, the audiological efficacy of the device 
needed to be investigated in a broader indication range of subjects with severe 
to profound MHL. Five tertiary referral centers in Europe participated in this 
study. As a first goal, speech understanding in quiet and certainly in noise was 
investigated, comparing the device to the subject’s best alternative treatment. 
Because of its powerful amplification, it is questioned whether this new 
technology can improve the signal-to-noise ratio for people with MHL, 
especially in difficult listening conditions. Additionally, because patients are 
treated, we aimed to extensively evaluate the amount of difficulty experienced 
with communication in various everyday situations and the impact of the 
hearing rehabilitation on general health and hearing. Previously to this research 
and as guidance for evidence-based research, the current literature was 
reviewed extensively for results on the hearing rehabilitation of purely MHL. 
Special attention is needed as its treatment balances between the need to 
overcome middle ear function and to explore the remaining cochlear reserve, 
without compromising either one of them. 
The second objective of this project was to develop and to investigate a method 
for the objective evaluation of the coupling of the DACI to the inner ear and the 
entire auditory pathway. Similar to CIs (Ménard et al, 2004; Hofmann & 
Wouters, 2010) we aimed to explore, in a non-invasive manner, the feasibility 
that ABRs and ASSRs can be evoked in response to acoustic stimulation with a 
1.7 Thesis outline 57 
DACI, and that they are closely related to behavioral measured thresholds. Only 
two studies have investigated the use of auditory evoked potentials in patients 
with AHIs (Colletti et al, 2012; Verhaegen et al, 2010), neither of them with 
digital speech processing devices, nor for the absolute determination of ABR 
and ASSR thresholds. 
As a third objective, the feasibility of coupling the DACI actuator to an 
anatomically easy accessible inner ear site was investigated in terms of acoustic 
performance. Surgery for DACI implantation is much alike cochlear implantation 
with risks of facial nerve exposure and inner ear damage. Consequently, it 
would be very interesting to develop an easier coupling strategy to the inner 
ear avoiding this exposure retaining, however, its powerful and broad spectrum 
output. The lateral semicircular canal (LC), being a part of the inner ear 
structures, is rapidly encountered when opening the mastoid cavity without the 
need for facial nerve exposure. For this reason, the standard coupling to the 
oval window was compared to different couplings at the level of the LC. 
Moreover, a stapes footplate fixation, as in otosclerosis, was induced artificially 
elucidating its impact on the DACI stimulation at the LC. 
 
1.7 Thesis outline 
In order to provide answers on the research questions raised in the previous 
paragraph, four studies have been carried out. The first two studies (Chapter 2 
and 3) will elaborate the questions regarding the first objective, the third study 
(Chapter 4) regarding the second objective and finally the fourth study (Chapter 
5) regarding the last. 
In Chapter 2, a systematic review of the literature was carried out to determine 
the clinical outcome and safety of the whole range of AHI in adults with MHL, 
using the databases of MEDLINE, Embase and the Cochrane Library up to March 
1, 2013. Previous work on conductive and sensorineural hearing loss solutions 
was excluded. The search syntax is shown in Appendix A.1. A study quality 
assessment was performed in the first part of this chapter. Meta-analyses could 
not be performed because of the heterogeneity of the studies. Therefore, in the 
second part, the results were presented in tables with structured review of 
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different outcome measures: safety, PTA, functional gain, impact of coupling, 
speech understanding in quiet and in noise, patient-reported measures. The 
content of this chapter has been published in Otology & Neurotology (Verhaert 
et al, 2013a). 
Chapter 3 reports the prospective audiological evaluation of the Codacs DACI, 
with a focus on speech understanding in quiet and in noise, in a multicenter 
study. The subjects, suffering from severe to profound MHL were fitted with 
hearing aids and/or a bone conduction implant on a headband before DACI 
implantation. This allowed direct comparison between different hearing 
rehabilitation solutions. Safety of the procedure and the subjective benefit 
were assessed. The content of this chapter has been published in Audiology & 
Neurotology (Verhaert and Lenarz3 et al, 2014). 
In Chapter 4, the development of objective measures for direct cochlear 
acoustic stimulation in humans was described. By measuring auditory evoked 
potentials the auditory pathway could be evaluated after DACI implantation in 
subjects with some remaining cochlear reserve. Specific research development 
items were the artifacts analysis of the implant and electrophysiological 
threshold determination using Auditory Brainstem Responses and Auditory 
Steady-State Responses in three subjects implanted at the University Hospitals 
Leuven. The three subjects formed part of the multicenter study described in 
Chapter 3. The content of this chapter has been submitted to Ear and Hearing 
(Verhaert and Hofmann et al, 2014). 
Another experimental investigation of direct acoustic cochlear stimulation is 
reported in Chapter 5, aiming to simplify the surgical coupling to the inner ear 
and to broaden the indication range. The feasibility of coupling the DACI device 
to the LC, thereby creating a ‘third-window’ in addition to the normal oval and 
round window of the human cochlea was examined. RW velocity, as a measure 
of the device’s performance and its coupling efficiency, was determined in 
fresh-frozen human cadaver heads using a LDV setup. The output of the device 
stimulating this ‘third-window’, even in case of stapes footplate fixation, was 
compared to the standard setup. The material presented in this chapter has 
been submitted to Hearing Research (Verhaert et al, 2014b). 
                                                                
3 If two names are cited, joint first authors are indicated. 
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In Chapter 6, the general findings of this PhD project are discussed and future 
research directions are presented.  
In Appendix A, to conclude, the search syntax and study selection criteria of the 
systematic review in Chapter 2 are described. Also the protocol of the 
prospective multicenter study from Chapter 3 is given. 
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  Chapter 2
Acoustic hearing implants for mixed 
hearing loss: a systematic review4 
2.1 Abstract 
Objective: A systematic review of literature to determine the clinical outcome 
and safety of the range of acoustic hearing implants (AHIs) in adults with mixed 
hearing loss (MHL). Data sources: Databases MEDLINE, Embase and Cochrane 
were searched with no language restrictions between 1950, or the start date of 
each database, up to March 1, 2013. Study Selection: Initial search found 1794 
studies, of which, 19 met the inclusion criteria of AHI for adults with MHL where 
safety, coupling strategies to the inner ear, hearing outcome and patient-
reported outcome measures (PROMs) were analyzed, preferably compared to a 
conventional hearing aid or a bone-conduction implant. Data extraction: A 
study quality assessment based on different parameters was included: 
specification of eligibility criteria, prospective study, ethical approval gained, 
appropriate controls, power calculation, outcome measures, and analysis 
performed. Data synthesis: Comparisons between studies were made based on 
structured review, as meta-analysis was not feasible because of the 
heterogeneity of outcome measures and reports. Conclusion: The current 
systematic review shows that AHIs and their different coupling strategies in the 
treatment of MHL were beneficial in terms of speech in quiet, PROM and safety 
regarding residual hearing. Overall, the level of evidence and the quality of the 
included studies was judged to be moderate to low. More comprehensive data 
on coupling to the inner ear and the comparison with conventional hearing aids 
                                                                
4 The content of this chapter has been published as: Verhaert N., Desloovere C., Wouters 
J. 2013. “Acoustic hearing implants for mixed hearing loss: a systematic review.” In: Otol 
Neurotol, 34:1201–9. 
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or alternatives for speech in noise is mandatory. Long-term follow-up data are 
also needed. Level of evidence: 3a 
 
2.2 Introduction 
Mixed hearing loss (MHL) is defined as a combination of conductive and 
sensorineural hearing loss. Different degrees of severity of MHL can be caused 
by several pathologies. One of them is otosclerosis, a disease characterized by 
lesions in the endochondral bone of the otic capsule (Chole & McKenna, 2001). 
A ‘cochlear’ otosclerosis is associated with sensorineural hearing loss. It has 
been estimated that 1.6% of patients with otosclerosis will eventually develop 
profound sensorineural hearing loss (Shea et al, 1999). A second pathology 
possibly resulting in MHL is chronic otitis media. Because of inflammation 
associated with, for example, tympanic membrane retraction, cholesteatoma or 
previous surgery, both conductive as sensorineural hearing loss can occur. Poor 
hearing outcome has been explained by absent or diminished ventilation of the 
middle ear space, prosthesis extrusion, tympanosclerosis, scar tissue, tympanic 
membrane lateralization and eroded or missing ossicles, even after proper 
placement of passive middle ear implants such as total or partial replacement 
prostheses (TORP or PORP) (Linder et al, 2009). Often in chronic otitis media 
cases with sequelae at the tympanic membrane (perforations or 
tympanosclerosis) or large open cavities, the use of conventional hearing aids 
(HAs) is problematic and unsatisfactory. 
Morphological abnormalities like congenital malformations could present 
themselves with MHL, even if conductive hearing loss is more frequent. The 
incidence of aural atresia is about 1:10000 births (Melnick et al, 1979). Other 
more seldom causes of MHL are associated with trauma; labyrinthine contusion 
and temporal bone fracture with stapes footplate fracture have been described. 
Over the last years, conventional HAs, although remarkably improved, have not 
always been able to overcome certain anatomical and hearing loss issues, as 
mentioned above. Acoustic hearing implants (AHI) can be divided in active and 
passive implants, whether the function of the implants depends on external 
energy or not. Currently, these AHI cover the broad range of mostly passive 
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bone-conduction implants, such as osseointegrated bone-conduction implants 
(BCI, formerly Bone-Anchored Hearing Aid (BAHA)), to active middle ear 
implants (AMEI) and direct acoustic cochlear implants, named DACI or DACS 
depending of the source of publication.  
Passive osseointegrated BCI could partially overcome the sensorineural hearing 
loss up 40 to 50 dB HL, as shown with the body-worn Baha Cordelle (Bosman et 
al, 2006). Substantial work comparing outcome of passive bone-conduction 
implants in severe MHL with matched HA controls have been performed by the 
Nijmegen group (Mylanus et al, 1994). Initially, certain AMEIs were thought to 
be an alternative to HA in sensorineural hearing loss for different reasons. A 
systematic and comprehensive review of the safety and benefit of AMEI for 
sensorineural hearing loss was performed by Tysome et al (2010). AMEIs are 
now approved for use in conductive and mixed hearing losses (Verhaert et al, 
2011). Snik et al (2004) evaluated the outcome of two electromagnetic AMEI. 
For the heterogeneous group of pathologies causing MHL different strategies 
for hearing rehabilitation have been proposed, some even as a combination, for 
instance, like TORP with AMEI (Beleites et al, 2011). Recently a new hearing 
implant has been introduced for severe to profound MHL, namely, the DACI 
system (Bernhard et al, 2006). An artificial actuator is coupled to a stapes piston 
within the vestibule, driving directly the cochlear fluids. Finally, the use of 
cochlear implants (CIs) for profound MHL, as seen in far advanced otosclerosis, 
has been described comprehensively before (Merkus et al, 2011).  
With the rise of new AHI solutions and, more importantly, new coupling 
strategies to the inner ear, an evidence-based overview for clinical use and 
decision-making is mandatory. By applying robust methodology to different 
studies of variable quality, a systematic review enables to evaluate the 
effectiveness of AHI in MHL. Different applications, coupling systems and their 
respective safety can be explored by analyzing the reported complication rate 
and the impact on residual sensorineural hearing. The efficacy of AHI in terms 
of functional gain, speech understanding in quiet and noise and PROM will be 
investigated. 
 
64  AHI for mixed hearing loss 
 
2.3 Methods 
This review was reported in accordance with the Preferred Reporting Items for 
Systematic reviews and meta-analyses statement (Moher et al, 2009).  
2.3.1 Search strategy 
A systematic review of the literature was conducted, without language 
restrictions, using the databases of MEDLINE (PubMed), Embase (based on 
EMTREE terms), and the Cochrane Library up to March 1, 2013. Search syntax is 
shown in Appendix A1. 
2.3.2 Study selection  
Studies were judged for inclusion if they fulfilled the criteria as determined in 
Appendix A2. All studies were assessed by reading title and abstract, then by 
retrieving the full article, hereby making the final selection based on the 
inclusion criteria. References and related articles were screened to verify if all 
valuable articles were included. Case reports, reviews and editorials were 
excluded. 
2.3.3 Data extraction 
Data was extracted from the included studies using standardized formats 
incorporating the following variables: number of patients, type of pathology, 
type of AHI, coupling to inner ear, time of follow-up, outcomes and level of 
evidence. The level of evidence was assessed according to the criteria of the 
Centre for Evidence-Based Medicine (University of Oxford), in agreement with 
the Belgian Centre for Evidence-Based Medicine, a branch of the Cochrane 
collaboration (Oxford Centre for Evidence-Based Medicine, 2009). 
Outcomes were recorded in terms of initial mean bone conduction (BC) 
thresholds determining the severity of inner ear damage, complications of 
procedure, functional gain, speech understanding in quiet and in noise and 
validated PROM questionnaires. Many variables and formats have already been 
suggested by Tysome et al (2010).  
2.4 Results  65 
2.3.4 Methodologic quality 
The quality of studies was assessed based on different categories: ethical 
approval, prospective study, eligibility criteria specified, a power calculation 
made, appropriate controls and outcome measures used, confounding factors 
reports and controlled for, appropriate analysis made, and any missing data 
accounted for (Tysome et al, 2010). 
2.3.5 Devices 
In this review several types of implantable hearing solutions are included: CI, 
osseointegrated bone-conduction implant (BCI) such as BAHA (Cochlear Bone 
Anchored Solutions AG, Mölnlycke, Sweden), Vibrant Soundbridge (VSB) and its 
floating mass transducer, FMT, (MED-EL, Innsbrück, Austria) and Otologics with 
its Middle Ear Transducer (MET-V, Otologics & Cochlear™, Boulder, CO, USA). 
Direct acoustic cochlear implantation, with the DACI system, has been 
described in previous reports (Bernhard et al, 2006; Häusler et al, 2008). As all 
devices have been described exhaustively previously, no additional description 
is provided in this review. 
 
2.4 Results 
2.4.1 Study selection and characteristics 
Figure 2.1 shows a flow chart of study selection process. Nineteen studies met 
the inclusion criteria, and 11 studies were excluded because only joint data on 
MHL and conductive hearing loss were presented and no separate analysis was 
performed, for example in Mylanus et al (1994) or in Verhaert et al (2011). 
Other, although valuable, studies showed nonextractable data because missing 
standard deviations or raw data, for example in the study of Lachance et al 
(2012). Many studies had different setup or outcome measures, making them 
unsuitable for comparison in this systematic review. 
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Figure 2.1 Flow chart of study selection. 
 
In all but 1 study, patients served as their own controls. Verhaegen et al (2012) 
represents the exception, as a group of hearing-matched patients with BCI and 
a group of sensorineural hearing loss patients with AMEI were chosen for 
comparison. Table 2.1 summarizes the characteristics of each included study. 
Speech tests in quiet were recorded in English, German, French, Italian, Dutch 
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and Cantonese. In some languages, both monosyllabic and disyllabic words 
were used. PROM was mainly assessed by the Abbreviated Profile of Hearing 
Aid Benefit (APHAB) questionnaire (Cox & Alexander, 1995), some also used the 
Glasgow Benefit Inventory (GBI) and the Hearing Device Satisfaction Scale 
(HDSS). 
2.4.2 Methodological quality of studies 
Neither a randomized controlled trial, nor a cross-sectional study was included. 
Figure 2.2 provides an overview of the different categories mentioned in the 
Methods section. It shows that only 21% of the studies were prospective cohort 
studies. Follow-up ranged from 6 weeks to 48 months. Seven studies reported 
on PROM. 
 
Figure 2.2 Quality of studies included. 
 
Many study protocols described correctly the patient selection criteria. 
Contrastingly, the results were not fully described in the text and confounding 
factors rarely addressed. Although comparison to alternatives, such as HA or 
TORP is not feasible for each pathology or subject, only few studies addressed 
this comparison. 
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Statistical comparison of the data is rendered difficult due to the small size of 
many of these studies. Meta-analyses could not be performed due to the 
heterogeneity of the studies. Therefore, similar as in Tysome et al (2010), the 
results are presented in tables with structured review. Rating the quality of 
these studies coherently was difficult because of the different study design and 
risk of bias; hence we divided them quantitatively. Two studies reported all 
categories of outcome measures specified in this review (de Wolf et al, 2011; 
Rajan et al, 2011). Nine studies reported between 5 and 8 categories, 
respectively, 8 under 5 categories. 
2.4.3 Outcome measures 
Safety  Complications were reported in 11 of the 19 articles (Table 2.2). 
One device failure was noted with the totally implantable MET system, 1 with 
the VSB system. Several TORP extrusions were noted in the comparative study 
of Colletti et al (2009). Respectively 3 VSB and 2 MET explantations were 
reported in the included studies. In general, most problems occurred in 
repositioning the FMT because of insufficient gain.  
 
Pure tone audiogram In most, but not all, studies the mean PTA was 
calculated according to AAO-HNS criteria (averaging the AC and BC pure tone 
thresholds at 0.5, 1, 2, 3 kHz). In general, residual hearing stayed unchanged, as 
shown in Table 2.3. Häusler et al (2008) measured an improvement of BC 
mainly at the Carhart notch. Two studies reported a deterioration of BC after 
the procedure: Linder et al (2009) noted a BC loss at 2 kHz of 10 to 30 dB after 
subtotal petrosectomy and VSB implantation. Colletti et al (2006) reported a 
mean BC threshold loss of 5 to 7 dB when placing a FMT to the round window 
(RW). Three studies did not specify the residual hearing; 2 out of these 3 were 
BCI procedures with no supposed risk to the inner ear.  
In 13 of the 19 studies, the mean preoperative BC was clearly cited. This varied 
between 38 and 53 dB HL with a median value of 39 dB HL, showing a moderate 
to severe hearing loss. Some subjects of the included studies had profound 
MHL, mainly in the studies of Bosman et al, (2006) and Häusler et al (2008).  
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Table 2.2 Complications of acoustic hearing implant in mixed hearing loss. 
Study 
No. Of 
patients 
Device Complications 
(Häusler et al, 
2008) 
4 DACI 1 temporary dysgeusia 
(Böheim et al, 
2012) 
12 VSB-RW 
1 FMT displacement; 1 recurrent 
cholesteatoma 
(Schwab et al, 
2012) 
3 VSB-TORP None 
(Kontorinis et 
al, 2011) 
2 VSB-stapes Bleeding intra-operatively 
(Orús Dotú et 
al, 2011) 
12 BCI 3 partial flap necrosis; 1 skin overgrowth 
(Martin et al, 
2009) 
11 MET 
2 explantations due to infection; 1 SNHL; 1 
device failure 
(Colletti et al, 
2009) 
38 
TORP 
versus VSB-
RW 
2 TORP extrusions, 2 TORP revision surgery for 
poor result; 2 VSB explantations: 1 for 
insufficient gain, 1 for device failure 
(Linder et al, 
2009) 
5 
SP + VSB-
RW 
1 retro-auricular wound infection; 1 system 
noise  
(Rajan et al, 
2011) 
10 VSB-RW 
1 explantation for infection; 1 inner ear 
damage; 3 FMT repositioning 
(Bernardeschi 
et al, 2011) 
25 VSB 
2 revisions for FMT displacement at RW; 1 
revision for stapedotomy with vertigo 
(Verhaert et al, 
2013b) 
16 
SP + VSB-
RW, -
stapes 
4 wound healing problems; 1 additional 
hearing loss 
SP, subtotal petrosectomy; FMT, Floating mass transducer, SNHL, sensorineural hearing 
loss. 
 
Functional gain  There was no uniform definition of the functional gain with 
AHI in the included studies. This renders results difficult to compare. Table 2.3 
provides the mean gain in dB when reported; for some studies, the range was 
given, depending on the frequency. Many authors defined functional gain as the 
improvement in PTA or in speech perception aided versus unaided 
preoperatively, some even postoperatively. In 3 studies, the gain was stated as 
an improvement over BC thresholds in aided condition. Bosman et al (2006) 
reported 1.5 dB gain at 0.5 kHz, 17.8 dB at 2 kHz; Colletti et al (2006) 0 (at 
0.5Hz) to 20 dB (higher frequencies); Beltrame et al (2009) described a mean 
gain of 12 dB on 2 kHz, but less at 0.250 and 0.5 kHz. Häusler et al (2008) stated 
the gain in terms of improvement with the DACI system activated versus HA 
with stapedotomy, showing an average improvement of 7.5 dB PTA for the first. 
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Impact of coupling  As shown in Table 2.1, 17 of the 19 studies provide details 
on the coupling to the middle or inner ear structure. In total, 155 subjects were 
implanted at the RW site, with or without coupler or fascia. Most of them were 
implanted with a VSB, 11 with a MET coupled to a ball prosthesis. Furthermore 
24 FMT’s were coupled to the stapes suprastructure or footplate, 13 to an oval 
window coupler. Three FMT and 4 DACI devices were coupled to a stapes 
piston.  
 
Speech understanding in quiet Table 2.3 gives a detailed overview of speech 
reception scores in quiet. Because to different speech material, an overall 
comparison of the study results is impossible. Kontorinis et al, (2011) compared 
rigorously outcomes to the preoperative HA-aided speech reception. A 
significant improvement of speech in quiet scores was noted when aided with 
VSB and stapes prosthesis in comparison to preoperatively aided situation with 
HA. In a study of Colletti et al (2009), a cohort-controlled study showed a 
statistical significant difference between a group of subjects aided with a RW-
VSB compared to subjects helped with a TORP alone, stating an aided speech 
reception score in quiet (at 65 dB HL, sic) of 86.2% (Standard deviation, SD = 
36.5) and 22.1% (SD = 11.3), respectively. Häusler et al (2008) compared the 
postoperative sound field results, showing an average improvement of 7.5 dB 
PTA for the DACI system in comparison to HA with stapedotomy. 
Speech understanding in noise  As shown in Table 2.3, none of the included 
publications compared AHI versus HA in noise. Six of the 19 included studies 
tested speech understanding in noise and compared this to the preoperative or 
postoperative unaided condition. de Wolf et al (2011) found a significant 
correlation between speech in noise scores and the air-bone gap, concluding 
that above an air-bone gap larger than 30 to 35 dB signal-to-noise ratio (SNR) 
were better with an osseointegrated BCI than with HA, but no mean values for 
the cohort were provided. Häusler et al (2008) reported on 50% speech 
understanding in noise in 2 subjects showing a significant improvement 
compared to the unaided condition. Yu et al (2012) showed a significant SNR 
improvement of 2.8 dB at noise in front. Rajan et al (2011) showed significant 
improvement in percentage correct using BKB sentences test. Böheim et al 
(2012) noted a statistically significant improvement of SNR ranging from 10 dB 
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preoperatively to 5 dB over 40 months of follow-up. Finally Beltrame et al 
(2009) reported a SRT 7 to 13 dB greater than normal-hearing controls. 
Table 2.3 Audiological outcome of acoustic hearing implants in mixed hearing loss. 
Study AHI 
Functional gain 
on PTA (unaided 
vs aided) 
Mean 
BC 
Residual 
hearing 
Speech 
perception in 
quiet vs control 
Speech 
perception in 
noise vs control 
(Streitberger et al, 
2009) 
VSB 30 44 = ++ not done 
(Bosman et al, 
2006) 
BCI NS 54 NA NS not done 
(Colletti et al, 
2006) 
VSB [10-40] 37 
↓ 5 à 7 dB 
HL 
++ not done 
(Häusler et al, 
2008) 
DACI 51 NS > ++ ++ (n=2) 
(Böheim et al, 
2012) 
VSB [15-43] NS = ++ ++ 
(Schwab et al, 
2012) 
VSB 36 [24-48] 35 = ++ not done 
(Yu et al, 2012) VSB 11* 39 = ++ ++ 
(Verhaegen et al, 
2012) 
VSB [ 0-28 ]** NS = = not done 
(Beleites et al, 
2011) 
VSB 26 45 = ++ not done 
(Kontorinis et al, 
2011) 
VSB 37 [33 – 44] 47 = ++ not done 
(Orús Dotú et al, 
2011) 
BCI 46 51 = ++ not done 
(Martin et al, 
2009) 
MET 29 NS = ++ not done 
(Colletti et al, 
2009) 
VSB vs 
TORP 
58 (SD=39) vs 10 
(SD=14) 
NS NS ++ not done 
(Linder et al, 2009) VSB 40 NS 
↓ 2kHz 10-
30 dB 
++ not done 
(Rajan et al, 2011) VSB NS NS NS NS ++ 
(de Wolf et al, 
2011) 
BCI NS 38 = + = 
(Bernardeschi et 
al, 2011) 
VSB 24 42 = + not done 
(Beltrame et al, 
2009) 
VSB 38* 44 = ++ ++ 
(Verhaert et al, 
2013b) 
VSB 33 38 = ++ not done 
In comparison to control: ++ indicates significant positive outcome; + positive 
outcome (not significant or no significance reported); = no difference; - negative 
outcome (not significant or no significance reported). NS= not stated or calculated; 
NA= not applicable; vs= versus. * compared to postoperative unaided values; ** 2 
non-users. 
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Self-reported measures  Table 2.4 provides an overview of the results 
obtained with different questionnaires, as investigated by 7 of the 19 studies. 
Six studies reported on APHAB, 2 on GBI and 1 on HDSS. Overall, APHAB scores 
show a significant improvement in ease of communication, reverberation in 5 of 
6 studies, and for background noise in 4 of 6. Overall, aversiveness did not 
change significantly. GBI showed a positive impact on the general benefit. In the 
study of Linder et al (2009), the combined effect of the middle ear exclusion 
and the VSB application was evaluated.  
Table 2.4 Validated patient-reported outcome measures (questionnaires). 
Study 
No. Of 
patients 
Device APHAB HDSS GBI 
(Häusler et 
al, 2008) 
4 DACI 
++EC, ++RV, ++BN, -AV 
in 1 pt, +AV in 1 pt   
(Böheim et al, 
2012) 
12 VSB ++EC, ++RV, ++BN, -AV ++ 
++ general, = social 
and physical 
(Yu et al, 
2012) 
5 VSB = 
  
(Martin et al, 
2009) 
7 MET ++EC, +RV , =BN , -AV 
  
(Linder et al, 
2009) 
5 
VSB in subtotal 
petrosectomy   
+ general, 
+physical, = social 
(Rajan et al, 
2011) 
10 VSB – RW ++ 
  
(de Wolf et 
al, 2011) 
16 BCI vs HA 
++EC, ++BN, ++RV if 
ABG > 37-47dB; =AV   
In comparison to control: ++ indicates significant positive outcome; + positive outcome 
(not significant or no significance reported); = no difference; - negative outcome (not 
significant or no significance reported). If case is empty test was not performed. APHAB, 
Abbreviated profile of hearing aid benefit; EC, ease of communication; RV, 
reverberation; BN, background noise; AV, aversive sounds; HDSS, Hearing device 
satisfaction scale; GBI, Glasgow Benefit Inventory; pt, patient. 
 
2.5 Discussion 
This systematic review provides a current overview of published studies on the 
effectiveness of treatment of mixed hearing loss with AHI. Most studies appear 
moderate to low in evidence and mainly focus on precomparison and 
postcomparison with the subject acting as its own control, mainly unaided. 
Because of the heterogeneity of the studies, a meta-analysis could not be 
performed. An initial hypothesis of this systematic review was the question 
74  AHI for mixed hearing loss 
 
whether AHIs and more specifically AMEIs, improve as much as conventional 
HAs. Due to a lack of comparative studies, as in the review of Tysome et al 
(2010), the focus was laid on different gains, safety, improvement in speech 
understanding and patient-reported outcome measures. Solely based on the 
results in the current systematic review, an implementation in daily clinical 
practice remains difficult. In this systematic review, data on children were not 
included. Much of the data, however, could be extrapolated.  
A general remark is whether active and passive AHI should be assessed 
separately. The authors feel that, based on the hypothesis of this study, they 
should be assessed jointly, as BCI and AMEI could be considered as alternatives 
in different pathologies of MHL and are used likewise in the daily clinical 
practice. 
 
Safety  Most included publications have provided data on residual 
hearing. Only few deteriorations are noted. Taking into account the challenging 
pathology of chronic otitis media, advanced otosclerosis and congenital 
malformations, AMEI seems considerable as an alternative to safer procedures, 
like HA or osseointegrated BCI, at least in experienced hands. Tysome et al 
(2010) concluded that AMEIs were safe to implant for sensorineural hearing 
loss, based on his systematic review. Naturally spoken, longer follow-up period 
is needed: here, only 2 studies provide follow-up data longer than 2 years 
(Linder et al, 2009; Böheim et al, 2012)(Böheim et al, 2012; Linder et al, 2009). 
Two more studies followed their subjects up till 2 years (Häusler et al, 2008; 
Martin et al, 2009). Two studies addressed in detail the safety of AHI surgery in 
combination to a history of cholesteatoma (Linder et al, 2009; Verhaert et al, 
2013b). Based on their suggestions and because of the incompatibility of follow-
up with MRI for most current AHI, a staged procedure in case of possible 
recurrence of cholesteatoma with first-stage middle ear cleft exclusion plus 
obliteration and in second-stage AHI implantation seems advisable. 
 
Functional gain  Regarding outcome, comparison remains difficult 
because of different speech material, speech testing (both in quiet and in 
noise), and reporting. Some studies report the improvement in SRT, others the 
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improvement in percentage correct. Also few studies compared preoperative 
best-aided condition with HA or BCI. Colletti et al (2009) compared RW 
implantation versus TORP and showed a statistically significant difference in 
improvement between both groups postoperatively in speech understanding in 
quiet. They stated the need for additional gain in nonventilated or scarred 
middle ears. Some interesting studies on the outcome of older osseointegrated 
BCI types, such as the study performed by Mylanus et al (1994) on BAHA HC220, 
were not included in this review due to difficulty in comparing their results to 
current speech in noise data and the lack of functional gain data. 
It is a well known fact that most governmental reimbursement authorities focus 
on cheaper alternative treatments. Therefore, a comprehensive comparison 
determining the benefit not only in terms of speech understanding in quiet and 
noise both also in terms of PROM and disability of life score is needed if 
considering the most adequate treatment of MHL. Another important factor 
remains that different pathologies can have different outcomes. Most subjects 
have undergone several surgeries and were most probably not helped with 
classic middle ear surgery, HA or even BCI. Obviously this creates a selection 
bias. On the other hand if HAs are not possible, comparison remains difficult. 
Similar to some studies, future studies should compare both PROM as 
functional results to HA or the best-aided condition. As stated before, acoustic 
hearing implants, such as AMEI, BCI and DACI, can be considered as a relatively 
safe and effective treatment option particularly for patients who could not 
achieve sufficient benefit with an HA or conventional middle ear surgery. 
 
Impact of coupling  Different strategies for coupling an amplifier to the 
middle and inner ear structures have been described in the included studies. So 
far, numerous data are lacking to perform comparison between different sites 
and materials of coupling, but the number of studies increases. In the study of 
Streitberger et al (2009), a subject with a fixed stapes and inaccessible RW, 
received coupling of the FMT to a ‘third-window’ by cochlear fenestration. 
Kontorinis et al, (2011) provide evidence of a significant improvement 
compared to the preoperative HAs with a so-called ‘power-stapes’, a 
combination of a classic stapedotomy with clipping of the FMT on the subject’s 
own incus. Apart from the study of Häusler et al (2008), there is a lack of studies 
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comparing stapedotomy plus HA versus stapedotomy plus AMEI, most likely 
because of ethical reasons.  
An interesting finding remains the presence of fixation of the stapes footplate. 
Both experimental as clinical data on the effect of coupling to a fixed stapes 
have been reported (Verhaert et al, 2011; Devèze et al, 2010). Some authors 
perform a RW vibroplasty, others a clipping of the VSB on to the fixed stapes. 
The obtained results remain variable and some even with limited benefit. 
Therefore, some authors have advocated performing a stapedotomy with direct 
acoustic cochlear stimulation (Schwab et al, 2012). So far, this direct coupling to 
the inner ear has been described in two clinical studies: Häusler et al (2008) 
described the coupling of a DACI transducer to a stapes prosthesis, through a 
fenestration hole, in 4 patients with otosclerosis. Schwab et al (2012) described 
the coupling of a FMT to a TORP through a fenestration hole into the vestibule 
in 3 patients, two of them with stapes fixation because of former 
cholesteatoma pathology. Based on the published data at the time of this 
systematic review, one could conclude that direct cochlear stimulation remains 
still experimental, although in experienced hands, the results seem 
encouraging. 
 
Speech understanding Böheim et al (2012) mentioned an stable 
improvement from 10 dB SNR preoperatively to 5 dB SNR at an average follow-
up of 40 months. This study examined the same study cohort as in the article of 
Baumgartner et al (2010) but with longer follow-up. Similar trends were 
observed, but there was no significant difference between 3 months 
postoperatively and 40 months. (de Wolf et al, 2011) described a better speech 
in noise understanding with an osseointegrated BCI compared with an HA if an 
air-bone gap above 30 to 35 dB was present. Gunduz et al (2012) compared the 
preoperative use of HA with VSB application on middle ear windows 
postoperatively, expressing functional gain in PTA and in speech discrimination 
scores. They found better functional outcomes with VSB than with HA. 
However, speech understanding with VSB and HA was similar. Unfortunately, 
this study could not be included in the current review because no separate 
analysis was made for conductive and mixed hearing loss, biasing the 
comparison to other studies.  
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Self-reported measures  Most studies showed a marked satisfaction 
and better quality of life with little impact on the aversiveness scale. Again, it 
must be stressed that most of included subjects could not wear HA for several 
reasons, so selection bias is evident. Only 2 studies compared patient’s 
satisfaction with AHI to HA. Yu et al (2012) showed no statistical significant 
different based on the APHAB subcategories. de Wolf et al (2011b) showed 
statistically significant improvement with BCI over HA in case of an air-bone gap 
above 30 to 35 dB in 3 subcategories: ease of communication, background noise 
and reverberation.  
 
Quality of studies and assessment On the one hand, this review was 
biased toward VSB as the search retrieved more data on VSB; on the other hand 
this finding seemingly reflects the current clinical daily use. Pure conductive 
hearing loss was excluded. Speech in noise testing was poorly reported and 
complication rates seemed incomplete in some studies. Another minor factor 
that could not be controlled for was the different types of HA. Seven studies 
reported a number of treated subjects lower than 10, lacking strong evidence. 
Finally, to some extent like in the review of Tysome et al (2010), no studies 
stratified data for analysis based on confounding factors, like duration of 
deafness or severity of hearing loss, number of previous surgery or type of 
pathology.  
 
2.6 Conclusion 
Acoustic hearing implants, such as AMEI, BCI and DACI are increasingly applied 
in mixed hearing loss. Use of Vibrant Soundbridge and osseointegrated BCI 
seems reliable based on long-term data, although the coupling mechanisms 
with AMEI still need longer follow-up data. Based on functional outcome and 
subjective parameters, reports indicate that selected subjects gain good benefit 
from AHI as a relatively safe and effective treatment option. More comparative 
data, based on PROM and speech in noise, and adequate controls to the best-
aided condition are needed for adequate assessment of the benefit in terms of 
functional hearing. 
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  Chapter 3
A comparative study on speech in noise 
understanding with a direct acoustic 
cochlear implant in subjects with severe to 
profound mixed hearing loss5 
3.1 Abstract 
Objective: The aim of this study was to investigate the efficacy of a direct 
acoustic cochlear implant (DACI) for speech understanding in noise in patients 
suffering from severe to profound mixed hearing loss (MHL) due to various 
etiologies compared to the preoperative best-aided condition. The study was 
performed at five tertiary referral centers in Europe (Belgium, Germany, Poland 
and Spain). Nineteen adult subjects with severe to profound MHL due to 
(advanced) otosclerosis, ear canal fibrosis, chronic otitis media, 
tympanosclerosis or previous cholesteatoma, were implanted with a Codacs 
DACI combined with a conventional stapes prosthesis. Unaided and aided 
speech reception scores in quiet and in noise, preoperative and postoperative 
air and bone conduction thresholds and aided and unaided sound field 
thresholds were measured prospectively during the study. Subjective benefit 
analysis was determined through the Abbreviated Profile of Hearing Aid Benefit 
(APHAB) questionnaire. Quality of life was measured by the Health Utilities 
Index (HUI). All subjects were fitted preoperatively with hearing aids and/or a 
bone conduction implant on a headband before DACI implantation. This allows 
                                                                
5 The content of this chapter has published as: Verhaert N. and Lenarz T., Desloovere C., 
Desmet J., D’hondt C., González J.C.F., Kludt E., Macías A.R., Skarżyński H., Van de 
Heyning P., Vyncke C. & Wasowski A. 2014. “A comparative study on speech in noise 
understanding with a direct acoustic cochlear implant in subjects with severe to 
profound mixed hearing loss.” In: Audiology & neuro-otology, 19, 164–74. 
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direct comparison between different hearing rehabilitation solutions. The mean 
speech reception threshold in noise improved significantly by 7.9 dB signal-to-
noise ratio (SNR) after activation of the DACI compared to the preoperative 
best-aided condition. For all 19 subjects, a mean postoperative aided speech 
reception threshold of 2.6 dB SNR (standard deviation = 8.3) was measured. On 
average, no significant shift in the bone conduction thresholds was noted 4-5 
months after implantation. A mean sound field threshold improvement of 46 dB 
and 16 dB was measured compared to the preoperative unaided and best-aided 
condition, respectively. Speech reception tests in quiet showed a mean 
improvement of the word recognition scores by 65% and 48% at 65 dB SPL 
compared to the preoperative unaided and best-aided condition, respectively. 
In summary, DACI provides an effective improvement of the speech reception in 
noise compared to the best-aided condition in subjects suffering from severe to 
profound MHL. 
 
3.2 Introduction 
Severe to profound mixed hearing loss (MHL) remains a challenge for adequate 
hearing rehabilitation. Conventional hearing aids (HAs) have to overcome the 
air-bone gap and compensate for the sensorineural hearing loss component, 
possibly leading to feedback, sound distortion and output saturation issues 
(Verhaegen et al, 2012). In profound MHL, amplification remains insufficient for 
adequate speech understanding. Ear canal problems, such as ear canal 
infections or ear canal fibrosis, could complicate their application even more. 
Passive percutaneous bone conduction implants (BCIs) can overcome MHL with 
a sensorineural hearing loss component of up to 50 dB (Bosman et al, 2006; 
Snik et al, 2005). However, many clinicians consider 45 dB as the upper limit for 
the application of this type of devices. Numerous reports have been published 
on active middle ear implants (AMEIs) in case of moderate MHL (Baumgartner 
et al, 2010; Beltrame et al, 2009; Bernardeschi et al, 2011; Colletti et al, 2013; 
Dumon et al, 2009; Martin et al, 2009; Schwab et al, 2012). Luers et al (2013) 
provided a recent overview of new coupling methods for an AMEI to the stapes 
structure and round window in case of conductive hearing loss or MHL. For 
severe MHL the outcome with active middle ear implants remains variable 
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(Verhaegen et al, 2012). Recently a new type of acoustic hearing implant (AHI) 
has been introduced for this type and degree of hearing loss: a direct acoustic 
cochlear implant (DACI). DACI couple directly to the inner ear, i.e. via the oval or 
round window or via a surgically created ‘third-window’. As a result, 
pathological outer and middle ear structures of the ear are bypassed and the 
amplified signal is directly provided to the cochlea. Bernhard et al (2006) and 
Häusler et al (2008) first described a DACI called DACS. The successor of the 
DACS, the Codacs investigational device, has been applied in a first European 
multicenter clinical trial between 2009 and 2011, confirming the clinical efficacy 
and safety of the DACI in subjects with severe to profound MHL due to 
advanced otosclerosis (Lenarz et al, 2013).  
Depending on the patient’s individual situation, hearing loss due to otosclerosis 
can be treated with stapes surgery, HA, BCI or AMEI. HAs are usually very 
effective early in the course of the disease. However, when the conductive 
component increases, high power outputs are needed to compensate for the 
conductive component, which often leads to complications with feedback and 
distorted sound quality. In recent years, AMEIs were implanted in patients with 
moderate or severe MHL. Although the results in patients with moderate MHL 
are very promising, in patients with severe MHL they remain variable 
(Verhaegen et al, 2012). At a later stage of the disease, a stapes surgery may be 
required. Nevertheless after surgery, patients still have to wear a HA to 
compensate for the sensorineural hearing loss component. In more advanced 
otosclerosis, a cochlear implant (CI) is currently the only alternative treatment 
to a stapes surgery combined with postsurgery hearing aid amplification 
(Merkus et al, 2011). Other causes of profound MHL, which can be treated with 
DACI, are for example chronic otitis media with destruction of the ossicular 
chain and some degree of inner ear damage or tympanosclerosis. 
A recent systematic review on the application of acoustic hearing implants for 
MHL concluded that most implants have favorable outcome, despite a high 
degree of variability in the results (Verhaert et al, 2013a). To accurately assess 
outcomes prospective and comparative studies are needed to compare speech 
perception in noise for different kinds of hearing implants and HAs and to 
collect long term data. The aim of the current study was to prospectively 
investigate the speech reception threshold (SRT) in noise for individuals with 
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MHL due to various etiologies using a DACI, compared to their performance 
preoperatively in the best-aided condition. In addition, postoperative functional 
results, subjective patient-reported outcome measures and adverse events are 
presented. 
 
3.3 Material and methods 
3.3.1 Population and study design 
Twenty adult subjects were enrolled in this prospective study, running from 
January 2012 until February 2013 at five tertiary referral centers. Eight subjects 
were enrolled at the Hannover Medical School (Germany), 5 at the World 
Hearing Center (Poland), 3 subjects at the University Hospitals of Leuven, 2 at 
the University Hospital of Antwerp (both Belgium) and 2 at the University 
Hospital Insular De Gran Canaria (Spain). Table 3.1 gives an overview of the 
subjects’ demographics. Nineteen of the 20 enrolled subjects were implanted 
with the Codacs investigational device (Cochlear Ltd., Sydney, Australia), which 
was described in detail by Lenarz et al (2013). One patient could not be 
implanted due to severe ossification of the cochlea, not identifiable on the CT 
scan preoperatively. This patient was excluded from the data analysis of the 
treatment outcomes. The average age at the date of implantation was 61 years 
(range 47-77 yrs). The study population consisted of 12 females and 8 males. All 
subjects had severe to profound MHL and met the eligibility criteria of the study 
(see Appendix A3). Eleven subjects were inconsistent users of a HA prior to 
surgery. Subjects not consistently wearing a HA preoperatively were fitted with 
a HA or BCI on a headband for the preoperative measurements. Care was taken 
to fit them with the most optimal hearing device according to their individual 
situation and hearing loss, e.g. a BCI in case of ear canal fibrosis. Non-HA users 
could not be fitted with a HA or BCI for a longer period of time due to logistical 
issues. However, most of the subjects had experience with hearing devices on 
the ipsilateral and/or contralateral ear (which facilitated the fitting procedure). 
On the contralateral ear, 9 subjects were fitted with a hearing aid, 1 subject had 
a CI (HiRes 90K, Advanced Bionics, Valencia, CA, USA), 1 subject was implanted 
with a Vibrant Soundbridge (VSB, MED-EL, Innsbruck, Austria), 1 subject was 
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wearing a DACS-PI (Phonak Acoustic Implants, Phonak AG, Stäfa, Switzerland) 
and 8 subjects did not use any amplification. The etiology of the hearing loss 
was otosclerosis for the majority of the enrolled subjects (n = 16, 80%), and 
tympanosclerosis, previous chronic otitis media, ear canal fibrosis and previous 
cholesteatoma each in 1 subject (5%). Nine of the 20 subjects (45%) had 
(several) previous surgery/surgeries in the implanted ear (stapedotomy, 
tympanoplasty, myringoplasty). The surgical technique to implant the direct 
acoustic cochlear implant was described by Lenarz et al (2013). 
Each subject served as his/her own control in this prospective single-subject 
repeated-measures study design. Given the paired setup of the study, the 
measurements done prior to implantation with the DACI and at 3 months after 
the initial activation of the DACI were compared pairwise using the paired 
Student’s t-test (parametric test) or the Wilcoxon matched-pairs signed-rank 
test (nonparametric test). The normality of the data distributions was checked 
with a one-sample Kolmogorov-Smirnov test. Only complete datasets were 
included for statistical analysis. In case of the presence of outliers and/or low 
numbers of complete pairs and/or no normal data distribution, nonparametric 
testing was used. Statistical analysis was performed with PASW 20.0 (SPSS 
Software®, SPSS Inc, Chicago, IL, USA). Throughout the entire statistical analysis, 
a significance level of 5% was adopted. A power calculation was done prior to 
the study to define the required number of subjects. All patients gave their 
written informed consent before being enrolled in the clinical trial. This study 
was approved by the ethical committee of each center and the competent 
authority of each country involved in the trial. The principles outlined in the 
Declaration of Helsinki (2008) were followed. 
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3.3.2 Audiometric Testing 
Pre- and postoperatively, all subjects underwent comprehensive audiological 
and medical evaluations. Audiological testing consisted of air conduction (AC, 
0.125-8 kHz) and bone conduction (BC, 0.25-4 kHz) audiometry. Sound field 
measurements were performed with warble tones ranging from 0.125 to 8 kHz 
(including half-octave bands) with the speaker positioned at 0° azimuth in 
unaided and aided conditions with the contralateral ear plugged and masked. 
All subjects were measured in their best-aided condition preoperatively, using 
their own HA (40%), a clinical trial/loan HA (20%) or a BCI (Baha Cordelle, 
Intenso or BP110) on a headband (40%), the latter two for acute testing. The 
DACI was activated 6 to 8 weeks after surgery. Preoperatively, and 
subsequently postoperatively at time of activation, 1 and 3 months after 
activation, speech reception tests were performed in aided condition with the 
contralateral ear plugged and masked if required. Speech audiometry tests 
using standardized Dutch (NVA monosyllables), German (Freiburger 
monosyllables), Polish (Pruszewicz monosyllables) and Spanish (bisyllabic) 
words were performed to assess the patients’ word recognition scores (WRS) in 
quiet at 50, 65 and 80 dB SPL. To evaluate the SRT in noise adaptive sentence 
tests in noise were used with a noise level fixed at 65 dB SPL (Belgium: LIST 
sentences; Germany: OLSA; Poland: sentence matrix test; Spain: Spanish HINT 
sentences) at 0° azimuth with speech and noise both coming from the front 
(S0N0), 3 months after activation. The SRT is defined as the signal-to-noise ratio 
(SNR), at which 50% of the words in a sentence are correctly repeated. The test 
setup was consistent in all centers. At each follow-up visit, the sound processor 
was adjusted with dedicated fitting software according to the subjects’ hearing 
loss and comfort. 
3.3.3 Patient-reported outcome measures  
Subjects responded to the Abbreviated Profile of Hearing Aid Benefit (APHAB) 
and Health Utilities Index (HUI®) questionnaires for both the preoperative (aided 
or unaided) and the postoperative condition (3 months after activation) to 
assess the patients’ satisfaction with the system. Each subject reported the 
amount of difficulty experienced with communication in various everyday 
situations. The APHAB produces scores of four subscales: ease of 
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communication (EC), reverberation (RV), background noise (BN) and 
aversiveness (AV) (Cox & Alexander, 1995). Higher scores reflect more 
communication problems. A difference of 22% or more in any of the 3 subscales 
EC, BN and RV or of 31% or more in the AV subscale or a difference of 10% in 
the global score is considered a clinically relevant difference as reported by the 
developers. The HUI is a generic, preference-scored, comprehensive system for 
measuring the overall health status and the health-related quality of life and 
can be used to calculate hearing utility scores. The HUI used in this study was a 
self-administered 15-item questionnaire. 
 
3.4 Results 
As mentioned above, all preoperative aided data are measured in the subject’s 
best-aided condition i.e. with HA or BCI on a headband. The APHAB and HUI 
data reflects the patient’s pre-operative binaural condition i.e. binaurally 
unaided, monaurally aided or bilaterally aided. The postoperative aided data is 
measured 3 months after activation of the DACI, i.e. approximately 5 months 
after surgery in the subject’s everyday DACI-aided condition. All but 1 subject 
are daily DACI-users. 
3.4.1 Audiometric results 
Speech reception in noise The average and individual SRTs in noise for 19 
subjects for the preoperative and postoperative aided condition were assessed 
and are shown in Figure 3.1. Five subjects could not perform the test 
preoperatively, including 2 who were not able to perform the test 
postoperatively. For these subjects, the easiest possible test condition, an SRT 
of +20 dB SNR, was determined as their SRT in noise score. Sixteen subjects 
(84%) had better postoperative results compared to the preoperative condition 
(light area in Figure 3.1). An improvement of more than 2 dB SNR (statistically 
significant and clinically relevant difference, higher than the known test-retest 
variability of the used adaptive sentence tests in noise) was measured in 14 
(74%) of these subjects. In 2 subjects (11%) no improvement concerning speech 
perception in noise was found; they were not able to perform the test either 
pre- or postoperatively. One subject showed a slightly poorer result 
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postoperatively while not statistically significant (difference of -0.8 dB SNR, dark 
area in Figure 3.1). 
 
Figure 3.1 Individual and average SRTs in noise for 19 subjects tested preoperatively with 
HA or BCI and 3 months after activation with DACI. Star shows average SRT in noise of 
2.6 dB SNR (SD 8.3 dB). 
For the group of 19 subjects, a mean postoperative aided SRT of 2.6 dB SNR 
(standard deviation (SD) = 8.3 dB) was noted. This represents a statistically 
significant mean improvement of 7.9 dB (SD = 7.6 dB) compared to the 
preoperative aided condition for the study cohort (p < 0.001). 
AC and BC, sound field thresholds  Figure 3.2 and Figure 3.3 show the 
individual and mean preoperative and postoperative pure tone threshold (pure-
tone average, PTA, average of hearing thresholds at 0.5, 1, 2 and 3 or 4 kHz) for 
AC and BC for the 19 implanted subjects, respectively. Preoperatively, the AC 
and BC PTA were 92 dB HL (SD= 1.5 dB) and 57.8 dB HL (SD= 5.2 dB), 
respectively, with a mean air-bone gap of 35 dB (SD= 6.9 dB), indicating a 
severe to profound MHL for the group. The postoperative AC and BC PTA were 
95.4 dB HL (SD= 4.1 dB) and 57.2 dB HL (SD= 7.6 dB), respectively. On average, 
the postoperative AC thresholds did not change significantly compared to the 
preoperative condition (p > 0.05), as can be seen by the triangle lying close to 
the straight line in Figure 3.2. 
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Figure 3.2 Individual and mean (n = 19) pre- and postoperative AC thresholds. Dotted 
lines show clinically significant mean PTA shift of 10 dB. 
 
Figure 3.3 Individual and mean (n = 19) pre- and postoperative BC thresholds. Dotted 
lines show clinically significant mean PTA shift of 10 dB. 
Twelve subjects (63%) had poorer AC thresholds after surgery, while in 6 
subjects (32%) the AC thresholds improved. In 1 subject (5%), thresholds did not 
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change. On average, the BC thresholds did not change significantly compared to 
the preoperative condition (p > 0.05), except at 0.750 kHz, where there was a 
significant improvement (p = 0.009). The preservation of the preoperative BC 
thresholds is indicated by the triangle lying on the straight line in Figure 3.3. In 1 
of the subjects (5%), a statistically significant improvement of the BC thresholds 
was measured. Three subjects (16%) had a clinically significant (defined as a 
mean PTA shift > 10 dB) decrement in hearing threshold after surgery. In 1 of 
those subjects, BC thresholds could not be measured any more after surgery 
(marked by an arrow on the postoperative PTA of 80 dB HL). This subject had a 
tympanosclerotic stapes fixation with additional intracochlear ossification, 
encountered during stapedotomy. The BC thresholds of this subject did not 
recover and the event was reported as a serious adverse event to the 
competent authorities.  
 
 
Figure 3.4 Mean (n = 19) pre- and post-operative unaided and aided free field (FF) 
thresholds (a) and BC thresholds and postoperative DACI-aided sound field thresholds 
(b). Error bars show SDs. 
Figure 3.4a depicts the mean unaided and aided sound field thresholds for 19 
subjects. The mean preoperative unaided and hearing aid/BCI-aided sound field 
thresholds were 88.9 dB HL (SD= 5.5 dB) and 59.3 dB HL (SD= 8.4 dB), 
respectively. The mean postoperative DACI- aided sound field threshold was 43 
dB HL (SD= 3.7 dB). Thus, the mean improvement by the hearing aid/BCI was 
a b 
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29.6 dB whereas the mean improvement by the DACI was 45.9 dB. A significant 
improvement in favor of the DACI (p < 0.05) compared to the preoperative 
unaided and aided thresholds was observed over all frequencies (except for 8 
kHz). The mean overclosure of the air-bone gap defined as the difference 
between the postoperative DACI-aided sound field thresholds and the 
preoperative BC thresholds, was 15.6 dB as shown in Figure 3.4b. 
 
 
Figure 3.5 Mean (n = 19) WRS (% correct) for presentation levels of 65 dB SPL (a) and 80 
dB SPL (b) for the preoperative unaided and aided condition and for the postoperative 
DACI-aided condition 3 months after activation. Lines shows median, crosses mean and 
error bars show SDs. *p < 0.005. 
 
Speech Reception in quiet  Speech reception in quiet was evaluated by 
measuring the WRS using recorded speech at input levels of 50, 65 and 80 dB 
SPL. The WRS were measured preoperatively unaided and hearing aid/BCI aided 
and postoperatively aided with the DACI. The WRS improved significantly by 
31% (SD= 31, p = 0.003), 65% (SD = 34, p < 0.001) and 69% (SD = 35, p < 0.001) 
at 50, 65 and 80 dB SPL, respectively, compared to the preoperative unaided 
condition and by 26% (SD = 32, p = 0.004), 48% (SD = 37, p < 0.001) and 29% (SD 
= 37, p < 0.001) at 50, 65 and 80 dB SPL, respectively, compared to the 
preoperative aided condition. Figure 3.5 demonstrates the unaided and aided 
WRS at 65 dB SPL (a) and 80 dB SPL (b), respectively. 
a b 
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3.4.1 Subject’s satisfaction 
 
Figure 3.6 Mean (n = 19) difficulty in hearing shown for the four subscales and the global 
score of the APHAB. Error bars show SD. *p < 0.05. 
 
Figure 3.7 Mean (n = 19) HUI index (HUI 3 and 2) of the HUI questionnaire. Error bars 
show SD. * p < 0.05. 
APHAB Score results  Figure 3.6 provides a summary of the APHAB 
subscales and global scores for the 19 subjects with respect to their 
preoperative (i.e. unaided or HA-aided) and their postoperative DACI-aided 
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condition. Three subscales (EC, BN and RV) improved significantly by 28% (p < 
0.001), 27% (p < 0.001) and 28% (p < 0.001), respectively, after implantation 
with the DACI. The AV subscale worsened significantly by 16% (p = 0.02), which 
is clinically not significant. Overall a global benefit in hearing ability was 
recorded at 16% (p < 0.001) for the group, which is both clinically and 
statistically significant. 
HUI overall utility score  Figure 3.7 shows the average HUI2 and HUI3 
scores for 19 subjects for their preoperative daily listening condition (i.e. 
unaided or HA-aided) and postoperative in the DACI-aided condition. 
Improvements for scores on the HUI3 by 0.18 (p = 0.009) were significant while 
scores improved on the HUI2 but were not significantly better (0.09, p = 0.064). 
A difference of 0.03 in the overall HUI score is considered clinically relevant 
(Drummond, 2001). The average improvement for the HUI3 and HUI2 combined 
scores is clinically significant. The majority, 79% of the subjects (15/19) have a 
clinically relevant improvement of more than 0.03 in their HUI3 score and just 
over half, 58% (11/19), of more than 0.03 in their HUI2 score. 
 
3.4.2 Safety 
The DACI could be implanted in 19 of the 20 enrolled subjects. One subject was 
not implanted with the DACI due to severe ossification in the cochlea, which 
could not be identified on the CT scan pre-operatively. The surgeon decided not 
to implant the DACI to minimize the risk of sensorineural deafness. During the 
trial 4 serious adverse events and 7 adverse events were reported. None of the 
serious adverse events were rated as device-related; two serious adverse 
events (retro-auricular abscess and increased hearing loss) were rated as 
procedure-related. The remaining two serious adverse events were unrelated 
to the device or the procedure. One adverse event was rated as device- and 
procedure-related (skin irritation in the fold behind the ear) and four adverse 
events were rated as possibly device-related (tinnitus, deterioration of bone 
conduction thresholds, vertigo, vertigo and instability and otitis media) with a 
potential procedure relationship for 4 of them. All but 2 events are resolved. 
One subject still had mild vertigo at the end of the study. Another subject with 
preoperative profound MHL (and a moderately severe sensorineural 
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component) due to a tympanosclerotic stapes fixation showed an additional 
hearing loss on nearly all frequencies after surgery as stated above. 
Stapedotomy in this subject was laborious due to intracochlear ossification. The 
subject experienced no WRS improvement and no longer wears the DACI 
device. Up to the time of writing this manuscript, no technical device failures 
were reported. 
 
3.5 Discussion 
3.5.1 Speech in noise and quiet 
In the current study, the SRT in noise improved by 2 dB or more in 74% of the 
subjects and the mean improvement was 7.9 dB. Preoperatively, little hearing 
benefit in quiet and noise was achieved with previous middle ear surgery, best 
fitted HA or BCI, as shown by poor speech test results preoperatively (mean 
aided SRT in noise of 10.5 dB SNR, mean aided WRS at 65 dB SPL of 24%). Some 
subjects were not able to wear a hearing aid preoperatively due to external ear 
canal problems. For patients with BC thresholds up to 45-50 dB HL, a BCI can be 
considered as an alternative treatment, and preferably the more powerful 
body-worn Baha Cordelle (Bosman et al, 2006; Snik et al, 2005). However, our 
study cohort displayed mean preoperative BC thresholds of 57.8 dB HL which 
lies above the upper indication limit, hence adequate amplification with the 
body-worn BCI was questionable. In a descriptive study of Verhaegen et al 
(2009) on 5 subjects with profound MHL, outcomes with a BCI (Baha Cordelle) 
were compared to those with a CI. They concluded, that if the speech 
perception score (phoneme score) at 65 dB SPL in quiet was less than 42% with 
the tested BCI preoperatively, a CI is a valuable option. In the current study, 2 
out of 4 subjects that were tested preoperatively with a Baha Cordelle (on a 
headband), showed a mean score (word score) of 35% in quiet at 65 dB SPL, i.e. 
a CI would be recommended for them following the criteria of Verhaegen et al 
(2009). However, better postoperative word scores would be expected after 
osseo-integration of the percutaneous BCI compared to the transcutaneous use 
in this study (Heywood et al, 2011). But it is also known that for severe to 
profound high frequency loss this disparity is less relevant. Also, Snapp et al 
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(2013) showed that there was no significant difference between preoperative 
speech in noise testing with the Baha Cordelle headband stimulator and the 
postoperative results with the implanted device in their study. Postoperatively, 
those 4 subjects had a mean score of 68% with the DACI. In general, most 
patients prefer an ear level device to a body-worn device, and feedback can be 
an issue with the body-worn BCI. In the current study it was shown that 
subjects with a mean BC threshold of 57.8 dB SPL could reach a mean WRS 
score of 70% at 65 dB SPL with the DACI. 
By implanting the subjects with a DACI, a CI surgery can be avoided and the 
cochlear reserve can be maintained and further utilized. As significant 
improvement in performance was observed for the group at the 3-month 
follow-up, one may hypothesize DACI patients adapt to the sound stimulation 
readily after implant fitting and it is expected that rehabilitation efforts and 
time will be considerably less than with a CI. Residual hearing can be preserved 
in CI surgery when using soft surgical techniques even with more conventional 
electrodes up to 50% (Fraysse et al, 2006). However the question still remains 
to what extent this residual hearing in conventional CI candidates is serviceable. 
Recent studies with the latest ‘soft’ electrodes, show higher rates of hearing 
preservation and aidable low frequency hearing in selected subjects (Büchner et 
al, 2009; Skarzynski et al, 2012). In the current study, 1 subject with profound 
MHL showed significant additional hearing loss at implantation. The subject had 
a tympanosclerotic stapes fixation. Studying the literature, one can notice that 
tympanosclerosis patients can benefit from stapes surgery with no major risk to 
the cochlea if careful patient selection and surgical technique is applied 
(Vincent et al, 2002). However, its surgical treatment remains a great challenge 
and surgeons should carefully select patients with this indication for DACI 
surgery. Other adverse events described above were mainly transient and are 
well known risks associated with stapes and implant surgery. In a systematic 
review by Verhaert et al (2013) complications from acoustic hearing implants 
were listed. Main complications were FMT displacements and wound healing 
problems. Additional inner ear damage was described in a few cases. 
Although the used sentence in noise tests were developed for severely impaired 
persons, and measuring the SRT has the advantage to avoid ceiling effects (van 
Wieringen & Wouters, 2008), 5 subjects in the current study could not perform 
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the test preoperatively. In their study, the authors also found that 2 out of 16 CI 
subjects found the task too difficult. 
Finally it should be noted that while the ossicular chain was disrupted during 
the surgical procedure to implant the DACI in the current study, no significant 
change in AC thresholds was measured for the study cohort. This may be 
explained by the presence of a profound hearing loss with complete stapes 
fixation and no middle ear amplification before implantation.  
 
3.5.2 Study quality 
Comparing the current results with other DACI or AMEI, such as the VSB or 
Carina/MET (Otologics & Cochlear™, Boulder, Colo., USA), remains difficult due 
to different study setups reported, different speech material and the lack of 
comparative data on preoperative use of HA or BCI (Verhaert et al, 2013a). As 
suggested in this review, the current study was designed as a multicenter, 
prospective study, using comparable speech material in four languages, 
enhancing the possibility to compare data. Very few studies, always through 
retrospective data collection, have published speech in noise results comparing 
the use of AHI to preoperative hearing aid scores. When comparing the VSB 
aided condition to an aided or unaided preoperative condition, reports show a 
variable improvement of 2.8 to 5 dB SNR (Beltrame et al, 2009; Böheim et al, 
2012; Rajan et al, 2011). Remarkably, with the current DACI, aided sound field 
thresholds show amplification on all frequencies i.e. an overclosure of the air-
bone gap, whereas it is known that other AHI, such as the VSB, show less 
amplification on the lower frequencies and are mostly not able to close the air-
bone gap in the low frequencies. The current results concur with previous 
results on the DACS (Häusler et al, 2008), reporting a significant improvement of 
speech understanding in noise in 2 subjects, compared to the unaided 
condition. A first clinical trial with the Codacs investigational device implanted 
in 15 subjects showed comparable results with the results reported here 
(Lenarz et al, 2013). In a subgroup of 11 out of 15 subjects aided preoperative 
scores were available, showing a statistically significant improvement in the 
DACI condition compared to the hearing aid condition. The postoperative aided 
SRT in noise, measured in 12 subjects, was 0.3 dB. WRS at 65 and 80 dB SPL 
improved significantly by 35.5% and 25.7%, respectively, compared to the 
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preoperative aided condition. In contrast with the current study, no systematic 
comparison to the preoperative aided condition with hearing aid or BCI, 
allowing for direct comparison between different solutions for hearing 
rehabilitation, was made in that study. Also different etiologies for MHL were 
treated in the current study whereas in the previous study MHL only due to 
otosclerosis was included.  
3.5.3 Alternatives 
A recent study determined the effectiveness of primary stapes surgery in 
patients with profound hearing loss due to far-advanced otosclerosis (Lachance 
et al, 2012). On average, the sentence recognition score after surgery with well 
fitted hearing aids improved by 54.4% compared to the preoperative aided 
condition with well-fitted HAs. However, a wide variability in outcomes from 0% 
to 93% existed. After stapes surgery, 87% of patients were no longer CI 
candidates.  
For conductive hearing loss and moderate MHL, newer coupling methods to the 
stapes with titanium couplers, so far described in mobile footplate cases, show 
more stable results than previous reports (Luers et al, 2013). The authors 
expect that by using titanium couplers, described by Hüttenbrink et al (2011) as 
a clip vibroplasty, surgeries with AMEI will be performed in a more standardized 
manner, possibly diminishing the current variable functional hearing gain after 
VSB implantation (Luers et al, 2013). In several studies, stapes fixation was 
encountered during VSB implantation without safe access to the round window, 
mainly due to congenital middle ear malformation (Beleites et al, 2011; 
Verhaert et al, 2011). Some authors, mostly for safety, coupled the floating 
mass transducer to the fixed stapes, as that procedure follows the normal 
auditory pathway, keeping the round window as a pressure outlet, achieving 
however suboptimal amplification. Also Devèze et al (2010) experimentally 
demonstrated a mean attenuation of 25 to 40 dB with a fixed stapes compared 
to a mobile stapes. Their study explains the suboptimal result, as the floating 
mass transducer cannot provide enough power to overcome the damping 
effect, mainly for the low frequencies. These reports demonstrate the need for 
direct acoustic coupling in pathologies other than otosclerosis. It is assumed 
that direct acoustic cochlear stimulation by DACI, overcomes the nonlinearities 
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caused by the stapes footplate fixation, possibly leading to a more natural 
hearing compared to overcoming the air-bone gap by acoustical amplification. 
Another potential solution is coupling the VSB directly with a TORP through a 
stapedotomy (Schwab et al, 2012). More and long-term results are needed for 
this application.  
Some studies have mentioned a window of opportunity for CI in otosclerosis 
(Merkus et al, 2011; Ramsden et al, 2007; Rotteveel et al, 2004). Although this 
will be true in cases of extensive cochlear involvement seen on high-resolution 
CT, evidence is lacking regarding the length of this time window. Even after a 
successful cochlear implantation, the speech and hearing rehabilitation in 
subjects with otosclerosis due to progressive otosclerotic changes in the 
cochlea can affect the performance of the implant (Toung et al, 2004). One 
could also hypothesize that providing several years of hearing rehabilitation 
with a DACI could mean a more rapid revalidation, as more spiral ganglion 
neurons are preserved due to a more adequate acoustic stimulation pattern. 
Although this sounds logical, proof is still needed. But in case of severe 
otosclerotic progression, the option for CI remains open in DACI subjects. 
There is a certain degree of variability in the results of the current study. This 
variability in success rates is also reported in stapedotomy for far-advanced 
otosclerosis. Outcome prediction remains a problem. The cochlear reserve of 
the ear to be implanted is difficult to determine due to bilateral mixed hearing 
loss. Several methods for outcome prediction are under discussion and will be 
evaluated in future studies. 
 
3.6 Conclusion 
The data presented here show that individuals with severe to profound MHL 
due to various etiologies and previous middle ear surgeries can substantially 
benefit from direct acoustic cochlear stimulation. The DACI used in this study 
provides a statistically significant mean improvement of the speech 
performance in quiet and in noise compared to the preoperative aided 
condition. It improves the ability of patients to communicate in everyday 
situations and their quality of life. No unanticipated device-related adverse 
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event occurred. As a consequence, DACI treatment can be considered a safe 
hearing treatment with acceptably low risks that are outweighed by the hearing 
benefits provided to the patients. Careful selection of patients, with a complete 
evaluation of the inner and middle ear imaging, is required by the implanting 
team to confirm suitability for surgery. 
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  Chapter 4
Transient and steady state auditory 
responses with direct acoustic cochlear 
stimulation6 
4.1 Abstract 
Objective: Direct Acoustic Cochlear Implants (DACIs) directly stimulate the 
cochlear fluid of the inner ear by means of a stapes piston driven by an 
actuator, and show encouraging speech understanding in noise results for 
patients with severe-to-profound mixed hearing loss. Auditory evoked 
potentials (AEPs) recorded in such patients would allow for the objective 
evaluation of the aided auditory pathway. The aim of this study was (1) to 
develop a stimulation setup for EEG recordings in subjects with Cochlear DACIs, 
(2) to show the feasibility of recording auditory brainstem responses (ABRs) and 
auditory steady state responses (ASSRs) and (3) to analyze the relation between 
electrophysiological thresholds derived from these responses and behavioral 
thresholds. Design: For the 3 subjects implanted during a phase Ib clinical study 
in our center, ABRs and 40 and 80 Hz ASSRs were recorded with a 
straightforward acoustic stimulation setup and a newly developed direct 
stimulation setup. Click trains with rates around 40 Hz and around 90 Hz were 
used as stimuli. By comparing amplitude growth function and phase delay in the 
same stimulus range, validity of the responses was confirmed. Results: With the 
acoustic stimulation setup, stimulation artifacts made it impossible to analyze 
responses. With the direct stimulation setup, stimulation artifacts could be 
removed completely and responses could be successfully recorded in a non-
                                                                
6 The content of this chapter has been submitted for publication to Ear and Hearing as 
Verhaert N. and Hofmann M., Wouters J. “Transient and steady state auditory responses 
with direct acoustic cochlear stimulation.”  
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invasive manner in all subjects. Response properties such as ABR peak V 
latencies and ASSR apparent latencies were similar to those for acoustic 
stimulation, with apparent latencies of 39.9 and 24.7 ms for 40 and 90 Hz, 
respectively. Electrophysiological thresholds could be objectively determined 
from the ABRs and ASSRs. In the 40 Hz range, the mean difference between 
electrophysiological ASSR thresholds and behavioral ones was 12 dB. 
Conclusion: The results show that AEP measurements with the developed direct 
stimulation setup are feasible and meaningful and could potentially be used to 
provide intra-operative feedback about the coupling of the actuator to the 
inner ear. 
 
4.2 Introduction 
For patients with severe to profound mixed hearing loss (MHL), several 
different treatment options are available. As some cochlear reserve remains, 
acoustical stimulation, utilizing the human cochlear function, can improve 
audiological results in difficult listening conditions (Büchner et al, 2009). 
Nevertheless, due to the severity of hearing loss, conventional hearing aids and 
less powerful acoustic hearing implants will only have limited benefit (Verhaert 
et al, 2013a; Zwartenkot et al, 2014). Electrical stimulation of the cochlea 
through cochlear implants (CIs) is another well-established therapy but requires 
longer rehabilitation, could cause fitting problems such as facial nerve 
stimulation, lacks speech’s fine structure coding and shows limited F0 
information transmission (Toung et al, 2004).  
Recently, a powerful acoustic hearing implant for direct acoustic cochlear 
stimulation was developed and showed encouraging results for speech 
understanding in noise, being an indicator for real-life communication, for 
subjects with severe to profound MHL (Busch et al. 2013; Lenarz et al. 2013; 
Lenarz and Verhaert et al. 2014). Subjects with bone conduction thresholds 
classifying them as CI candidates were able to achieve remarkable 
improvements in speech understanding in noise with direct acoustic 
stimulation. Additionally, much faster speech and hearing rehabilitation 
compared to the period typically observed after cochlear implantation was 
noted. In this implant system, an actuator causes mechanical movement of a 
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rod coupled to the inner ear fluid at the level of the oval window. By doing so, 
the direct acoustic cochlear implant (DACI) provides the amplified signal directly 
to the cochlea, through an acoustical pathway.  
At this stage of development, an important challenge for DACIs is the 
assessment and fitting of this device to the needs of the individual patient. For 
established hearing implants such as CIs, several objective electrophysiological 
measures are available. Electrically evoked auditory potentials can be recorded 
from within the cochlea (Brown et al, 1990). Auditory brainstem responses 
(ABRs), regularly used for threshold determination in infants, have been 
determined experimentally during stapedotomy surgery (Stapells & Oates, 
1997; Hsu, 2010). Initially proposed for clinical hearing testing (Galambos et al, 
1981), auditory steady-state responses (ASSRs) can also be used in CI subjects 
(Ménard et al, 2004; Hofmann & Wouters, 2010, 2012). Although direct 
cochlear acoustical stimulation was proven to be clinically effective and safe 
with approval for clinical use in Europe, the availability of such measures for 
DACIs is important for the objective evaluation of large parts of the auditory 
pathway both during (intra-) and after implantation (postoperatively). As the 
number of implantations will grow significantly, early research in this field is 
urgently needed, also providing the necessary tools to objectively evaluate the 
outcome of new applications, e.g. in case of alternative DACI coupling to the 
inner ear.  
The objectives of this study were (1) to develop objective electrophysiological 
measures for direct acoustic cochlear stimulation in humans, both in the time 
domain (ABRs) and frequency domain (ASSRs), and (2) to evaluate the ability of 
such responses to assist in future intra-operative testing and the device’s fitting 
process. 
Table 4.1 Overview of the tested subjects. Sex: M male, F female; age: at the time of 
testing (in years); PTA: unaided average pure tone audiometry threshold at 0.5, 1, 2 and 
3 kHz, AC air conduction, BC bone conduction. 
Subject Sex Age PTA (AC/BC) in dB HL Side Etiology 
S1 F 62 96/58 left otosclerosis 
S2 M 78 117/64 right otosclerosis 
S3 M 50 111/66 right otosclerosis 
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4.3 Methods 
4.3.1 Subjects and device  
So far, only a limited number of subjects in a few countries were implanted. The 
implantations occurred during a multicenter clinical study (Lenarz and Verhaert 
et al. 2014). Three subjects with severe to profound MHL were implanted at the 
University Hospitals Leuven and all of them took part in the experiments (Table 
4.1). The subjects suffered from advanced otosclerosis and underwent an 
implantation with a Cochlear Codacs DACI (Bernhard et al, 2006). Clinical and 
surgical information are described in detail in Lenarz et al. (2013). All the 
experiments on subjects were performed at least four months after activation 
of the DACI device. The experiments were approved by the Medical Ethics 
Committee of the UZ Leuven/KU Leuven (approval number B322201112184). 
The protocol had been assigned with a NCT01780025 ClinicalTrials.gov ID. The 
subjects took part voluntarily and gave their written informed consent.  
The Codacs DACI system consists of an external speech processor and an 
internal implant connected by a wireless radio-frequency (RF) transmission link 
that provides both power and a bidirectional communication link. The incoming 
acoustic signal is received by the speech processor, sampled at a rate of 19607 
Hz and preprocessed. Each individual sample is then converted to an RF frame 
and transmitted to the implant along a 5 MHz RF link (Zeng et al, 2008). The RF 
frames are decoded in the implant and used to drive an electro-magnetic 
actuator in the middle ear. The actuator in turn is connected to a conventional 
stapes prosthesis coupled to the perilymph of the inner ear. 
4.3.2 Stimulation and recording setup 
The stimulation and recording setup are shown in Figure 4.1. The experiments 
are controlled by a measurement laptop equipped with the RBA measurement 
software platform developed in our lab (Hofmann & Wouters, 2012). RBA 
handled both the generation of the stimuli and the recording of the evoked 
responses. Two different methods for the generation and transmission of the 
auditory stimuli were evaluated. 
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Figure 4.1 Stimulation and recording setup. POD: programming device. Line colors show 
connections for different stimulation setups: red – analog stimulation, blue – direct 
stimulation. 
For analog stimulation, the stimuli generated by RBA at a sample rate of 32 kHz 
were provided to an external RME Hammerfall DSP Multiface II sound card, 
which was connected via the personal audio cable accessory to a Cochlear 
Freedom™ speech processor. The speech processor was equipped with a special 
pass-through firmware that did not modify the acoustic signal from the audio 
cable. The optional equalizer of the firmware was disabled. For direct 
stimulation, the stimuli were generated at the frame rate of the DACI of 19607 
Hz. The digital stimuli were directly sent to a programming device (POD) 
connected to a Cochlear L34 research speech processor. For both methods, the 
clinical processor of the subjects was not used. Whereas the analog stimulation 
setup was more or less readily available, the direct stimulation mode needed to 
be developed. By analyzing and comparing both methods, the most optimal 
stimulation method for AEP recording was obtained. 
For recording, surface electrodes were placed on the head of the patients in 
accordance with the international 10-20 system (Malmivuo & Plonsey, 1995) at 
conventional ASSR positions (Johnson & Brown, 2005). The reference (negative) 
electrode was placed on the ipsilateral mastoid (TP9 or TP10) relative to the side 
of the implanted DACI. The active (positive) electrode was placed on the vertex 
(CZ), and the ground electrode was placed on the contralateral mastoid (TP9 or 
TP10). The electrode-skin contact was prepared by scrubbing and cleaning, with 
resulting electrode impedances of 5 kΩ or less as verified with a General 
Devices EIM-107 Prep-Check Plus EEG electrode impedance meter. The 
electrodes were connected to a Stanford Research Systems SR560 medical 
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preamplifier with a variable gain of 20000 to 50000. The internal linear band 
pass filter (6 dB/octave attenuation outside the pass band) of the amplifier was 
set to 0.3 Hz to 30 kHz. The amplified signal was recorded by the RME sound 
card and saved on the measurement laptop. Recording occurred at a sample 
rate of 32 kHz with 24 bit resolution at about 10 VPP, resulting in a least-
significant bit (LSB) of 0.02 nV at an amplification of 50000. 
For analog stimulation, stimulation and recording were inherently synchronized 
as both were done with the same RME. The latency between stimulation and 
recording because of the processing delay in the personal audio cable was 
determined by the position of the stimulus artifacts (see below). For direct 
stimulation, trigger pulses generated by the POD for each stimulus were 
recorded by the RME alongside the EEG. 
During the measurements, the subjects were either sitting in a comfortable 
chair or lying on a couch and instructed to move as little as possible. They 
watched a silent subtitled movie to keep them awake.  
4.3.3 Stimulus construction and verification 
For all experiments, the stimulus intensity was expressed in dBpeFS, i.e. as the 
level of a sinusoid with the same peak amplitude as the stimulus clicks, relative 
to the level of a maximum-amplitude sinusoid generated with direct 
stimulation. For analog stimulation, monophasic alternating (condensation – 
rarefaction) clicks with a click width of 100, 200 and 300 μs were generated by 
the RME. For direct stimulation, monophasic alternating clicks with a click width 
of 102, 204 and 306 μs, corresponding to 2, 4 and 6 RF frames, respectively, 
were used. 
Correctness of stimulation was verified in a three-step procedure. In the first 
step, the stimulation patterns were validated with an oscilloscope connected to 
a DACI implant-in-a-box (IIB). The scope showed the RF signal from the coil 
obtained by inductive coupling, the actual sample values decoded from the RF 
frames and the output of the IIB to the actuator (Figure 4.2). In this figure an 
example of direct stimulation was given, using clicks with alternating polarity. 
The output signal was also provided to a pair of headphones. For direct 
stimulation, the scope was synchronized to the trigger from the POD.  
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Figure 4.2 Screenshot of DACI stimulus verification setup. From top to bottom, left (20 
ms trace, 2 ms per division): trigger (blue), captured RF (yellow), actuator output 
(purple), actuator output low-pass filtered with 10kHz (green); right (1 ms trace, 100 µs 
per division): decoded stimulus amplitude (orange), and zoomed versions of the left 
plots. 
In the second step, the EEG analysis was replicated on the bench. The stimulus 
artifacts originating from the RF transmission were measured with electrodes in 
a 1 l bowl containing physiological saline solution (NaCl 0.9%), mimicking the 
electrophysiological human head. The coil of the speech processor was fixed 
against the bowl by a magnet directing the RF energy at the recording 
electrodes positioned under the surface of the saline solution. The positions of 
ground, active and reference electrode were fixed both relative to each other 
and to the RF coil. The same recording setup and amplifier settings as for the 
physiological EEG measurements were used.  
In the last step, the velocity of the stapes prosthesis for different stimuli was 
measured with laser Doppler vibrometry (LDV, Laser head OFV534, Polytec Inc., 
Europe) and recorded by a Rohde and Schwartz UPV audio analyzer. 
4.3.4 EEG analysis 
The EEG signal was divided into epochs of 32 768 samples, resulting in an epoch 
length of 1.024 s. Each individual EEG measurement lasted about 6 minutes and 
was manually stopped after about 3500 epochs were recorded. Epochs with 
recording artifacts such as muscle movements and skin potentials were rejected 
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to prevent the erroneous detection of neural responses and the distortion of 
response properties. To this end, epochs were sorted by maximum peak-to-
peak amplitude and the top 5% of the epochs (i.e., the ones with the highest 
peaks) were removed from the measurement. After recording artifact removal, 
the average evoked response was determined by non-weighted averaging of all 
remaining responses to both condensation (positive) and rarefaction (negative) 
clicks. 
4.3.5 Experiments 
In a first group of experiments, the correct functioning of the analog stimulation 
setup as described above was verified with the oscilloscope and on the bench. 
As unusual artifact patterns were observed for analog stimulation, pilot 
measurements were performed in-vitro. To confirm the RF transmission as the 
source of the stimulus artifacts, the actually transmitted RF frames for a given 
analog stimulus were recorded and analyzed in Matlab. 
To avoid distortion of responses by the observed artifacts, all further 
experiments were performed with the direct stimulation setup. The setup was 
again verified on the bench and the linearity of the actuator peak amplitude for 
stimuli with different click widths and at different stimulus intensities was 
analyzed with LDV. 
In three subjects, auditory evoked responses to 204 μs click trains in the 40 and 
90 Hz range at different stimulus intensities were recorded. In the 40 Hz range, 
click trains with rates of 33 and 44 Hz were used. For the 90 Hz range, rates of 
82 and 97 Hz were used. Stimulus artifacts were removed by linear 
interpolation of the EEG during a blanking period of 1.4 ms similar to the 
method used in Hofmann and Wouters (2012). The ASSR was obtained from the 
bin corresponding to the stimulation rate of the frequency spectrum of the 
average epoch. The response amplitude was determined as the absolute 
amplitude, and the response phase delay as the inverse phase of the frequency 
bin. To determine the delay introduced by the auditory system, the mean 
apparent latency (i.e., group delay) was calculated as the ratio of the 
differences of phase delay and stimulation rate divided by 2π (John & Picton, 
2000) for corresponding measurements with different stimulation rates. Only 
measurements at stimulus intensities with significant responses at both 
4.3 Methods 107 
stimulation rates as determined by a one-sample Hotelling T2 test (Hotelling, 
1931; Hofmann & Wouters, 2010) were considered.  
Electrophysiological thresholds were estimated from the amplitude growth 
functions per frequency range. A two-sample Hotelling T2 test was used to 
compare the responses for the two stimulation rates and to determine the 
presence of a neural response (Hotelling, 1931; Hofmann & Wouters, 2012). 
Thresholds were determined by bracketing, i.e. as the mean between the last 
significant (p < 0.05) and the first insignificant response. Additionally, thresholds 
were also estimated by visual inspection of the ABR recordings by an 
experienced clinician, and latencies of peak V were determined (Lasky et al, 
1987). Behavioral thresholds were obtained for 200 μs click trains at 40 Hz using 
the 6 last reversals of a 2-up 1-down adaptive procedure (van Wieringen & 
Wouters, 2001) and compared to the electrophysiological thresholds. Statistical 
correlations for the determined threshold were not calculated because of the 
small sample size. 
 
 
Figure 4.3 Bench test recordings of the stimulus artifacts with the analog stimulation 
setup for 200 μs click trains at different intensities: comparison between EEG recording 
(in blue) and the energy of the corresponding RF frames (in green). Ρ: correlation 
coefficient. Measurement at +7 dBpeFS: clipped by firmware to 0 dBpeFS. 
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4.4 Results  
4.4.1 Analog stimulation 
After the verification of the analog stimulation setup with the oscilloscope, 
simulated EEG recordings of the stimulus artifacts for 200 μs click trains at 
different stimulus intensities were made on the bench without the actual 
implant or actuator present (Figure 4.3). While the click width was always fixed 
at 200 μs, the resulting stimulus artifacts differed in length between 2 and more 
than 15 ms for stimuli at -43 and 0 dBpeFS, respectively. The artifacts consisted 
of a sharp rise during the actual stimulating click, followed by a slow decay 
component and superimposed fast oscillations. For stimulus intensities of -
13 dBpeFS and above, the slow decay component exhibited one or multiple 
peaks with a latency in the range of ABRs. To confirm the presence of similar 
stimulus artifacts in in-vitro recordings, pilot measurements for 100 μs clicks 
were performed in 3 subjects (see Figure 4.4 for an example). Again, similar 
stimulus artifacts could be observed, obscuring any possibly present neural 
response. 
 
 
Figure 4.4 Recordings with subject S2 of possible neural response and stimulus artifacts 
with the analog stimulation setup for 100 μs 33 Hz click trains at different intensities (in 
equivalent dBpeFS). 
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As in-vitro artifacts were very similar to the ones already observed on the 
bench, the RF transmission was considered the most probable source of the 
artifacts. Recordings with the oscilloscope of the low-pass filtered RF signal 
revealed no low-frequency component that could have explained the observed 
artifact. To account for any non-linear demodulation effects in the saline 
solution, the ability of the root-mean-square (RMS) energy of the RF signal to 
predict the observed artifacts was explored (Figure 4.3). Depending on stimulus 
intensity, correlations between RMS energy of the RF signal and stimulus 
artifacts ranged from ρ=0.82 (-43 dBpeFS) to ρ=0.98 (0 dBpeFS), confirming the 
RF transmission as the most probable source of the stimulus artifacts. 
 
 
Figure 4.5 (left panel), Stimulus artifact for bench-test recording: difference between 
analog and direct stimulation setup for 200 μs click with equal intensity. (right panel), 
Amplitude growth function of the actuator as a relation between stimulus amplitude (3 
different click trains of 102, 204 and 306 µs) and the actuator output measured with a 
LDV. A linear amplification is noted with this direct stimulation setup. 
 
4.4.2 Direct stimulation 
For the direct stimulation setup, bench recordings of 200 μs click trains resulted 
in stimulus artifacts with a constant duration of less than 0.3 ms below 2µV 
independent of stimulus intensity, in contrast to the artifacts of the analog 
stimulation setup which were much longer and varied in length (Figure 4.5, left 
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panel). LDV measurements of the oscillations of the stapes prosthesis on the 
bench in response to 102, 204 and 306 μs click trains at different stimulus 
intensities confirmed the linearity of the direct stimulation setup for stimuli 
with peak amplitudes between -70 and -10 dBpeFS (Figure 4.5, right panel). As 
the peak amplitudes of the 102 μs clicks were attenuated by about 4 dB 
compared to the peak amplitudes of the 204 and 306 μs clicks, all further 
experiments were performed with a click width of 204 μs. 
 
 
Figure 4.6 Response waveforms of subject S1 for 33 (left) and 82 Hz (right) click trains at 
different intensities (from -25 to -70 dBpeFS). Waveforms plotted with positivity at 
vertex upwards. Markers show ABR peak V as determined by an experienced clinician. 
Partial AMLR (Na/Pa) responses can be seen for the 33 Hz stimuli. 
 
4.4.3 Response properties 
Figure 4.6 shows representative examples of the time-domain response shapes 
in the 40 and 90 Hz ranges. Due to response filtering, the duration of stimulus 
artifacts increased to 1.4 ms in subjects, independent of stimulus intensity. 
Within the first 10 ms, ABR peaks V with variable amplitude and latency can be 
seen for both frequency ranges. At a stimulus intensity of -30 dBpeFS and 
stimulation rate of 33 Hz, peak V latencies were estimated at 6.03, 6.60 and 
6.85 ms, for S1 to S3, respectively, which seemed to increase slightly with 
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stimulation rate up to latencies of 6.66, 6.85 and 7.28 ms at 97 Hz. For the 40 Hz 
responses, auditory middle latency responses (AMLRs) could also be 
recognized.  
ASSR amplitude growth functions of all 3 subjects for the 40 Hz range are shown 
in Figure 4.7. Similar growth functions were recorded for the 90 Hz range 
(Figure 4.8). Response amplitudes grew monotonically and did not seem to 
reach saturation at the highest stimulation level in 64 out of 66 measurements 
(except for S1 at 33 and 97 Hz). Out of 66 measurements, 54 significant 
responses could be reliably recorded.  
 
 
Figure 4.7 Response amplitudes and phase delay of all 3 subjects in the 40 Hz range. 
Stimulus intensity: in dBpeFS; error bars: phase delay change corresponding to the 
standard error of the response bin across epochs. 
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Figure 4.8 Response amplitudes and phase delay of all 3 subjects in the 90 Hz range. 
Stimulus intensity: in dBpeFS; error bars: phase delay change corresponding to the 
standard error of the response bin across epochs. 
The mean amplitudes of all significant ASSRs for all stimulus intensities across 
subjects were 646 nV (interquartile range (IR) = 687 nV) and 531 nV (IR = 583 
nV), for stimulation rates of 33 and 44 Hz, respectively. For the 90 Hz range, 
mean ASSR amplitudes for 82 and 97 Hz stimuli were 111 nV (IR = 90 nV) and 
130 nV (median, IR = 89nV), respectively. Comparison between the two ranges 
showed higher ASSR amplitudes for the 40 Hz (mean 588 nV, IR = 618 nV) than 
for the 90 Hz range (mean 122 nV, IR = 85 nV). This difference was statistically 
significant (Wilcoxon signed rank test, p < 0.001). 
The differences in phase delay between the two adjacent stimulation rates of all 
significant responses were calculated per frequency range (Figure 4.7 and 
Figure 4.8). The mean differences in phase delay were 128, 207 and 77 degrees 
for the 40 Hz range (frequencies 33 and 44 Hz) and 101, 139 and 207 degrees 
for the 90 Hz range (82 and 97 Hz), for S1 to S3, respectively. Again the 
difference between the two ranges was statistically significant (Wilcoxon signed 
rank test, p = 0.003). Mean apparent latencies were 39.9 ms (SD = 9.7 ms) and 
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24.7 ms (SD = 13.0 ms) for the 40 and 90 Hz range, respectively (Figure 4.9). 
Both for the 40 and 90 Hz range, higher response latency values were calculated 
for S2 and S3 than for S1, although the difference was statistically not 
significant (p > 0.05). 
 
 
Figure 4.9 Individual apparent latencies for each subject in 40 Hz and 90 Hz range. Bars: 
minimum, maximum and mean latencies. 
 
4.4.4 Thresholds 
The estimated electrophysiological thresholds detected from the ASSRs as well 
as from the ABR peak V and their relationship with the behavioral thresholds at 
40 Hz can be seen in Table 4.2. With the bracketing method, 
electrophysiological ASSR thresholds of -75, -38 and -65 dBpeFS for the 40 Hz 
range and -75, -38 and -45 dBpeFS for the 90 Hz range were determined for S1 
to S3, respectively. Except for S3 in the 90 Hz range, these thresholds were the 
same for both frequency ranges. For ABR peak V, thresholds were -65, -35 and -
35 dBpeFS for S1 to S3, respectively. 
114  Auditory evoked potentials with DACI 
 
Table 4.2 Relationship between behavioral and electrophysiological thresholds obtained 
from ABRs and ASSRs. Thresholds: in dBpeFS; behavioral: at 40 Hz. 
Subject Behavioral ASSR (40 Hz) ASSR (90 Hz) ABR peak V 
S1 -87 -75 -75 -65 (Latency = 7.8 ms) 
S2 -41 -38 -38 -35 (Latency = 6.6 ms) 
S3 -87 -65 -45 -35 (Latency = 6.8 ms) 
 
Behavioral thresholds were lower than electrophysiological thresholds, with 
differences of 12, 3 and 22 dB for thresholds based on 40 and 90 Hz ASSRs, and 
of 12, 6 and 52 dB based on ABR peak V, for S1 to S3 respectively. Mean 
differences between behavioral and electrophysiological thresholds were 12, 19 
and 26 dB for electrophysiological thresholds based on 40 and 90 Hz ASSRs and 
ABR peak V, respectively.  
 
4.5 Discussion 
4.5.1 Analog and direct stimulation 
Only a few other studies have investigated the use of auditory evoked 
potentials in acoustic hearing implants, none of them with digital speech 
processing devices. Verhaegen et al. (2010) reported ASSR measurements in 4 
subjects with severe MHL for the intra-operative verification of a floating mass 
transducer (FMT) placement. Subjects were implanted with a MED-EL Vibrant 
Soundbridge device (VSB), using a 404 analog audio processor driven by an 
audiometer. As the measurements were relative (i.e., ASSR thresholds with a 
certain FMT coupling compared to those with another coupling), the authors 
stated that the calibration of the setup was of minor importance and no specific 
reporting on the artifacts was provided. In contrast to the DACI, the VSB device 
relies on analog sound transmission based on amplitude modulation, which 
could partially explain the difference in the observed artifacts. In temporal bone 
specimens, Radeloff et al. (2011) identified artifacts, occurring at 40 dB HL and 
above, which arose from electrical cross-talk of the FMT during 
electrocochleography (ECoG) using broad spectrum clicks and sinusoidal tone 
bursts. Averaging of responses to rarefaction and condensation stimuli resulted 
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in a significant reduction, with a remaining artifact arising from asymmetrical 
signals. The analog transmission resulted in linear growth of the artifacts, and 
no artificial signal was identified mimicking the typical shape of compound 
action potentials in their 3 subjects. A third study investigated the role of intra-
operative ECoG to optimize the placement of the FMT of the VSB on the round 
window membrane in subjects with conductive and MHL (Colletti et al, 2012). 
Relative ECoG measurements using alternating clicks were recorded during FMT 
placement, demonstrating a reduced latency and higher amplitude of the 
compound action potential in the case of a better coupling of the FMT to the 
round window membrane. While such measurements might intra-operatively 
be also applicable for DACIs, certainly to analyze the coupling to the cochlea, 
postoperative ECoG measurements remain difficult to perform due to the 
invasive character of the measurement. Due to middle ear changes, causing 
mixed hearing loss, postoperative electrode placement could be complex and 
cause local damage. Additionally, ABRs and ASSRs provide information about 
the auditory pathway from the VIIIth nerve up to the auditory cortex that cannot 
be obtained from ECoG measurements. 
In the current study, it was found that the stimulus artifacts for the investigated 
DACI were related to the energy of the RF transmission. In contrast, the 
actuator did not seem to interfere with the EEG recordings. With the analog 
stimulation setup, the non-linear stimulus artifacts were much longer than the 
theoretical click stimuli and obscured any possibly present neural responses. 
The stimulus artifacts were directly linked to the RMS energy of the 
corresponding RF frames, suggesting that the actual stimuli extended beyond 
the monophasic clicks. This was confirmed by the decoding of the transmitted 
sample values in the RF signal, which showed a slow delay component of the 
actual stimuli with a similar length as the artifacts themselves. As inspection of 
the audio signal, provided to the personal audio cable accessory of the sound 
processor, showed stimuli that were very close to ideal clicks, the source of this 
effect is most likely found either in the circuitry in the cable or the signal 
processing hardware of the speech processor. 
Because of these limitations, the proposed direct stimulation setup was 
developed. By using a digital path that converts the stimulus directly into the 
corresponding RF frames, any non-linear effects because of, e.g. the sample 
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coding, are only present during the stimulus clicks, with enough time between 
the stimuli to record the neural responses. For ASSRs, time-domain 
interpolation of the EEG signal for the duration of the artifacts allows the 
recovery of the undistorted neural responses. 
In clinical practice with unaided stimulation, click stimuli for ABR and ASSR 
measurements most commonly use a click width of 100 μs. Beattie and Boyd 
(1984) showed that latencies increased approximately 0.1 ms as duration 
increased from 100 to 200 µs. In the current study, stimulation by a Codacs 
DACI even with the direct stimulation setup resulted in attenuated peak 
amplitudes for stimuli with a click width of 104 μs when compared to the 
theoretical amplitude as seen for longer click widths. As such a click width 
corresponds to only two samples at the internal sample rate of 19607 Hz, this is 
most probably caused by the actuator impulse response characteristics. The 
selected click width of 204 μs resulted in clearly recognizable ABR peaks V for 
most subjects, but more work is needed to determine the optimal stimulation 
settings for aided ABR recordings with such a device. 
4.5.2 Response properties and thresholds 
With the direct stimulation setup, ABRs and ASSRs could be reliably recorded. 
ABR peaks V were clearly recognizable in the 40 and 90 Hz range, but latencies 
were longer than for normal hearing subjects. This might be partially explained 
by a cochlear impairment, certainly in the basal (high-frequency) portion of the 
cochlea (Yamada et al, 1979). The different ages and degrees of hearing loss of 
the three subjects tested might also account for some peak V latency variability 
(Jerger & Hall, 1980; Debruyne, 1986). Standardized ABR peak V latencies 
obtained by aided stimulation with acoustic hearing implants are currently 
lacking in the literature. Overall, the recording and analysis of ABRs under 
general anesthesia seems feasible for future implantations. 
ASSR amplitudes were similar to amplitudes for responses to electrical CI stimuli 
(Hofmann & Wouters, 2012), and amplitudes were larger in the 40 Hz than the 
90 Hz range. Amplitudes increased non-linearly with increasing stimulus 
intensity (Lins et al, 1995). The mean response latency of 39.9 ms for the 40 Hz 
range is in accordance with the latency of acoustically evoked ASSRs in response 
to clicks, e.g. 33.3 ms (SD = 8.6 ms, 35 to 55 Hz) and 41.1 ms (SD = 5.7 ms, 29 to 
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54 Hz) (Stapells et al, 1984, 1987), and the latency of electrically evoked ASSRs 
in response to low-rate pulse trains of 35.6 ms (SD = 5.3 ms, 35 to 47 Hz) 
(Hofmann & Wouters, 2010). In the 90 Hz range, the mean response latency of 
24.7 ms is slightly longer than the latencies found for acoustically evoked ASSRs 
in literature, e.g. 15.7 to 22.0 ms (80 to 92 Hz) for beats or 16.1 to 20.7 ms (81 
to 95 Hz) for amplitude-modulated stimuli (John & Picton, 2000; Purcell et al, 
2003). It is longer than the one found for electrically evoked ASSRs of 12 ms (79 
to 91 Hz), which could only partly be attributed to the mechanical transmission 
in the cochlea (Hofmann & Wouters, 2010; Purcell et al, 2003). As shown in 
Figure 4.9, within-subject variability was low, except for one value in the 90 Hz 
range for S3. For both frequency ranges, the found latencies allow the 
estimation of the predominant neuronal generator, with 40 Hz responses most 
likely originating beyond brainstem and 90 Hz responses originating in the 
brainstem, further confirming the correct measurement of the neural responses 
(Picton et al, 2003). In the future, measurements for a larger number of DACI-
aided subjects might allow setting of standardized values according to hearing 
loss.  
In general, response properties were in line with the hearing characteristics of 
the subjects, e.g. S2 showed a steeper response amplitude growth across a 
smaller clinical dynamic range in comparison to the other two subjects. No 
correlation coefficients could be calculated between behavioral and 
electrophysiological thresholds due to the small sample size, but differences of 
12, 3 and 22 dB, for S1 to S3, are in line with data obtained for unaided 
stimulation (Herdman & Stapells, 2001). In the field of acoustic hearing 
implants, we are not aware of any other study that has reported on absolute 
threshold determination with evoked potentials. Comparing behavioral and 
electrophysiological thresholds, differences were lowest for ASSRs in the 40 Hz 
range and for 2 out of 3 subjects in the 90 Hz range, followed by ABR peak V, 
where the detection of ABR peak V proved difficult especially for lower signal-
to-noise ratios. 
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4.6 Conclusion and future research 
This study demonstrated for the first time that auditory evoked potentials could 
reliably be recorded and analyzed in patients with a digital speech processing 
DACI. The proposed direct stimulation setup minimized interference because of 
stimulus artifacts and allowed the recording of ABRs as well as 40 and 90 Hz 
ASSRs, with response properties and electrophysiological thresholds that were 
similar to those reported in the literature.  
Future research includes recording intra-operative feedback of direct cochlear 
acoustical stimulation and the automatic post-operative determination of 
preliminary fitting parameters. Methods need to be developed to reduce the 
recording time, rendering this method feasible for intra-operative 
measurements. As the current study focused on feasibility, in future, a higher 
number of subjects needs to be tested before clinical implementation is readily 
available. The use of narrow-band stimuli such as tone bursts (Stapells et al, 
1984) could allow the recording of more frequency specific responses. As the 
indication criteria extend to profound MHL, the further development of the 
proposed techniques might provide an objective measure for the adequate 
coupling to the inner ear, but also for the correct auditory processing in the 
cochlea and brainstem for difficult differential diagnosis cases. Absent 
electrophysiological responses indicating insufficient cochlear reserve during 
intra-operative measurements in such cases could pose an indication to convert 
the surgery to a cochlear implantation. The authors feel that sharing this insight 
early at this stage of direct acoustic cochlear stimulation development will 
greatly improve near future clinical and translational research. 
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  Chapter 5
Is the lateral semicircular canal a coupling 
site for direct acoustic cochlear 
stimulation?7 
5.1 Abstract  
Objective: Various etiologies of severe to profound mixed hearing loss are 
associated with difficulties for adequate hearing rehabilitation. Recently, 
promising results for speech understanding in quiet and noise were obtained 
with a direct acoustic cochlear implant (DACI). Its surgical implantation may be 
regarded as challenging, however, certainly in the case of chronic otitis media. 
Straightforward, reproducible acoustic stimulation of an anatomically easy 
accessible inner ear site is desired and could reduce surgical risks and possibly 
extend current indications of DACI. In this experimental study, the possibility of 
DACI stimulation of the intact, blue-lined and opened lateral semicircular canal 
(LC) was investigated and compared with standard oval window coupling. 
Round window (RW) velocity, as a measure of the performance of the device 
and its coupling efficiency, was determined in fresh-frozen human cadaver 
heads using a laser Doppler vibrometry setup. From these measurements, 
equivalent sound pressure level (LE) output was calculated. The surgical 
coupling technique was also described. Results for the different conditions 
obtained in 5 heads were analyzed in 3 frequency ranges: low (0.1-0.8 kHz), 
middle (0.8-2.5 kHz) and high (2.5-8 kHz). With LC opened stimulation, a 
maximum LE of 126 equivalent dB SPL (SD = 10 dB) was reached, comparable to 
                                                                
7 The content of this chapter has been submitted for publication to Hearing Research as 
Verhaert N., Walraevens J., Desloovere C., Wouters J., Gérard J. “Is the lateral 
semicircular canal a coupling site for direct acoustic cochlear stimulation?” 
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the standard oval window DACI position (127 dB SPL, SD = 21 dB). Pairwise 
comparisons revealed that RW velocity was significantly lower in the LC intact 
condition than in the standard condition in the low and middle frequency 
range, confirming the added value of direct acoustic inner ear stimulation. LE 
analyses showed modest but significant added value of the LC blue-lined 
condition over the LC intact condition for the low and high frequency range. In 
the LC opened condition, higher RW velocity was obtained than in LC intact or 
blue-lined conditions for all frequency ranges. The effect of an induced stapes 
footplate fixation was also investigated. LE analyses showed no significant 
difference between LC opened and LC opened with stapes fixation conditions in 
the middle and high frequency ranges. These results demonstrate for the first 
time that the LC may be a potential site for direct acoustic stimulation, even in 
case of stapes footplate fixation. Future studies need to address long-term in 
vivo effects of LC stimulation and their impact on cochlear micromechanics and 
vestibular system. 
 
5.2 Introduction 
In the past decade, considerable temporal bone and human clinical research 
has been conducted on the efficiency of acoustic hearing implants, such as 
active middle ear implants (AMEIs) and direct acoustic cochlear implants 
(DACIs), in several anatomical sites. Although initially proposed for 
sensorineural hearing loss, most acoustic hearing implants are currently used 
for conductive or mixed hearing loss. Because they are indicated for various 
pathologies, many different ways of implantation have been described, each 
with its own advantages and disadvantages (Martin et al, 2009; Baumgartner et 
al, 2010; Häusler et al, 2008; Schwab et al, 2012; Luers et al, 2013; Tringali et al, 
2010; Verhaert et al, 2011). Recently, a systematic review of clinical results was 
published on this subject, demonstrating a certain degree of variability in 
functional outcome (Verhaert et al, 2013a). With the introduction of titanium 
couplers, this non-uniformity could potentially be reduced (Luers et al, 2013), 
but dislocation of a non-fixed stimulator with loss of amplification remains a 
possibility (Bernardeschi et al, 2011).  
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For severe to profound mixed hearing loss, only powerful implants can produce 
sufficient output to stimulate the remaining cochlear reserve. A Codacs DACI 
device produces high output, thereby achieving encouraging speech perception 
results, even compared to the best conventional treatments, such as hearing 
aids (Lenarz et al, 2014; Zwartenkot et al, 2014). The surgical procedure is often 
regarded as challenging, as it involves posterior tympanotomy, fixation of the 
transducer inside a small mastoid cavity, and then a transmastoid or endaural 
approach for stapedotomy with coupling of a stapes prosthesis to an actuator 
(Lenarz et al, 2013). Taking into account its initial phase, the average time of 
surgery was around 3.5 hours (communication from the manufacturer) and the 
approach carries risks of facial nerve exposure or damage to residual hearing, 
well known from cochlear implant surgery and stapes surgery in case of 
advanced otosclerosis or tympanosclerosis (Vincent et al, 2002). 
Straightforward, reproducible acoustic stimulation of an anatomically easy 
accessible inner ear site could reduce these risks associated with middle and 
inner ear implant surgery. Driving the cochlea at other sites, such as a ‘third-
window’, has been proposed experimentally in an animal model (Lupo et al, 
2012) and implemented in selected cases, where neither the oval window nor 
round window (RW) could be reached (Pau & Just, 2010). The aim of this 
experimental study was (1) to investigate the feasibility of acoustic stimulation 
of the lateral semicircular canal (LC), (2) to develop an adequate surgical 
technique, and (3) to assess coupling efficiency compared to standard oval 
window coupling, as described by Lenarz et al. (2013). Experiments were 
performed in fresh-frozen human cadaver heads to obtain data mimicking an in 
vivo context as closely as possible.  
 
5.3 Methods 
5.3.1 Human cadaver temporal bone preparation 
Fresh frozen cadaver heads were used for this experiment. Six entire heads 
were evaluated after obtaining authorization to use organs and tissues for 
research (Science Care, Inc., Phoenix, AZ, USA). The medical history of each 
head was provided by the supplying company. After thawing, all experiments 
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were performed within an 8-hour period and the heads were rinsed 
meticulously to prevent mechanical changes due to dehydration during the 
experiments. Microscopic visual inspection was carried out to verify temporal 
bone integrity and quality, as well as the absence of otologic disease, as 
recommended in the ASTM standard practice (ASTM, 2005). The study was 
approved by the local ethics committee.  
Surgical preparation consisted of a canal wall-up mastoidectomy, with 
preservation of the posterior border of the mastoid cavity for placement of the 
implant’s fixation system. The facial recess was opened through a large 
posterior tympanotomy to achieve exposure of the stapes crura, stapes 
footplate and the round window membrane (RWM), with removal of its 
secondary mucosal membrane. Care was taken not to alter ossicular chain 
integrity. Visual inspection was performed to check for perilymph leakage. One 
head (1/6), considered for training purpose, was excluded from further analysis, 
as drilling of the LC accidently led to perilymph evaporation. The heads were 
firmly held in a holding block during all procedures.  
5.3.2 Acoustic hearing implant 
Throughout this study, the driving force for acoustic stimulation was an 
electromagnetic actuator, which is part of an acoustic hearing implant, the 
Codacs™ DACI system (Cochlear™ Ltd. Sydney, Australia). This system was 
recently CE-approved and made commercially available for clinical use, 
indicated for severe to profound mixed hearing loss. The surgical procedure to 
implant the DACI system was previously described in detail (Lenarz et al, 2013). 
In brief, following the manufacturer’s specifications, the actuator’s artificial 
incus (1 mm diameter), or rod, is connected to a conventional stapes prosthesis 
coupled to the perilymph of the inner ear at the level of the oval window niche. 
Coupling to the inner ear is done after removal of the stapes superstructure, i.e. 
stapedotomy or stapedectomy. For clinical application, a calibrated-hole 
technique using a laser or skeeter burr is preferred for stapedotomy. In 
temporal bone experiments, stapedectomy with complete removal of the entire 
footplate and placement of fibrous tissue for oval window sealing is more 
feasible. This is consistent with the first DACI implantations, as described by 
Häusler et al. (Häusler et al, 2008). Previous investigations have confirmed 
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linearity of actuator output up to 1 V root mean square (RMS) (Verhaert et al, 
2014a), potentially limiting non-linear vestibular effects. 
5.3.3 Measurement setup  
An insert earphone (ER-2, Etymotic Research, USA) was fixed inside the external 
ear canal with adaptive foam to seal it externally. The tube of a probe 
microphone (ER-7C, Etymotic Research, USA) was positioned within 1-2 mm of 
the tympanic membrane and used as a reference. The insert earphone 
assembly was calibrated before each use. The earphone was driven by a sine 
sweep at approximately 94 dB SPL between 100 and 10000 Hz generated by an 
audio analyzer (UPV, Rhode and Schwartz, Munich, Germany). For velocity 
measurements, a Zeiss microscope-mounted laser Doppler vibrometry (LDV) 
system (OFV5000 Vibrometer Controller, OFV-534 Compact Sensor Head and A-
HLV MM 30 Micromanipulator; Polytec GmbH, Waldbronn, Germany) was 
utilized. To enhance light reflection, markers made from small pieces of 
reflective tape (0.5 mm2) were placed on the posterior stapes crus and RWM. 
Anatomical preparation ensured an optimal laser angle of about 70- 80° to the 
RWM and posterior crus of the stapes. The LDV controller was set to 10 mm/s/V 
with a 100 kHz low-pass and 100 Hz high-pass filter.  
Stapes and RW velocity were evaluated with closed-field acoustic 
measurements in a quiet room to check the temporal bone quality. Obtained 
middle ear transfer functions (HTV) were calculated as previously described 
(ASTM, 2005). To quantify the performance of a device coupled to the ossicles, 
a method calculating equivalent sound pressure levels (LE), in equivalent dB SPL, 
and maximum equivalent sound pressure levels (LE,max) from sound-induced 
stapes velocity was developed by Rosowski et al. (2007). Unlike with RW-driven 
AMEIs (Tringali et al, 2010), computing the electrovibrational transfer function 
(HEV) of the stapes was not possible, as during standard DACI implantation the 
stapes superstructure is removed and the cochlea is driven by a conventional 
stapes prosthesis. Therefore, as in the procedure described by Chatzimichalis et 
al. (2012), output was derived from RWM velocity measurements, expressed in 
dB m/s. Stimulation of 1 V RMS was applied directly to the actuator. The audio 
analyzer simultaneously captured stapes or RW velocity output from the LDV 
and probe microphone signals near the tympanic membrane. In general, the 
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recommendations as in the ASTM practice were followed for specimen 
preparation, measurement setup and analysis, however, whole heads were 
used mainly for intra-head comparisons, and thus a minimal deviation regarding 
the velocity criteria range was regarded as acceptable. 
5.3.4 Experiments 
After quality control, each cadaver head was implanted with a DACI coupled to 
the inner ear in 5 consecutive conditions, as illustrated in Figure 5.1. The same 
investigators conducted each experiment, reducing variability. RW velocity was 
measured at a similar angle for each condition. Three repetitive LDV 
measurements were carried out for each velocity measurement. In each of the 
first four conditions, contact between the actuator’s artificial incus and the 
coupling site was made neither applying too much pressure on the surface nor 
impeding a correct movement of the rod.  
Condition 1 – LC intact: The actuator was approximated against an intact LC 
easily accessed through a basic mastoidectomy, keeping the ossicular chain and 
buttress intact. Contact was made at the dome of the LC, posterior to the 
ampulla.  
Condition 2 – LC blue-lined: Using a 0.5-mm diamond burr and intermittent 
irrigation the LC was blue-lined, indicating imminent appearance of the 
endosteum of the labyrinth, similar to posterior canal occlusion (Parnes, 1996). 
Again, the actuator was approximated against the blue-lined surface, without 
breaching it.  
Condition 3 – LC opened: The canal was opened further (size 0.5 x 0.7 mm) until 
the last endosteal bone shell could be gently fractured with a fine spatula, 
keeping the membranous labyrinth intact. This was defined as a canalotomy. 
The surgical technique was inspired by the early fenestration operation 
described by Sourdille and Lempert, although the endosteal flaps were not 
folded back (Shambaugh & Wiet, 1979; Farrior & Rophie, 1985). At this point, 
no perilymph aspiration was performed. The opening was directly covered with 
fibrous tissue obtained from the temporalis fascia. The actuator’s artificial incus 
was gently brought into contact in a perpendicular manner (Figure 5.1 a,b). 
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Figure 5.1 Coupling of DACI actuator with its artificial incus to the lateral semicircular 
canal (LC). (a) Schematic illustration demonstrating the perpendicular position of the 
actuator’s tip (diameter of 1 mm) to the LC. Posterior tympanotomy is drawn for 
illustrative reasons. (b) Fresh head preparation showing LC stimulation (LC opened 
condition) with fascia interposition, view from posterior with reflective mirror on RWM. 
Note the proximity of the facial nerve with the narrow access to the oval window. 
 
Condition 4 – LC opened with stapes fixation: After completing condition 3, 
stapes footplate fixation was achieved using techniques previously described 
for the dental acrylic application (Nakajima et al, 2005; Devèze et al, 2010). 
Thus, LC stimulation could be investigated in case of stapes fixation, similar to 
otosclerosis pathology, as this is one of the principal clinical indications for DACI 
implants. The LDV was used to measure stapes velocity attenuation at the 
stapes posterior crus (4 heads) and/or the RWM (3 heads).  
Condition 5 – Standard: After elimination of any dental acrylic surplus, the 
entire stapes was removed without suction and fibrous tissue was immediately 
a 
b 
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placed to seal the oval window. The footplate was removed for reasons of 
reproducibility and to avoid footplate manipulations. The actuator of the DACI 
implant was then introduced through the opening of the posterior 
tympanotomy and placed about 4-6 mm above the oval window. A 
conventional stapes prosthesis, titanium K-Piston type, 0.6 mm in diameter with 
a loop (Heinz Kurz GmbH, Dusslingen, Germany), was placed on the fibrous 
tissue in the oval window and firmly crimped to the actuator. The fascia was 
maintained on the canalotomy to avoid leakage. 
After checking for normality, data were statistically analyzed using paired 
samples t-tests, with RW velocity as a dependent variable. Third octave band 
frequencies were analyzed represented by the center frequency in the figures. 
Analyses were separately performed for each frequency range using the 
geometric mean (low, 0.1-0.8 kHz; middle, 0.8-2.5 kHz; high 2.5-8 kHz), and 
comparisons were made between the given conditions. Similar to Tringali et al 
(2010), these three frequency ranges were chosen to investigate the coupling in 
three clinically relevant ranges. For all analyses, an effect size (r) was calculated 
using Equation 1, derived from the t-value and degrees of freedom (df) (Rosnow 
& Rosenthal, 2005). 
Equation 1        √
  
      
 
In a first step, LC intact, LC blue-lined and LC opened conditions were compared 
with each other and with the standard condition. In a second step, the 
additional effect of stapes fixation on top of the LC opened condition was 
investigated (LC opened with stapes fixation). After RW velocity analyses, data 
were re-analyzed taking account of individual variance of cadaver head 
mobility, using LE measurements as a dependent variable. Only outcomes that 
differed from RW velocity analyses were reported. 
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5.4 Results 
5.4.1 Closed-field acoustic transfer functions  
 
Figure 5.2 Closed-field acoustic middle ear transfer function (HTV) at the stapes (a) and 
the RWM (b) in 5 human heads (in dB m/s normalized to 1 Pa). Additionally in panel a, as 
a gray shaded region, the mean and +/- 95% CI of HTV measured in a large population of 
temporal bones is shown, as reported by Rosowski et al. (2007). 
 
HTV was computed in units of dB m/s normalized to acoustic input pressure (Pa) 
(ASTM, 2005). Figure 5.2 depicts stapes and RW velocity as individual curves 
a 
b 
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obtained with a sine signal for each cadaver head, plotted against the range, as 
described by Rosowski et al. (2007) for temporal bones. Both stapes and RW 
transfer functions were comparable. At 1.6 kHz, a mean stapes velocity of -85.8 
dB m/s was in line with findings of previous studies. For RW velocity, a peak of -
81.7 dB m/s was measured at 1.25 kHz, with a second similar peak around 2.5 
kHz. Although a mean stapes velocity in the low frequency range was slightly 
below (<3.5 dB) the 95% confidence interval (CI) of the accepted range 
(Rosowski et al, 2007), these heads were included because the main goal in this 
experimental study was to investigate relative intra-head comparisons for 
different coupling strategies, as mentioned previously. 
5.4.2 LC stimulation  
Coupling of the actuator to the LC was investigated at 1 V RMS through the 
output measured at the RWM level in terms of RW velocity. Figure 5.3 shows 
the mean RW velocity of 5 heads plotted in the frequency domain for the 
different experimental conditions. Measurement variability per condition per 
head was very low (0.8 dB for 3 repetitions) and therefore the average value 
was used. LC intact and LC blue-lined conditions yielded similar findings, with an 
RW velocity above noise level (not shown), but well below output in the 
standard condition, especially in the low and middle frequency range. Means, 
standard deviations and peak values in 3 adjacent frequency ranges (with 
geometric means per frequency range) for the 5 different conditions are 
detailed in Table 5.1. Statistical analysis confirmed that obtained RW velocity 
data were normally distributed for all conditions. Conditions were compared 
using paired samples t-tests, as mentioned before. 
RW velocity was significantly lower in the LC intact condition than the standard 
condition in the low (t(4)= -5.34, p= .006, r= .94) and middle (t(4)= -4.28, p= 
.013, r= .91) frequency range, confirming the added value of direct acoustic 
inner ear stimulation. The same trend was observed for the high frequency 
range, but it was not statistically significant (t(4)= -1.72, p= .16, r= .65). There 
was no impact of blue-lining on coupling efficiency (LC intact vs. blue-lined 
conditions) in the low and middle frequency ranges (low: t(4)= -.60, p= .58, r= 
.29; middle: t(4)= -1.00, p= .37, r= .45). In the high frequency range there was a 
significant difference (t(4)= -4.23, p= .013, r= .90). 
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Figure 5.3 Performance of the DACI in different coupling positions, mean velocity (dB 
m/s) measured at RWM (n=5), with error bars as standard errors. 
 
Table 5.1 Mean (n=5), standard deviation (SD) of RW velocity for the 3 frequency ranges 
and peak value over all frequencies for the 5 measurement conditions (in dB m/s re 1 
Pa). 
Condition Low Mid High Peak 
 Mean SD Mean SD Mean SD  SD 
LC intact -105.6 12.8 -90.8 7.3 -88.4 7.6 -78.0 8.6 
LC blue-lined -103.8 9.7 -90.1 8.1 -86.8 7.5 -79.6 6.6 
LC opened -75.2 11.4 -60.9 17.8 -65.2 11.8 -58.5 17.3 
LC opened +  
stapes fixation 
-79.2 11.3 -57.9 10.0 -59.6 11.6 -56.5 17.0 
Standard -63.2 20.4 -56.6 22.1 -78.2 14.3 -55.7 19.4 
 
When comparing blue-lined and standard conditions, the findings were 
unsurprisingly similar to the LC intact condition. Here again, results were 
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significant in the low (t(4)= -6.28, p= .003, r= .95) and middle (t(4)= -4.43, p= 
.011, r= .91) frequency range, and the same trend, though not significant, was 
found for the high (t(4)= -1.53, p= .20, r= .61) frequency range.  
In the LC opened condition, higher RW velocity was obtained than in the LC 
intact condition for all frequency ranges (low: t(4)= -14.39, p= .001, r= .99; 
middle: t(4)= -3.36, p= .028, r= .86; high: t(4)= -4.24, p= .013, r= .90). The same 
advantage of the LC opened condition was found compared to the LC blue-lined 
condition (low: t(4)= -17.54, p= .001, r= .99; middle: t(4)= -3.32, p= .030, r= .86; 
high: t(4)= -4.06, p= .015, r= .90). 
Both LC opened and standard conditions appeared to have an advantage over 
LC intact and blue-lined conditions. There was no indication of any difference in 
performance of the DACI coupled to the LC or the oval window (low: t(4)= -1.86, 
p= .137, r= .68; middle: t(4)= -.55, p= .609, r= .27; high: t(4)= 1.74, p= .156, r= 
.66). 
5.4.3 Stapes fixation 
Stapes footplate fixation resulted in loss of stapes velocity, with an average 
attenuation of 12 dB (SD = 7 dB) at the stapes (4 heads) and 15 dB (SD = 8 dB) at 
the RW (3 heads), measured via acoustic stimulation. The paired samples test 
revealed a significant difference in stapes velocity in the middle frequency 
range (p=.001), but not in the low or high range. Figure 5.4 shows mean and 
individual attenuation in HTV obtained at the stapes.  
The LC opened with stapes fixation condition investigated the influence of 
induced stapes fixation on LC stimulation with the DACI. Figure 5.3 depicts 
mean RW velocity in the frequency domain for this condition, plotted against 
the other experimental conditions. The paired samples t-test between the LC 
opened condition and the LC opened with stapes fixation condition suggested 
added value of the latter in the low frequency range (t(4)= 3.23, p= .032, r= .85). 
RW velocity was similar in the middle (t(4)= -.536, p= .62, r= .26) and high (t(4)= 
-1.12, p= .32, r= .49) frequency range. Similarly to the LC opened condition, 
higher RW velocity was found in the LC opened with stapes fixation condition 
compared to the LC intact condition (low: t(4)= -11.25, p= .001, r= .98; middle: 
t(4)= -4.55, p= .010, r= .92; high: t(4)= -4.23, p= .013, r= .90) and LC blue-lined 
condition (low: t(4)= -12.86, p= .001, r= .99; middle: t(4)= -4.33, p= .012, r= .91;  
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Figure 5.4 Experimental induced stapes footplate fixation (n=4) shown as mean 
attenuation of HTV for stapes velocity (difference relative to velocity, in dB). 
 
high: t(4)= -3.99, p= .016, r= .90). Direct comparison between the standard 
condition and the LC opened with stapes fixation condition also revealed no 
difference in terms of performance, similarly to the LC opened condition.  
 
5.4.4 Equivalent sound pressure level 
Figure 5.5 demonstrates mean LE and LE,max obtained for all 5 conditions in 3 
frequency ranges. With a peak value of 95.8 equivalent (eq.) dB SPL (SD = 17.9 
dB) in the LC intact condition, DACI stimulation performed less well than 
expected compared to the standard position (LE,max of 126.9 eq. dB SPL, SD = 
20.6). Blue-lining the LC yielded improved output, reaching 105.4 eq. dB SPL (SD 
= 11.4 dB). With LC opened stimulation, an LE,max of 126.2 eq. dB SPL (SD = 9.9 
dB) was reached, comparable with the standard condition. 
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Figure 5.5 Mean (n=5) equivalent sound pressure level output (LE) in response to DACI 
stimulation in different coupling positions with error bars as standard errors. 
 
In case of stapes fixation, DACI stimulation at the opened LC resulted in a peak 
of 124.5 eq. dB SPL (SD = 15.3 dB). As with LC opened stimulation, LC opened 
with stapes fixation also resulted in a shift in resonance frequency and 
improved performance in a wider frequency range at the minor expense of low-
frequency amplitude, compared to the standard condition. Means, standard 
deviations and peak values in 3 adjacent frequency ranges for the 5 different 
conditions are detailed in Table 5.2. 
Calculated LE data were normally distributed for all conditions and all frequency 
ranges. Paired samples t-test showed similar results to RW velocity analyses, 
except in one case. In contrast to RW velocity, which showed a difference 
between the LC intact and LC blue-lined conditions in the high frequency, LE 
analyses revealed added value of the LC blue-lined condition over the LC intact 
condition for the low (t(4)= -3.56, p= .024, r= .87) and high (t(4)= -2.95, p= .042, 
r= .82) frequency range. The same trend was observed for the middle frequency 
range, but it was not statistically significant (t(4)= -2.47, p= .069, r= .78). 
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Table 5.2 Mean (n=5), peak and standard deviation (SD) of equivalent sound pressure 
level for the 3 frequency ranges and 5 conditions (in eq. dB SPL). 
Condition Low Middle High LE,max  
 Mean SD Mean SD Mean SD  SD 
LC intact 72.4 8.1 61.3 21.4 76.8 15.3 95.8 17.9 
LC blue-lined 83.9 10.9 85.3 8.6 95.1 11.9 105.4 11.3 
LC opened 115.9 14.4 119.2 13.0 115.2 9.2 126.2 9.9 
LC opened + stapes 
fixation 
110.5 16.1 115.9 21.0 119.9 13.8 124.5 15.3 
Standard 123.1 22.9 119.8 22.8 102.8 12.2 126.8 20.5 
 
 
5.5 Discussion 
5.5.1 Experiments 
Although the ASTM standard describes a method on temporal bone 
preparations (Rosowski et al, 2007; ASTM, 2005), whole heads were used in this 
experimental study, representative of real-life DACI implantation. Using a 
complete head avoids the possible exclusion of physiological third-windows 
(paths for leakage flow). In the low frequencies, the included heads (except for 
head 6) showed ossicular chain mobility marginally within the criterion of the 
95% CI range of Rosowski’s group. This is consistent with the wide variability 
described before in living humans with normal hearing (Whittemore et al, 
2004). Since the focus of the investigation was on different coupling conditions 
within each head, minor variability between heads was acceptable. In addition, 
by calculating the LE relative to the individual middle ear transfer function, 
intrinsic variability of each head was taken into consideration. As in the study by 
Chatzimichalis et al. (2012), evaluation of DACI performance was derived from 
measured RW velocity. Maier et al. (2013) already remarked that use of RWM 
displacement as an output measure for some input forces requires some degree 
of assumption. Coupling an actuator to the LC, at the side of the scala vestibuli, 
creates a kind of forward stimulation with the RWM acting as a pressure outlet 
(Stieger et al, 2013). Nevertheless, underestimation of equivalent sound 
pressure output is possible to some extent. As discussed further, input 
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impedance of the cochlea does not appear to be changed by DACI application in 
the LC opened condition (though covered with fibrous tissue).  
Taking into account verification by induced stapes footplate fixation performed 
in all heads, mean attenuation was measured via acoustic stimulation with an 
undisrupted ossicular chain in 4 and 3 heads for stapes and RW velocity, 
respectively. A reduction in stapes velocity of at least 30 dB has previously been 
described (Nakajima et al, 2005), and 20 dB for RW velocity, which is more than 
the respective 12 dB and 15 dB reduction in stapes and RW velocity reported in 
our study. One reason for the difference might be that fresh-frozen heads are 
less opted for drying of the dental acrylic; another reason is the creation of a 
third-window. In the LC opened condition, a canalotomy was performed, 
thereby creating a third-window on the side of the scala vestibuli, possibly 
represented by conductive hearing loss in vivo (Merchant & Rosowski, 2008). 
Although this site was covered with fascia and the artificial incus, a certain 
degree of energy loss can occur during fluid displacement. The third-window 
leads to an alternative pressure outlet instead of the pressure difference 
between the oval and round window (Wever et al, 1949), so the impact of 
stapes fixation can be minimized. Feasibility measurement with acoustic 
stimulation in case of stapes fixation was performed in one head, indicating that 
RW velocity is significantly different if the opened LC is covered or not with 
fascia and the actuator (p < 0.001). Further studies are required to investigate 
the effect of LC canalotomy on the magnitude and phase of the middle ear 
transfer function, and on cochlear micromechanics. Use of intracochlear 
pressure sensors, regardless of experimental alterations such as stapes fixation 
or stapedectomy, may help to shed light on in this matter (Olson, 1998; 
Nakajima et al, 2009).  
5.5.2 LC stimulation 
Experimental DACI stimulation at the level of the lateral canal was investigated 
in different conditions. The inertial mode for bone conduction hearing is the 
strongest in the lateral direction when the axis of the vibration coincides with 
the axis of the position of the cochlea (Tonndorf, 1966). Subsequently, the first 
two conditions (LC intact and LC blue-lined) aimed to evaluate DACI 
performance without opening the canal, thereby avoiding limited risks like mild 
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hearing loss (9%), instability or even vertigo, as described for semicircular canal 
plugging procedures (Chen et al, 2010; Ramakrishna et al, 2012). Output 
measured at the RW was, however, insufficient for amplification in either of 
these two conditions. LE analyses, on the other hand, revealed modest but 
significant added value of the LC blue-lined condition over the LC intact 
condition for the low (p= .024) and high (p= .042) frequency range. Once the LC 
was opened, large-spectrum mean output of 116, 119 and 115 eq. dB SPL in the 
lower, middle and higher frequency range, respectively, and a peak output of 
126 eq. dB SPL were obtained. This performance is fully consistent with 
previous temporal bone investigations, such as the study by Maier et al. (2013) 
using 1 V RMS input to an actuator coupled to the RW. With the DACS-PI 
(Phonak Acoustic Implants SA, Switzerland) coupled to the oval window at an 
input of 0.3 V RMS, an LE,max of 110 eq. dB SPL was recorded (Chatzimichalis et 
al, 2012), but higher input voltages were not investigated in this study. As the 
system acts linear, going from 0.3 V to 1 V RMS would mean an increase of 6 dB 
SPL. Interestingly, in the current study, no sharp resonance peak was noted in 
RW velocity with DACI stimulation of the LC, in contrast to standard oval 
window coupling (Bernhard et al, 2011). In standard oval window coupling with 
stapes prosthesis, this resonance peak is damped after the healing process in 
vivo. In addition to increased performance in a wide frequency range, the LC 
stimulation pathway could potentially facilitate fitting issues, circumventing the 
need for damping the peak to avoid overstimulation.  
No loss of DACI performance, stimulating the LC, was observed when the stapes 
footplate was fixed, as revealed by pairwise comparisons (p= .168). Regarding 
RW velocity measurement, stapes fixation resulted in higher values in the high 
frequency range than in the LC opened alone condition (p= .033), although this 
was not confirmed by LE comparisons. This is in line with findings on third-
window stimulation with AMEIs (Lupo et al., 2012) in case of stapes footplate 
fixation. Accordingly, it may be hypothesized that stimulation of a third-
window, in the context of stapes fixation, with an unobstructed round window, 
results in improved impedance at the base of the cochlea. Achieving similar 
peak output to the LC opened condition, the DACI device can be applied in case 
of stapes footplate fixations, such as otosclerosis. It should be noted that phase 
investigations were not taken into account and warrant further study. 
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Unlike conventional DACI coupling after calibrated-hole stapedotomy a 
stapedectomy was performed in the current study, as a laser was not available 
in the temporal bone laboratory. The absence of a stapes footplate resulted in 
lower than expected high-frequency amplification, although the results were 
consistent with RW DACI stimulation and DACI stimulation with a 0.8-mm 
stapes piston (Maier et al, 2013; Chatzimichalis et al, 2012). Neither LC opened 
condition, with or without stapes fixation, showed any significant difference 
compared to the standard condition, demonstrating that in terms of 
performance, LC stimulation after canalotomy with fascia interposition could be 
an alternative for the standard DACI procedure. Compared to an AMEI device 
coupled to the RW (Pennings et al, 2010), much higher velocity values, i.e. peak 
values up to -56 dB m/s versus about -90 dB m/s, were obtained with DACI 
stimulation in both LC opened and standard conditions, confirming the powerful 
output of the investigated implant.  
5.5.3 Clinical implications and future research  
Coupling a powerful acoustic hearing implant to an anatomically easy accessible 
site can have far-reaching clinical implications. As mentioned before, in a 
number of disorders, such as chronic otitis media with tympanosclerosis, radical 
cavities, congenital malformations or advanced otosclerosis, neither the oval 
window nor RW may be available for adequate coupling (Lupo et al, 2012). 
Moreover, if facial nerve exposure and time-consuming surgical actions like 
stapes prosthesis coupling to the actuator are excluded, surgical risks associated 
with the DACI procedure can be minimized (Verhaert et al, 2013a).  
The described LC stimulation technique derives from closed fenestration 
procedures introduced at the beginning of the 20th century by Jenkins and 
Holmgren, and later refined by Sourdille and then by Lempert (1952). Vertigo, 
instability and induced hearing loss are fairly limited in experienced hands. In 
contrast to open fenestration surgery, contact with open air, epidermal growth 
and granulation tissue is avoided, minimizing risks of vertigo or dizziness, similar 
to plugging procedures. Furthermore, the size of the canalotomy in our study 
was only 0.7 mm, and it was covered with fascia. Future research will clearly 
need to investigate long-term biology of the canalotomy, assessing, for 
example, risks of bony tissue regrowth in case of non-stimulation and effects on 
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the vestibular system in the event of non-linearity. It is known that bone 
conduction implants do not affect the vestibular organ. It can therefore be 
assumed that acoustic stimulation, with frequencies above 100 Hz, is well above 
vestibular stimulation frequency range. A shortcoming in this cadaver study is 
that possible non-linear effects causing vertigo cannot be investigated. LC 
fibrosis could potentially hinder the recorded output. Electrophysiological 
measurements, first in animal models as demonstrated in AMEIs in case of 
third-window stimulation (Lupo et al, 2012), then in humans using reliable 
techniques, can provide objective feedback on adequate coupling to the inner 
ear, and also on the correct auditory processing in the cochlea and brainstem 
(Verhaert et al, 2014a). 
Finally, with the development of specially designed drills or robot-controlled 
microdrill that avoid perforation of the membranous labyrinth, results can be 
reproducible and risks well controlled (Coulson et al, 2013). Also, laser-assisted 
calibrated hole techniques can be used for the canalotomy. 
 
5.6 Conclusions 
This study demonstrates the feasibility of LC stimulation with a DACI device for 
severe to profound hearing loss. The surgical techniques of coupling the device 
to the LC with fascia interposition are described. Opening the lateral 
semicircular canal resulted in performance efficiency similar to conventional 
oval window coupling. Stapes fixation did not impede DACI performance at the 
level of the LC. Future studies need to address the long-term effects of LC 
stimulation and its impact on cochlear micromechanics. 
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  Chapter 6
General discussion and conclusions 
An idea, like a ghost, must be spoken to a little before it 
will explain itself. - C.Dickens. 
 
6.1 Summary of research findings 
The general objective of this PhD project was the investigation and 
development of objective measures and a new coupling strategy for direct 
acoustic cochlear stimulation, in addition to the clinical application and 
audiological evaluation of DACI in subjects with severe to profound MHL. 
The core findings of this PhD project are: 
 Systematic review of the current literature revealed that AHIs are 
effective in terms of speech understanding in quiet, patient-reported 
outcome measures and safety regarding residual hearing for the 
treatment of mixed hearing loss. Although already investigated for 
passive percutaneous BCIs to a certain extent, for other acoustic 
hearing implants more comprehensive data are needed on coupling 
strategies to the inner ear and the comparison with best-fitted 
alternatives, certainly with respect to speech understanding in noise 
(Chapter 2). 
 Direct acoustic cochlear stimulation provides a significant 
improvement of the speech perception in quiet and in noise compared 
to the preoperative aided condition. It improves significantly the ability 
of patients to communicate in everyday situations and their quality of 
life (Chapter 3). 
 DACI treatment can be considered a safe and effective hearing 
treatment (Chapter 3). 
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 ABRs and ASSRs can be recorded in subjects with a DACI. 
Electrophysiological thresholds can be determined through the 
combined information of the amplitude response growth function and 
the phase delays of the responses, using a statistical method (Chapter 
4).  
 AEPs latencies were in agreement with electrophysiological auditory 
pathway studies (Chapter 4). 
 DACI stimulation at the level of the lateral semicircular canal (LC), 
investigated in human cadaver heads, can facilitate the surgical 
implantation. Stimulation at an opened LC resulted in an output similar 
to the oval window coupling, confirming its efficiency (Chapter 5). 
 Induced stapes footplate fixation did not impede the DACI output 
when stimulating the opened LC (Chapter 5). 
In the following sections, both clinical as well as experimental topics will be 
discussed separately including remarks or shortcomings, reflections and future 
perspectives. 
6.2 Severe to profound MHL treatment revisited 
Before the introduction of DACIs, the treatment of severe to profound MHL 
mainly consisted of a hearing aid, whether or not in combination with a middle 
ear procedure; in more severe cases a CI was inserted. Other AMEI could not 
provide sufficient output (see Chapter 2). With correct preoperative selection of 
subjects, the DACI treatment can offer an important improvement of speech in 
noise understanding with a relatively short (less than three months) 
rehabilitation period, as shown in Chapter 3. In the current PhD project, the 
device was still under investigational use and implemented in a selected group 
of centers of excellence in hearing implants. From a clinical perspective, several 
issues can be discussed.  
Clinical indication  Especially for advanced otosclerosis, the 
DACI treatment can be added to the ongoing debate between preservation of 
the remaining cochlear function versus a cochlear implantation with electrical 
stimulation. The main point of discussion is the presence of variable results in 
case of stapedotomy alone with HA in comparison to CI (Merkus et al, 2011; 
6.2 Severe to profound MHL treatment revisited 141 
Sheehy, 1978). Despite the fact that CI is associated with a higher chance of 
acceptable speech understanding in quiet, the possibility of retaining acoustic 
hearing, cues for enjoying music and a shorter rehabilitation period persuade 
most ENT-specialists to perform a stapedotomy prior to cochlear implantation. 
In certain studies, a fairly high (38%) risk of facial nerve stimulation has been 
reported for these patients (Rotteveel et al, 2004). On the other hand, some 
reports show a clear improvement in open-set speech understanding in quiet 
with stapedotomy plus HA in more than half of the advanced otosclerosis cases 
(Lachance et al, 2012). In that study, however, only 16 subjects were studied, 
some bilateral. Also, the intensity of the open-set speech understanding testing 
was not defined and no speech in noise scores were provided. As reported in 
Chapter 3, speech in noise understanding results, obtained with DACI 
treatment, with a mean SRT score of + 2.6 dB SNR, are very encouraging. These 
results, however, cannot be extrapolated for comparison with cited CI scores, 
ranging from + 2 to + 16 dB SNR (van Wieringen & Wouters, 2001) because of a 
wide range of profoundly deaf subjects. Important for real-life communication, 
as suggested in Chapter 1, 2 and 3, the improvement of speech in noise 
understanding is very encouraging for such patients. AMEI and BCIs, even the 
most powerful BAHA, cannot overcome 50 dB HL inner ear hearing loss. The 
powerful, large spectrum amplification provided by a DACI surpasses not only 
preoperative best-aided therapy but also alternatives such as a stapedectomy 
plus HA or BCI. As otosclerosis or other causes of MHL equally affects the lower 
frequency hearing, inserting a shorter CI electrode in the cochlea, like in 
electro-acoustic stimulation for the preservation of low frequency hearing, 
would seem less adequate. Also it should be noted that an electrode insertion 
with too flexible electrode arrays can be difficult in case of cochlear otosclerosis 
(Toung et al, 2004).  
So far, all subjects descripted in Chapter 3, except for the one subject with 
additional hearing loss, are wearing their speech processor. Results, also from a 
previous study (Lenarz et al, 2013), indicate stable scores up until now. 
Obviously, longer follow-up period than two to three years is needed to observe 
long-term evolutions. Certainly for slowly progressive advanced otosclerosis 
cases, aided hearing will preserve and enhance spiral ganglion neuron survival, 
important for better CI performance later on (Blamey et al, 2013). Cochlear 
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implantation remains feasible after DACI implantation but cost-effectiveness 
studies are needed to investigate this sequential treatment. With a more rapid 
rehabilitation, less than 3 months as can be understood from Chapter 3, the 
DACI treatment seems advantageous over electrical cochlear implantation, 
especially for certain older patients with less means of training or with mobility 
issues. This hypothesis, however, needs further comparative study. In very 
advanced otosclerosis cases though, with important cochlear reorganization, a 
window of opportunity for CI should be taken into account (Merkus et al, 2011), 
as mentioned before. Future research, for this clinical perspective, should 
include prospective comparisons between stapedotomy plus HA versus DACI 
versus CI.  
DACI fitting PROM indicate a relatively high aversiveness score at three 
months post-activation in Chapter 3, also in comparison to previous reports 
(Lenarz et al, 2013). Aversiveness is related to negative reactions to 
environmental sounds. This score can partially be explained by the relatively 
short measurement point of three months and by necessary improvements to 
be made in the current fitting procedure. The current first fitting session relies 
on the intra-operatively measured transfer function of the implant and on the 
most comfortable loudness level. Because of the healing process, however, in 
some subjects the implant’s transfer function can be altered possibly resulting 
in suboptimal coupling efficiency and unexpected performance results initially. 
Evaluating and adjusting the current fitting rule to real ear measurements, 
similar to the NAL fitting rule, with higher maximum performance possibilities 
and more adequate amplification at the lower intensity of 50 dB SPL, could 
maybe improve patient-reported outcome scores. While also profound hearing 
loss subjects are being implanted, the compensation for certain non-functional 
cochlear regions, known as dead regions, should be taken into account when 
developing new fitting algorithms. Recently, the prevalence of dead regions was 
investigated in new and existing hearing aid users, showing a common (1 out of 
3) but mostly clinically irrelevant presence of a dead region (Pepler et al, 2014). 
Only in 3% of the users, an extensive dead region was present. New insights in 
the pathophysiology of hearing loss, as mentioned in Chapter 1, are to be taken 
into consideration when developing new speech processing algorithms for 
acoustic hearing implants, just as in hearing aids and CIs (Pfingst et al, 2004). As 
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with all newly introduced therapies, a learning curve for surgery and fitting, 
together with an increasing experience from the implanted subjects, is within 
normal expectancy. The stability of the results, probably due to the fixation 
system, is very encouraging. With a very recently updated speech processor and 
gaining clinical experience, scores could equally improve. A longer follow-up 
multicenter study, focusing on the optimization of the fitting parameters, is 
planned for the subjects implanted so far.  
Predictive factors Retrospective analysis of the gathered aspects on 
radiological, audiological and surgical data of 23 subjects from 4 centers 
(Leuven, Antwerp, Hannover, and Nijmegen) is planned in the forthcoming 
months. It is hypothesized that the duration of preoperative HA-use influences 
the audiological outcome of the DACI-user. Very little variability in the surgical 
parameters (width of stapedotomy, type of stapes piston etc.) is being 
observed. One of the few subjects with poor improvement identified in Chapter 
3, despite of uncomplicated DACI surgery and postoperative healing, has been 
diagnosed with auditory neuropathy, explaining his poor outcome. 
Subsequently, tools will have to be evaluated to sharpen the indication range 
and to predict outcome, as this has been done for CI as well in the past. Neural 
degeneration could influence the final speech performance, as in cochlear 
implantation. 
Two ears  Stereophony, considering both ears, has not been taken 
into account sufficiently in this project. Stereophony is regarded as a 
prerequisite for appropriate directional hearing and binaural hearing. In 
Chapter 3, only subjects with contralateral moderate to profound hearing loss 
were included. Known as the Belfast rule of thumb, interaural hearing 
differences play an important role for the degree of success reported by the 
patients themselves after ear surgery (Smyth & Patterson, 1985; Hazenberg et 
al, 2013). Another perspective is the analysis of the binaural cues with the DACI 
device. Although not reported, spatial hearing questionnaires have been 
administered before and after DACI surgery in our single center. Bilateral fitting 
with a HA or another AMEI has been performed in the clinical setting, but data 
gathering is still ongoing presently. Future research on DACI will need to include 
localization tasks, investigating the preservation of fine structure and interaural 
cues, and exploring other possible advantages over cochlear implantation. If 
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reimbursement will be provided, the number of implanted subjects will grow 
and clinical experience will grow rapidly.  
6.3 AEPs for DACI 
As described in Chapter 4, for the first time ABRs and ASSRs have been recorded 
through a digital acoustic hearing implant in humans. With the acoustic 
stimulation setup, stimulation artifacts made it impossible to analyze responses. 
With the direct stimulation setup, using click trains, stimulation artifacts could 
be removed completely, and responses could be successfully recorded in all 
subjects. At this stage, sinusoidally amplitude-modulated stimuli, being more 
frequency-specific, could not yet be used. They provoke unpredictable artifacts 
on the experimental bench setup and therefore they were not applicable in 
vivo. Other more frequency-specific stimuli, such as tone burst or chirps 
(Kristensen & Elberling, 2012), do not provoke unpredictable artifacts with 
direct stimulation when tested on the experimental bench setup. In recent 
studies about auditory threshold determination in adults at a high rate of 
stimulation, chirp stimuli are associated with shorter detection time than a click 
(Elberling et al, 2007). Further methodological study, also with chirps, is needed 
with direct stimulation, similar to electric ASSRs in CI (Hofmann & Wouters, 
2010).  
Electrophysiological thresholds, and their relation to behavioral thresholds, 
have been determined in this study. Mean differences between behavioral and 
electrophysiological thresholds were 12, 19 and 26 dB for electrophysiological 
thresholds based on 40 and 90 Hz ASSRs and ABR peak V, respectively. As a next 
step, correlations between electrophysiological and behavioral thresholds 
should be investigated in a larger study cohort. The reported mean differences 
for ASSRs concur with values reported for acoustic stimulation, indicating an 
overall Pearson correlation up to 0.83 (Alaerts et al, 2010). Even if only 
investigated in a small group of DACI-wearers, potential AEP implementations 
can be developed in the near future. Automatic fitting applications will need 
reliable detection of ASSRs, similar to the challenges of ASSR detection for 
automatic CI fitting in children as suggested before (Hofmann & Wouters, 
2012). But it can be interesting to facilitate the initial postoperative fitting 
session. The device is currently not indicated for children. Future research 
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should therefore mostly focus on recording intra-operative feedback of direct 
cochlear acoustical stimulation, reducing the recording time, and the post-
operative determination of preliminary fitting parameters.  
Another perspective is the development of an electrophysiological alternative 
for current intra-operative measurements. These measurements analyze the 
coupling and performance of the device through velocity measurements done 
with an LDV setup. Other applications, such as middle ear admittance 
measurements, are currently being tested but lack information on the auditory 
system coupling. More frequency-specific stimuli for ASSR recording, such as 
tone bursts or chirps, should be developed to obtain the transfer function of the 
actuator. Using a frequency sweep technique, or by sweeping through different 
values of a stimulus parameter, as demonstrated for visual stimuli by Regan 
(1973), can have interesting applications for recording steady-state responses 
(Picton et al, 2003). If the general shape of the resulting graph is known 
beforehand, the averaged graph can be smoothed to fit this shape. Then the 
sweep technique can be more rapidly recorded and more efficiently than 
multiple individual measurements. Theoretically, the ideal output graph is 
known for each produced DACI implant, for this reason the sweep technique 
can be applied, estimating the correct coupling to the inner ear. Another 
valuable intra-operative application could be ECoG with a direct stimulation 
setup focusing just on the DACI coupling to the cochlea.  
With the indication criteria extending to profound MHL, the development of the 
proposed techniques might also provide an objective measure for the correct 
auditory processing in the cochlea and brainstem for difficult differential 
diagnosis cases. Absent electrophysiological responses during intra-operative 
measurements may be related to insufficient cochlear reserve and pose an 
indication to convert the surgery to a cochlear implantation. As remarked 
before, AEPs have the advantage that they can be recorded both intra- as 
postoperatively and provide information beyond merely the coupling to the 
cochlea, as do ECoG. 
6.4 Lateral canal stimulation  
An important challenge of the DACI treatment is the surgery involved. Although 
stapes surgery is commonly performed, the implantation is overall not an easy 
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procedure. It requires a high level of surgical expertise. In Chapter 5, the 
stimulation of the inner ear through an alternative pathway has been 
investigated experimentally. As a first step, the performance of the device when 
coupled to the LC has been documented by measuring the output at the level of 
the round window. If a reliable stimulation can be developed in this way, then it 
might reshape the landscape of DACI, and possibly AMEI, implantation. The first 
parts of DACI surgery would become easier, as a standard mastoidectomy 
would suffice. Opening the facial recess would become unnecessary, avoiding 
rare risks of facial paralyses due to drilling injuries, exposure or impression on 
the facial nerve (House & Luxford, 1993). In some cases, neither the oval nor 
the round window can be exposed, directing the surgeon to perform a ‘third-
window’ (Pau & Just, 2010). For all the above reasons, the LC stimulation has 
been investigated. Regarding inner ear damage, the proposed surgical 
technique in Chapter 5 can be considered as a safe procedure, similar to 
posterior canal plugging or stapedotomy procedures (Chen et al, 2010; Parnes 
et al, 2003). The reported performance, with a peak performance up to 126 eq. 
dB SPL with LC opened and 125 eq. dB SPL in case of stapes fixation, 
respectively, is well within range for the treatment of severe to profound mixed 
hearing loss. Similar output was achieved in another experiment with RW 
stimulation with a DACS-PI actuator (Maier et al, 2013). Both LC and RW 
stimulation with a DACI achieve higher outputs than experiments that described 
‘third-window’ coupling with an AMEI (Lupo et al, 2012). However, comparisons 
should be interpreted with care due to different stimulation pathways and thus 
different cochlear input impedance. 
A shortcoming of this feasibility study is the lack of in vivo experiments. 
Fenestration surgery, as described by Sourdille and later developed endaurally 
by Lempert in the first half of the 20th century (Shambaugh & Wiet, 1979), was 
associated with frequent reclosing of the canalotomy. Recurrently, spontaneous 
sealing was induced by granulation due to contact with the external air and the 
radical cavity. This could possibly be avoided with the surgical technique 
described in Chapter 5 where contact neither with epidermal tissue nor with 
external air is present. From posterior canal plugging procedures, it could be 
expected that fibrosis in the lumen of the canal occurs at the level of the 
canalotomy. Covering it with fascia can even induce fibrosis. To that end the 
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analysis of short- and long-term biology of this canalotomy in response to 
continuous DACI stimulation remains to be performed in vivo. Its analysis can 
have implications on the DACI outcome reported in this project at long-term. 
Once confirmed in animal studies, the coupling of the DACI to the LC can be 
monitored with electrophysiological methods in humans (as described in 
Chapter 4).  
Another point of future research is the possible impact on vestibular function. 
In Chapter 4 and in Bernhard et al (2011), it has been shown that the DACI 
system provides linear amplification up until high amplitudes and that non-
linear distortion is almost absent. Possible fibrosis at the LC coupling site, 
however, can induce non-linear spreading of acoustic energy, causing vestibular 
symptoms. Experimental study on chinchillas, useful also for 
electrophysiological testing (Lupo et al, 2012), could help elucidating this 
research question. 
Finally, as mentioned in Chapter 5, the impact of creating and stimulating a 
‘third-window’ at the scala vestibule side of the cochlea, albeit covered with 
fascia and the actuator’s tip, should be investigated in terms of cochlear 
mechanisms. Whereas the role of ‘third-window’ has been investigated before 
(Merchant & Rosowski, 2008), our research is the first to report the DACI 
stimulation at this site. Moreover, the impact of a canalotomy on the cochlear 
impedance in case of stapes footplate fixation has not been investigated before. 
For this research question, intra-cochlear pressure sensors may help to shed 
light on this matter (Nakajima et al, 2009; Olson, 1998). 
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Appendix 
A.1 MEDLINE search strategy (Chapter 2) 
#26 (#15 AND #25) 1482 
#25 (#17 OR #19 OR #21 OR #23 OR #24) 14662 
#24 prosthes* AND (middle ear) 2231 
#23 (implant OR implants) AND (middle ear) 2314 
#21 “Cochlear Implants”[Mesh] OR (cochlear implant*) 9628 
#19 “Bone Conduction”[Mesh] OR BAHA OR (bone conduction implant) 3019 
#17 “Ossicular Prosthesis”[Mesh] OR “Ossicular Replacement”[Mesh] 1036 
#15 (#5 OR #7 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14) 12885 
#14 (#5 AND (middle ear malformation)) 71 
#13 tympanosclerosis 409 
#12 (#5 AND (ear abnormalities)) 157 
#11 otoscleros* 5213 
#10 (Otitis Media) AND chronic* 6681 
#9 (“Otitis Media”[Mesh]) AND chronic* 5410 
#7 “Otosclerosis”[Mesh] 4633 
#5 (#2 OR #3 OR #4) 1087 
#4 (hearing loss) AND mixed 1087 
#3 (mixed hearing loss) 1007 
#2 “Hearing Loss, Mixed Conductive-Sensorineural”[Mesh] 165 
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A.2 Study selection (Chapter 2) 
Participants:  Patients > 18 yrs with a mixed hearing loss 
Interventions:   Active middle ear implants OR osseointegrated bone-
conduction implant (BCI) OR cochlear implants OR 
stapedotomy OR ossicular prosthesis OR DACS OR 
conventional hearing aid 
Comparator:  HA (if stated), BCI, none 
Outcomes:   Hearing: pure tone audiogram (PTA) 
Speech in quiet, speech in noise 
Safety (complication rate) 
PROM (patient-reported outcome measures): validated 
questionnaires 
Study design:   Randomized controlled trials, cohort studies, case-control 
trials (also when subjects act as their own controls) 
A.3 Eligibility criteria DACI study (Chapter 3) 
Inclusion criteria 
 Eighteen years of age or older 
 In the ear to be implanted: 
o Severe to profound mixed hearing loss 
o Conductive hearing loss due to otosclerosis, failed stapes surgery 
or other middle ear and/or external ear pathologies and/or 
anomalies 
o Well ventilated middle ear  
o Closed eardrum with normal anatomical position except for outer 
ear canal anomalies 
o Bone conduction thresholds are equal to or worse than 40 dB HL 
and equal to or better than 80 dB HL in the frequencies 0.5 kHz, 1 
kHz, 2 kHz, 3 kHz and 4 kHz 
o  Air-bone-gap is equal to or greater than 20 dB on at least 3 out of 
the 5 frequencies 0.5 kHz, 1 kHz, 2 kHz, 3 kHz and 4 kHz 
 In the contralateral ear: 
o Moderate to profound hearing loss 
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Exclusion criteria 
 Active chronic otitis media, in the ear to be implanted 
 Contraindication for opening of the inner ear, in the ear to be implanted 
 Unwillingness or inability of the subject to comply with all study 
requirements 
 Unrealistic expectations on the part of the subject regarding the possible 
benefits, risks and limitations that are inherent to the procedure and the 
device 
 Medical conditions that would contraindicate undergoing surgery or 
participation in this study 
 Sudden hearing loss 
 Insufficient mastoid and/or ear canal size or too large mastoid cavity (to be 
checked on CT scan) 
 MRI required for any disease follow-up 
 Best aided speech perception in quiet at 65 dB is 75% or more in the ear to 
be implanted 
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